Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

Line-1 inhibitors as cognitive enhancers

Номер патента: US20240285664A1
Опубликовано: 29-08-2024
Автор(ы): Andrew Satlin, Eckard Weber
Принадлежит: Transposon Therapeutics Inc
Получить PDF файл: Открыть в новом окне

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Line-1 inhibitors as cognitive enhancers

Номер патента: EP4346835A1. Автор: Eckard Weber,Andrew Satlin. Владелец: Transposon Therapeutics Inc. Дата публикации: 2024-04-10.

Line-1 inhibitors as cognitive enhancers

Номер патента: AU2022283915A1. Автор: Eckard Weber,Andrew Satlin. Владелец: Transposon Therapeutics Inc. Дата публикации: 2024-01-18.

Line-1 inhibitors as cognitive enhancers

Номер патента: CA3221190A1. Автор: Eckard Weber,Andrew Satlin. Владелец: Transposon Therapeutics Inc. Дата публикации: 2022-12-08.

Line-1 inhibitors as cognitive enhancers

Номер патента: IL309036A. Автор: Eckard Weber,Andrew Satlin. Владелец: Transposon Therapeutics Inc. Дата публикации: 2024-02-01.

Line-1 inhibitors to treat disease

Номер патента: AU2021347247A9. Автор: Claudio Sturino,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics Inc. Дата публикации: 2024-09-05.

Line-1 inhibitors to treat disease

Номер патента: EP4216962A1. Автор: Claudio Sturino,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics Inc. Дата публикации: 2023-08-02.

Line-1 inhibitors to treat disease

Номер патента: WO2022066880A1. Автор: Claudio Sturino,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics, Inc.. Дата публикации: 2022-03-31.

Line-1 inhibitors to treat disease

Номер патента: US20230414616A1. Автор: Claudio Sturino,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics Inc. Дата публикации: 2023-12-28.

Line-1 inhibitors to treat cns and systemic diseases

Номер патента: US20240173346A1. Автор: Eckard Weber,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics Inc. Дата публикации: 2024-05-30.

Line-1 inhibitors to treat cns and systemic diseases

Номер патента: CA3211369A1. Автор: Eckard Weber,Michael Graham Cordingley. Владелец: Transposon Therapeutics Inc. Дата публикации: 2022-09-22.

Line-1 inhibitors to treat cns and systemic diseases

Номер патента: EP4308237A1. Автор: Eckard Weber,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics Inc. Дата публикации: 2024-01-24.

Line-1 inhibitors to treat cns and systemic diseases

Номер патента: AU2022237405A1. Автор: Eckard Weber,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics Inc. Дата публикации: 2023-11-02.

Line-1 inhibitors to treat cns and systemic diseases

Номер патента: IL305869A. Автор: Eckard Weber,Michael G Cordingley. Владелец: Michael G Cordingley. Дата публикации: 2023-11-01.

Viroporins blockers/inhibitors as anti-influenza agents

Номер патента: WO2024127407A1. Автор: Isaiah Arkin,Hiya Lahiri. Владелец: YISSUM Research Development Company of the Hebrew University of Jerusalem LTD.. Дата публикации: 2024-06-20.

Nucleoside line-1 inhibitors

Номер патента: AU2023243106A1. Автор: William Brown,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY,Andrew James BURNIE,Chandra Mohan DARAPANENI,Marco PALADINO,Jigneshkumar Jashbhai PATEL. Владелец: Transposon Therapeutics Inc. Дата публикации: 2024-10-17.

Nucleoside line-1 inhibitors

Номер патента: WO2023192491A2. Автор: William Brown,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY,Andrew James BURNIE,Chandra Mohan DARAPANENI,Marco PALADINO,Jigneshkumar Jashbhai PATEL. Владелец: Transposon Therapeutics, Inc.. Дата публикации: 2023-10-05.

Nucleoside line-1 inhibitors

Номер патента: WO2023192491A3. Автор: William Brown,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY,Andrew James BURNIE,Chandra Mohan DARAPANENI,Marco PALADINO,Jigneshkumar Jashbhai PATEL. Владелец: Transposon Therapeutics, Inc.. Дата публикации: 2023-11-02.

Cdk4/6 inhibitors as a treatment for clonal hematopoiesis

Номер патента: US20240108625A1. Автор: Kelly Bolton. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2024-04-04.

Extract of andrographis paniculata for cognitive enhancement

Номер патента: WO2017204619A1. Автор: Johnson STANSLAS,Dahiru SANI,Hamidon BASRI,Md. Shariful HASAN SUMON,Chee Woei LIM,Charng Choon WONG,Mohd Al-Saufreen AKHIRUDDIN,Audreychee Hui YONG,Brian Patrick KIRBY. Владелец: UNIVERSITI PUTRA MALAYSIA (UPM). Дата публикации: 2017-11-30.

Extract of andrographis paniculata for cognitive enhancement

Номер патента: EP3463407A1. Автор: Johnson STANSLAS,Dahiru SANI,Hamidon BASRI,Md. Shariful HASAN SUMON,Chee Woei LIM,Charng Choon WONG,Mohd Al-Saufreen AKHIRUDDIN,Brian Patrick KIRBY,Audrey Chee Hui YONG. Владелец: UNIVERSITI PUTRA MALAYSIA (UPM). Дата публикации: 2019-04-10.

USE OF DDX3 INHIBITORS AS ANTIPROLIFERATIVE AGENTS

Номер патента: US20190099403A1. Автор: Botta Maurizio,BRAI Annalaura,TINTPRO Cristina,MAGA Glovanni. Владелец: AZIENDA OSPEDALIERA UNIVERSITARIA SENRESE. Дата публикации: 2019-04-04.

Thromboxane synthase inhibitors as antiobesity agents

Номер патента: US4591594A. Автор: Joseph Triscari,Ann C. Sullivan,James G. Hamilton,Lawrence D. Tobias. Владелец: Hoffmann La Roche Inc. Дата публикации: 1986-05-27.

NOVEL DNMT INHIBITOR AS SOLID TUMOR THERAPEUTIC DRUG

Номер патента: US20200061093A1. Автор: MAGOICHI SAKO,USHIJ1MA TOSHIKAZU,HATTORI NAOKO. Владелец: . Дата публикации: 2020-02-27.

Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents

Номер патента: WO2010048731A1. Автор: Christopher John Ong,Nadya Ogloff. Владелец: Nadya Ogloff. Дата публикации: 2010-05-06.

Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents

Номер патента: WO2010048731A8. Автор: Christopher John Ong,Nadya Ogloff. Владелец: Nadya Ogloff. Дата публикации: 2010-07-22.

Preventive or therapeutic agents for myocarditis, dilated cardiomyopathy and heart failure comprising nf-kb inhibitors as active ingredients

Номер патента: CA2350992A1. Автор: Akira Matsumori,Yoichi Nunokawa. Владелец: Individual. Дата публикации: 2001-03-29.

Extract of andrographis paniculata for cognitive enhancement

Номер патента: EP3463407A4. Автор: Johnson STANSLAS,Dahiru SANI,Hamidon BASRI,Md. Shariful HASAN SUMON,Chee Woei LIM,Charng Choon WONG,Mohd Al-Saufreen AKHIRUDDIN,Brian Patrick KIRBY,Audrey Chee Hui YONG. Владелец: UNIVERSITI PUTRA MALAYSIA (UPM). Дата публикации: 2019-11-06.

EXTRACT OF ANDROGRAPHIS PANICULATA FOR COGNITIVE ENHANCEMENT

Номер патента: US20190125814A1. Автор: STANSLAS Johnson,SANI Dahiru,BASRI Hamidon,HASAN SUMON Md. Shariful,LIM Chee Woei,WONG Charng Choon,AKHIRUDDIN Mohd Al-Saufreen,YONG Audrey Chee Hui,KIRBY Brian Patrick. Владелец: UNIVERSITI PUTRA MALAYSIA (UPM). Дата публикации: 2019-05-02.

Viroporins blockers/inhibitors as anti-flaviviruses agents

Номер патента: WO2024009307A1. Автор: Isaiah Arkin,Hiya Lahiri. Владелец: YISSUM Research Development Company of the Hebrew University of Jerusalem LTD.. Дата публикации: 2024-01-11.

Means and methods for identifying a patient having a BRAF-positive cancer as a non-responder to a BRAF inhibitor as a responder to an MAPK/ERK inhibitor

Номер патента: US20190194757A1. Автор: Reinhard DUMMER,Daniel Widmer,Mitchell Paul LEVESQUE,Marieke Ineke Geertje Raaijmakers. Владелец: Universitaet Zuerich. Дата публикации: 2019-06-27.

Composition comprising mir 145 inhibitor as active ingredient for treatment of myocardial infarction

Номер патента: US20240301407A1. Автор: Il Hoan Oh,Hun Jun Park,Bong Woo Park. Владелец: Regen Innopharm Inc. Дата публикации: 2024-09-12.

THERAPEUTIC AGENT FOR CANCER CONTAINING AXL INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20200197385A1. Автор: Tanaka Kohei,YASUHIRO Tomoko. Владелец: ONO PHARMACEUTICAL CO., LTD.. Дата публикации: 2020-06-25.

Pre-Activated Nucleoside IMPDH Inhibitors As Anti-Infective Drugs

Номер патента: US20210353660A1. Автор: Sherden Nathaniel. Владелец: Octagon Therapeutics Inc.. Дата публикации: 2021-11-18.

Composition comprising cd83 inhibitor as effective ingredient for preventing or treating behcet's disease

Номер патента: WO2020054979A1. Автор: 손성향. Владелец: 아주대학교산학협력단. Дата публикации: 2020-03-19.

Use of arginase inhibitor as an agent for slowing down hair loss, eyebrows or eyelashes, and for preventing and treating hair loss of natural origin

Номер патента: FR2973234A1. Автор: Albert Duranton. Владелец: LOreal SA. Дата публикации: 2012-10-05.

Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF

Номер патента: EP1731609A1. Автор: Yasufumi Kaneda. Владелец: GenomIdea Inc. Дата публикации: 2006-12-13.

A Composition for Preventing or Treating Metabolic Disorders Comprising Viperin Inhibitors as Active Ingredients

Номер патента: KR102176937B1. Автор: 서준영,손수진,김일용,서현주,윤슬기,성제경. Владелец: 재단법인 국가마우스표현형분석사업단. Дата публикации: 2020-11-10.

Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF

Номер патента: WO2005095613A1. Автор: Yasufumi Kaneda. Владелец: Genomidea Inc.. Дата публикации: 2005-10-13.

Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF

Номер патента: EP1731609A4. Автор: Yasufumi Kaneda. Владелец: GenomIdea Inc. Дата публикации: 2010-04-07.

Composition comprising mir 145 inhibitor as active ingredient for treatment of myocardial infarction

Номер патента: EP4279091A1. Автор: Il Hoan Oh,Hun Jun Park,Bong Woo Park. Владелец: Regen Innopharm Inc. Дата публикации: 2023-11-22.

Glycosylation inhibitors as therapeutics for stroke

Номер патента: WO2023205124A2. Автор: Napoleone Ferrara,Pin LI. Владелец: The Regents of the University of California. Дата публикации: 2023-10-26.

Glycosylation inhibitors as therapeutics for stroke

Номер патента: WO2023205124A3. Автор: Napoleone Ferrara,Pin LI. Владелец: The Regents of the University of California. Дата публикации: 2023-11-23.

Lsd1 inhibitor, as well as its production method and its application

Номер патента: RU2763898C2. Автор: Ли ЧЖАН,Шухуэй Чэнь,Цзянь ЛИ,Линюнь У,Леле Чжао,Цзяньцзюнь СУНЬ,Чжаого ЧЭНЬ. Владелец: Цспц Чжунци Фармасьютикал Текнолоджи (Шицзячжуан) Ко., Лтд.. Дата публикации: 2022-01-11.

Lsd1 inhibitor, as well as its production method and its application

Номер патента: RU2763898C9. Автор: Ли ЧЖАН,Шухуэй Чэнь,Цзянь ЛИ,Линюнь У,Леле Чжао,Цзяньцзюнь СУНЬ,Чжаого ЧЭНЬ. Владелец: Цспц Чжунци Фармасьютикал Текнолоджи (Шицзячжуан) Ко., Лтд.. Дата публикации: 2022-03-18.

Neddylation-activating enzyme inhibitors as viral sensitizers and uses thereof

Номер патента: WO2024011332A1. Автор: Jean-Simon Diallo,Rozanne ARULANANDAM,Boaz WONG,Anabel BERGERON,Glib Viktorovich MAZNYI. Владелец: Ottawa Hospital Research Institute. Дата публикации: 2024-01-18.

Composition comprising pip4k2c inhibitor as active ingredient for treatment of cancer

Номер патента: US20240316066A1. Автор: Darren Williams,Da-Woon Jung,Hyunju Lee,Eun-mi Jang,Jihee SOH. Владелец: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY. Дата публикации: 2024-09-26.

Disubstituted pyrazolobenzodiazepines used as cdk2 and angiogenesis inhibitors, as well as for treating malignant growths in mammary glands, large intestines, lungs and prostate glands

Номер патента: RU2394826C2. Автор: Цзиньцзунь ЛЮ,Чжумин ЧЖАН,Кин-Чун ЛУК,Джякомо ПИЦЦОЛАТО,И Рэнь,Кшитий Ччабилбхай ТХАККАР,Питер Майкл ВОВКУЛИХ. Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2010-07-20.

Pharmaceutical composition for treating thyroid cancer comprising tyrosine kinase activity inhibitor as active ingredient

Номер патента: US12011447B2. Автор: Byeong Cheol Ahn,Ji Min Oh. Владелец: Industry Academic Cooperation Foundation of KNU. Дата публикации: 2024-06-18.

Muscarinic Agonists as Cognitive Enhancers

Номер патента: US20140045863A1. Автор: JR. William S.,Messer,Ragozzino Michael E.. Владелец: . Дата публикации: 2014-02-13.

Muscarinic agonists as cognitive enhancers

Номер патента: US10835532B2. Автор: William S. Messer, Jr.,Michael E. Ragozzino. Владелец: University of Illinois. Дата публикации: 2020-11-17.

Muscarinic agonists as cognitive enhancers

Номер патента: WO2009140483A1. Автор: William S. Messer, Jr.,Michael Ragozzino. Владелец: University of Illinois at Chicago. Дата публикации: 2009-11-19.

BET INHIBITORS AS A TREATMENT FOR MYELOFIBROSIS

Номер патента: US20220265617A1. Автор: Liu Yu,Esposito Oriana,DAS Sharmila,Aronchik Ida,Nikolova Zariana,Beltran Valencia Roxxana Valeria,Carrancio Anton Maria Soraya,Chang Henry H.,Coker Shodeinde,Filvaroff Ellen Hope,Guarinos Marhuenda Carla,Hanna Bishoy. Владелец: . Дата публикации: 2022-08-25.

THERAPEUTIC AGENT FOR SOLID CANCERS, WHICH COMPRISES AXL INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20200330453A1. Автор: Tanaka Kohei,TAKAYAMA Koichi,YASUHIRO Tomoko,Yamada Tadaaki. Владелец: . Дата публикации: 2020-10-22.

Small molecule wnt inhibitor as treatment for dyslipidemia

Номер патента: US20200360375A1. Автор: Julie Goodwin. Владелец: YALE UNIVERSITY. Дата публикации: 2020-11-19.

Composition for Skin Whitening and Treating Disorders of Melanin Hyperpigmentation Comprising p21-Activated Kinase Inhibitor As Active Ingredient

Номер патента: KR101730595B1. Автор: 신은영,김응국,윤청용. Владелец: 충북대학교 산학협력단. Дата публикации: 2017-05-11.

D-cycloserine and its prodrugs as cognitive enhancers

Номер патента: CA1328617C. Автор: Joseph B. Monahan,Alex A. Cordi,Gail E. Handelmann. Владелец: GD Searle LLC. Дата публикации: 1994-04-19.

Nitrate esters and their use for introducing neuroprotection and cognition enhancement

Номер патента: WO2000054756A3. Автор: Khem Jhamandas,Gregory R J Thatcher,Brian M Bennett,James N Reynolds,Roland J Boegman. Владелец: Univ Kingston. Дата публикации: 2001-01-25.

Nitrate esters and their use for inducing neuroprotection and cognition enhancement

Номер патента: EP1163029A2. Автор: Khem Jhamandas,Gregory R. J. Thatcher,Brian M. Bennett,James N. Reynolds,Roland J. Boegman. Владелец: Queens University at Kingston. Дата публикации: 2001-12-19.

Nitrate esters and their use for inducing neuroprotection and cognition enhancement

Номер патента: EP1163029B1. Автор: Khem Jhamandas,Gregory R. J. Thatcher,Brian M. Bennett,James N. Reynolds,Roland J. Boegman. Владелец: Queens University at Kingston. Дата публикации: 2012-02-22.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: AU2020337054B2. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2024-10-17.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: AU2020337054B9. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2024-11-07.

Venlafaxine in the inducement of cognition enhancement

Номер патента: US5530013A. Автор: Magid A. Abou-Gharbia,G. E. Morris Husbands,Eric A. Muth,John A. Moyer. Владелец: American Home Products Corp. Дата публикации: 1996-06-25.

Venlafaxine and its analogues for inducing cognition enhancement

Номер патента: LV13000B. Автор: George Edward Morris Husbands,Eric Anthony Muth,Magid Abdel-Megid Abou-Gharbia,John Allen Moyer. Владелец: Wyeth Corp. Дата публикации: 2003-07-20.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: US20220288143A1. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2022-09-15.

Pharmaceutical composition for preventing or treating cancer, containing mtor-signaling inhibitor as active ingredient

Номер патента: US20230346762A1. Автор: Seyun KIM,Boah LEE,Seung Ju PARK. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2023-11-02.

PYRIDAZIN-3(2H)-ONE DERIVATIVES AS MONOAMINE OXIDASE SELECTIVE ISOFORM B INHIBITORS (As Amended)

Номер патента: US20180215718A1. Автор: Pedro Besada Pereira,Dolores Viña Castelao,Mª del Carmen TERÁN MOLDES,Tamara COSTAS CAAMAÑO,Mª del Carmen COSTAS LAGO,Noemí Vila Molares. Владелец: Universidade de Vigo. Дата публикации: 2018-08-02.

PYRIDAZIN-3(2H)-ONE DERIVATIVES AS MONOAMINE OXIDASE SELECTIVE ISOFORM B INHIBITORS (As Amended)

Номер патента: US20180215718A1. Автор: TERÁN MOLDES Mª del Carmen,BESADA PEREIRA Pedro,COSTAS CAAMAÑO Tamara,COSTAS LAGO Mª del Carmen,VILA MOLARES Noemí,VIÑA CASTELAO Dolores. Владелец: . Дата публикации: 2018-08-02.

Therapeutic agent for solid cancers, which comprises Axl inhibitor as active ingredient

Номер патента: US11826363B2. Автор: Koichi Takayama,Tadaaki Yamada,Kohei Tanaka,Tomoko Yasuhiro. Владелец: Kyoto Prefectural Public Univ Corp. Дата публикации: 2023-11-28.

Use of xanthine oxidase inhibitors as anti-ischaemic agents

Номер патента: WO1996017610A1. Автор: Surinder Singh,Anthony Edward Lewis. Владелец: British Technology Group Limited. Дата публикации: 1996-06-13.

Therapeutic agent for solid cancers, which comprises axl inhibitor as active ingredient

Номер патента: US20240189300A1. Автор: Koichi Takayama,Tadaaki Yamada,Kohei Tanaka,Tomoko Yasuhiro. Владелец: Kyoto Prefectural PUC. Дата публикации: 2024-06-13.

Composition for preventing or treating ischemia reperfusion injury comprising nadph oxidase 1 inhibitor as active ingredient

Номер патента: EP4140488A4. Автор: Se-Hyun Oh,Jang-Hee Cho,Hee-yeon JUNG. Владелец: Industry Academic Cooperation Foundation of KNU. Дата публикации: 2024-05-15.

FOCAL ADHESION KINASE INHIBITOR AS A THERAPEUTIC AGENT IN DIABETES

Номер патента: US20200046700A1. Автор: Hu Jing,Esni Farzad. Владелец: University of Pittsburgh - of the Commonwealth System of Higher Education. Дата публикации: 2020-02-13.

Pharmaceutical composition containing hdac6 inhibitor as active ingredient for prevention or treatment of itching

Номер патента: US20210077487A1. Автор: Jun Ho Jang,Jeong Ah YOON. Владелец: Bnh Research Co Ltd. Дата публикации: 2021-03-18.

Syk kinase inhibitors as treatment for malaria

Номер патента: US20140309233A1. Автор: Philip S. Low,Francesco Michelangelo Turrini,Kristina Rose Kesely. Владелец: HULOW LLC. Дата публикации: 2014-10-16.

Syk kinase inhibitors as treatment for malaria

Номер патента: US20200345737A1. Автор: Philip S. Low,Antonella Pantaleo,Francesco Michelangelo Turrini,Kristina Rose Kesely. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2020-11-05.

Method of using a cyclooxygenase-2 inhibitor and one or more ornithine decarboxylase inhibitors as a combination therapy in the treatment of neoplasia

Номер патента: US20030203956A1. Автор: Jaime Masterrer. Владелец: Pharmacia LLC. Дата публикации: 2003-10-30.

Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation

Номер патента: CA2304712A1. Автор: Klaus Münter,Michael Kirchengast,Horst Korioth. Владелец: Abbott Gmbh. Дата публикации: 1999-04-08.

Endothelin antagonist imidazole derivatives and renin-angiotensin system inhibitors as combined preparations and process for producing them

Номер патента: HU0004298A3. Автор: . Владелец: Abbott Gmbh & Co Kg. Дата публикации: 2002-06-28.

aminoimidazopyridazine inhibitors as kinase inhibitors

Номер патента: BR112020007557A2. Автор: William J. Pitts,Guanglin Luo,John E. Macor,Jianliang Shi,Carolyn Diane Dzierba,Jason M. Guernon,Steven H. Spergel,Amy C. HART,Michael E. Mertzman. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2020-09-24.

ENDOTHELIN ANTAGONIST AND RENIN-ANGIOTENSIN SYSTEM INHIBITOR AS COMBINATION PRODUCTS

Номер патента: DE59810600D1. Автор: Klaus Muenter,Michael Kirchengast,Horst Korioth. Владелец: Abbott GmbH and Co KG. Дата публикации: 2004-02-19.

Therapeutic agent for solid cancers, which contains axl inhibitor as active ingredient

Номер патента: WO2019074116A1. Автор: ▲高▼山　浩一,忠明 山田,とも子 康廣,昂平 田中. Владелец: 京都府公立大学法人. Дата публикации: 2019-04-18.

Use of COX-2 inhibitors as gastroprokinetics

Номер патента: US20040192694A1. Автор: Alan Naylor,Allen Mangel. Владелец: Mangel Allen Wayne. Дата публикации: 2004-09-30.

Selective PDE 2 inhibitors as medicines to improve perception

Номер патента: DE10122893A1. Автор: Martin Hendrix,Ulrich Niewoehner,Gerhard Koenig,Frank-Gerhard Boess,Toshiya Moriwaki,Rudy Schreiber,Franz-Josef Van Der Staay,Kalr-Heinz Schlemmer,Dagmar Schaus. Владелец: Bayer AG. Дата публикации: 2002-03-21.

combination of antimitotic agent and aurora kinase inhibitor as anticancer treatment.

Номер патента: BRPI0814874A2. Автор: Dawn Basso-Porcaro Andrea. Владелец: Schering Corp. Дата публикации: 2019-09-24.

Syk kinase inhibitors as treatment for malaria

Номер патента: US20230128322A1. Автор: Philip Stewart Low,Antonella Pantaleo,Francesco Michelangelo Turrini,Kristina Rose Kesely. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2023-04-27.

Use of xanthine oxidase inhibitors as anti-ischaemic agents

Номер патента: AU4122396A. Автор: Surinder Singh,Anthony Edward Lewis. Владелец: British Technology Group Ltd. Дата публикации: 1996-06-26.

Use of xanthine oxidase inhibitors as anti-ischaemic agents

Номер патента: AU697643B2. Автор: Surinder Singh,Anthony Edward Lewis. Владелец: British Technology Group Ltd. Дата публикации: 1998-10-15.

Cognition-enhancing selective adenosine receptor agents

Номер патента: IL108750A0. Автор: . Владелец: Merrell Dow Pharma. Дата публикации: 1994-05-30.

Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients

Номер патента: US20120083472A1. Автор: Sang Chul Park,Eui Ju Yeo,Ji Heon Rhim. Владелец: SNU R&DB FOUNDATION. Дата публикации: 2012-04-05.

Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-?B inhibitors as the active ingredient

Номер патента: KR100704152B1. Автор: 누노카와요이치,마쓰모리아키라. Владелец: 다이이치 아스비오파마 가부시키가이샤. Дата публикации: 2007-04-09.

Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing nf-kappa b inhibitors as the active ingredient

Номер патента: EP1132093A4. Автор: Akira Matsumori,Youichi Nunokawa. Владелец: Daiichi Suntory Pharma Co Ltd. Дата публикации: 2006-04-19.

Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing nf-kappa b inhibitors as the active ingredient

Номер патента: EP1132093A1. Автор: Akira Matsumori,Youichi Nunokawa. Владелец: Suntory Ltd. Дата публикации: 2001-09-12.

Method Of Inhibiting Myopia And Application Of An Adenylyl Cyclase Inhibitor As A Drug For inhibiting Myopia

Номер патента: US20120270887A1. Автор: Jia Qu,Xiangtian Zhou,Miaozhen Pan,Yijin TAO. Владелец: SCHOOL OF OPHTHALMOLOGY AND OPTOMETRY WENZHOU MEDICAL COLLEGE. Дата публикации: 2012-10-25.

Method for inhibiting myopia and use of adenylate cyclase inhibitor as drug for inhibiting myopia

Номер патента: EP2589386A4. Автор: Jia Qu,Xiangtian Zhou,Miaozhen Pan,Yijin TAO. Владелец: School Of Optometry & Ophthalmology Wenzhou Medical College. Дата публикации: 2013-06-12.

Method for inhibiting myopia and use of adenylate cyclase inhibitor as drug for inhibiting myopia

Номер патента: EP2589386B1. Автор: Jia Qu,Xiangtian Zhou,Miaozhen Pan,Yijin TAO. Владелец: School of Opthalmology & Optometry Wenzhou Medical College. Дата публикации: 2015-06-17.

Method for inhibiting myopia and use of adenylate cyclase inhibitor as drug for inhibiting myopia

Номер патента: EP2589386B8. Автор: Jia Qu,Xiangtian Zhou,Miaozhen Pan,Yijin TAO. Владелец: School of Opthalmology & Optometry Wenzhou Medical College. Дата публикации: 2015-08-26.

Method of inhibiting myopia and application of an adenylyl cyclase inhibitor as a drug for inhibiting myopia

Номер патента: US9084791B2. Автор: Jia Qu,Xiangtian Zhou,Miaozhen Pan,Yijin TAO. Владелец: SCHOOL OF OPHTHALMOLOGY AND OPTOMETRY WENZHOU MEDICAL COLLEGE. Дата публикации: 2015-07-21.

A2a antagonists as cognition and motor function enhancers

Номер патента: KR20130143597A. Автор: 스테펜 아이. 반닥,케빈 제이. 블랙,메건 씨. 캠벨. Владелец: 바이오티 세라피스, 인크.. Дата публикации: 2013-12-31.

A2A Antagonists as Cognition and Motor Function Enhancers

Номер патента: US20130317019A1. Автор: Bandak Stephen I.,Black Kevin J.,Campbell Meghan C.. Владелец: BIOTIE THERAPIES, INC.. Дата публикации: 2013-11-28.

A2a antagonists as cognition and motor function enhancers

Номер патента: CA2816834A1. Автор: Stephen I. Bandak,Kevin J. Black,Meghan C. Campbell. Владелец: Biotie Therapies Inc. Дата публикации: 2012-05-10.

Polyamine transport inhibitors as antivirals

Номер патента: US20220071928A1. Автор: John Connor,Otto Phanstiel, Iv. Владелец: Boston University. Дата публикации: 2022-03-10.

Pyrrolidine Main Protease Inhibitors as Antiviral Agents

Номер патента: US20240158368A1. Автор: David A. Degoey,Eric R. Miller,Timothy R. HODGES,Michael R. Schrimpf,Gregory A. Gfesser,Andrew Bogdan,Robert G. Schmidt,Xenia B. Searle,Edgars JECS,David J. Hardee,Justin D. DIETRICH,Alberto Munoz,Jacob LUDWIG,Sarah J. PERLMUTTER,Alvin JANG,Elizabeth L. NOEY,Boguslaw P. NOCEK,Huan-Qiu X. Li. Владелец: AbbVie Inc. Дата публикации: 2024-05-16.

1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof

Номер патента: US09951040B2. Автор: Suresh Kumar,Ram Asrey Vishwakarma,Thanusha THATIKONDA,Umed SINGH,Priya MAHAJAN,Girish Mahajan,Amit NARGOTRA,Fayaz Malik,Dilip Manikrao Mondhe,Parvinder Pal SINGH. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2018-04-24.

BCL6 inhibitors as anticancer agents

Номер патента: US09943506B2. Автор: Fengtian Xue,Alexander D. Mackerell,Ari Melnick,Leandro Carlos A. Cerchietti,Mariano G. Cardenas. Владелец: University of Maryland at Baltimore. Дата публикации: 2018-04-17.

Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors

Номер патента: CA2703519C. Автор: Greg E. Lemke,Carla V. Rothlin. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 2017-04-18.

ANIMAL TRAINING USING COGNITIVE ENHANCEMENT

Номер патента: US20160113938A1. Автор: Rahman Muhit. Владелец: . Дата публикации: 2016-04-28.

Hemp Oil / Magnesium Preparation for Cognitive-Enhancement and Reduction of Stress and Inflammation

Номер патента: US20200397717A1. Автор: Timothy McCoy Marshall. Владелец: Food Technology And Design Bda Foodpharma LLC. Дата публикации: 2020-12-24.

Benzoperhydroazepinone compounds as glycogen phosphorylase inhibitors as well as preparation method and medical application thereof

Номер патента: CN103497181A. Автор: 张丽颖. Владелец: Chengde Medical University. Дата публикации: 2014-01-08.

Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer

Номер патента: WO2008028903A2. Автор: Dan Peters,Jeppe Kejser Christensen,Bjarne H. Dahl,Gunnar M. Olsen,Daniel B. Timmermann,Steven Charles Loechel. Владелец: NEUROSEARCH A/S. Дата публикации: 2008-03-13.

pyrimidine compound substituted by bicyclic group, its use as a pde-5 inhibitor, as well as pharmaceutical formulation comprising said compound

Номер патента: BR112015003232B1. Автор: Wu Frank,Wang Aichen. Владелец: Xuanzhu Pharma Co Ltd. Дата публикации: 2020-04-07.

Nutraceutical formulation of a cognitive enhancement system

Номер патента: US20060211721A1. Автор: Alan Roberts. Владелец: Roberts Alan R. Дата публикации: 2006-09-21.

Animal training using cognitive enhancement

Номер патента: US9999203B2. Автор: Muhit Rahman. Владелец: Pohela LLC. Дата публикации: 2018-06-19.

Therapeutic combination for cognition enhancement and psychotic disorders

Номер патента: CA2549638A1. Автор: Steven Joseph Romano. Владелец: Steven Joseph Romano. Дата публикации: 2005-07-14.

Pharmaceutical composition for preventing or treating cancer comprising naphthoquinone-based compound and immune checkpoint inhibitor as active ingredients

Номер патента: US20230255904A1. Автор: Tae Hwan Kwak,Hong Seob So. Владелец: Nadianbio Ltd. Дата публикации: 2023-08-17.

Hemp Oil/Magnesium Preparation for Cognitive-Enhancement and Reduction of Stress and lnflammation

Номер патента: US20230372265A1. Автор: Timothy McCoy Marshall. Владелец: Fp Nutraceuticals LLC. Дата публикации: 2023-11-23.

New braf inhibitors as paradox breakers

Номер патента: CA3158541A1. Автор: Daniel Hunziker,Juergen Wichmann,Cosimo Dolente,David Stephen HEWINGS,Daniela Krummenacher,Piergiorgio Francesco Tommaso PETTAZZONI. Владелец: Individual. Дата публикации: 2021-06-17.

New braf inhibitors as paradox breakers

Номер патента: EP4073044A1. Автор: Daniel Hunziker,Juergen Wichmann,Cosimo Dolente,David Stephen HEWINGS,Daniela Krummenacher,Piergiorgio Francesco Tommaso PETTAZZONI. Владелец: F Hoffmann La Roche AG. Дата публикации: 2022-10-19.

Pharmaceutical composition for preventing or treating cancer comprising naphthoquinone-based compound and immune checkpoint inhibitor as active ingredients

Номер патента: AU2021305584A8. Автор: Tae Hwan Kwak,Hong Seob So. Владелец: Nadianbio Ltd. Дата публикации: 2023-03-09.

USE OF TAM RECEPTOR INHIBITORS AS IMMUNOENHANCERS AND TAM ACTIVATORS AS IMMUNOSUPPRESSORS

Номер патента: US20190134193A1. Автор: Rothlin Carla V.,Lemke Greg E.. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 2019-05-09.

HETEROCYCLIC AMIDES AS RIP1 KINASE INHIBITORS AS MEDICAMENTS

Номер патента: US20170266199A1. Автор: GOUGH Peter J.,BERGER Scott B.,WEISEL Kathleen M.. Владелец: . Дата публикации: 2017-09-21.

Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors

Номер патента: EP2902495A1. Автор: Greg E. Lemke,Carla V. Rothlin. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 2015-08-05.

ALK kinase inhibitor as well as preparation method and application thereof

Номер патента: CN105294654A. Автор: 石全,张德仪,张锐豪,仲伯禹,董加强,袁宏斌,储少松. Владелец: Beijing Purunao Biotechnology Co Ltd. Дата публикации: 2016-02-03.

heterocyclic amides as rip1 kinase inhibitors as drugs

Номер патента: BR112017003546A2. Автор: M Weisel Kathleen,J Gough Peter,B Berger Scott. Владелец: Glaxosmithkline Ip Dev Ltd. Дата публикации: 2017-12-05.

Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors

Номер патента: EP2219671A4. Автор: Carla V Rothlin,Greg E Lemke. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 2011-02-09.

NEW ASSOCIATION OF A SINUSAL CURRENT INHIBITOR IF AND OF A CALCIUM INHIBITOR AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING IT.

Номер патента: ES2356660T3. Автор: Vidal Benatar,Guy Lerebours-Pigeonniere. Владелец: Laboratoires Servier SAS. Дата публикации: 2011-04-12.

Bromodomain inhibitor as an adjuvant in antitumor immunotherapybromodomain inhibitor as an adjuvant in antitumor immunotherapy

Номер патента: RU2745999C1. Автор: Эдуардо М. СОТОМЭЙЕР,Джеймс БРЭДНЕР,Цзяньго ТАО. Владелец: Х. Ли Моффитт Кэнсер Сентер Энд Рисёч Инститьют, Инк.. Дата публикации: 2021-04-05.

Bcl6 inhibitors as anticancer agents

Номер патента: WO2014204859A3. Автор: Fengtian Xue,Alexander D. Mackerell,Ari Melnick,Leandro Carlos A. Cerchietti,Mariano G. Cardenas. Владелец: Mackerell Alexander D. Дата публикации: 2015-02-12.

Bcl6 inhibitors as anticancer agents

Номер патента: US20160166549A1. Автор: Fengtian Xue,Alexander D. Mackerell,Ari Melnick,Leandro Carlos A. Cerchietti,Mariano G. Cardenas. Владелец: University of Maryland at Baltimore. Дата публикации: 2016-06-16.

Highly potent tacc3 inhibitor as a novel anticancer drug candidate

Номер патента: WO2020018039A3. Автор: Ozge Akbulut,Ozgur Sahin,Erden BANOGLU,Burcu CALISKAN,Deniz LENGERLI. Владелец: Sahin Oezguer. Дата публикации: 2020-03-19.

Highly potent tacc3 inhibitor as a novel anticancer drug candidate

Номер патента: EP3801529A2. Автор: Ozge Akbulut,Deniz LENGERL,Erden BANO LU,Burcu ÇALI KAN,Özgür AH N. Владелец: A2A Pharmaceuticals Inc. Дата публикации: 2021-04-14.

Bromodomain inhibitor as adjuvant in cancer immunotherapy

Номер патента: US20170360801A1. Автор: James Bradner,Eduardo M. Sotomayor,Jianguo Tao. Владелец: Moffitt Cancer Center And Research Institute Inc. Дата публикации: 2017-12-21.

Bromodomain inhibitor as adjuvant in cancer immunotherapy

Номер патента: EP3226898A1. Автор: James Bradner,Eduardo M. Sotomayor,Jianguo Tao. Владелец: H Lee Moffitt Cancer Center and Research Institute Inc. Дата публикации: 2017-10-11.

Bromodomain inhibitor as adjuvant in cancer immunotherapy

Номер патента: IL252636A0. Автор: . Владелец: H Lee Moffitt Cancer Ct & Res. Дата публикации: 2017-07-31.

New BRAF inhibitors as paradox breakers

Номер патента: AU2020403082A1. Автор: Daniel Hunziker,Juergen Wichmann,Cosimo Dolente,David Stephen HEWINGS,Daniela Krummenacher,Piergiorgio Francesco Tommaso PETTAZZONI. Владелец: F Hoffmann La Roche AG. Дата публикации: 2022-05-12.

Trpv4 inhibitor as a therapeutic agent for ocular diseases

Номер патента: US20230255965A1. Автор: Eiji Sugaru,Hideaki Hara,Shuzo Watanabe,Masamitsu Shimazawa,Kentaro Ohara. Владелец: Raqualia Pharma Inc. Дата публикации: 2023-08-17.

Potent dual brd4-kinase inhibitors as cancer therapeutics

Номер патента: US20190055203A1. Автор: Ernst SCHÖNBRUNN,Nicholas J. Lawrence,Harshani R. LAWRENCE. Владелец: H Lee Moffitt Cancer Center and Research Institute Inc. Дата публикации: 2019-02-21.

Trpv4 inhibitor as therapeutic drug for eye disease

Номер патента: EP4183415A4. Автор: Eiji Sugaru,Hideaki Hara,Shuzo Watanabe,Masamitsu Shimazawa,Kentaro Ohara. Владелец: Raqualia Pharma Inc. Дата публикации: 2024-07-17.

Enpp1 inhibitors as inhibitors of metastasis

Номер патента: EP4422639A1. Автор: Jackie Papkoff,James Johnston,Randolph Mellus Johnson,Neil A. Verity,Nigel RAY. Владелец: Angarus Therapeutics Inc. Дата публикации: 2024-09-04.

Prostaglandin d2 production inhibitors as preventative and therapeutic agents for sarcopenia

Номер патента: EP3782648B1. Автор: Masaki Inada,Daisuke Kajiwara. Владелец: Tokyo University of Agriculture and Technology NUC. Дата публикации: 2024-09-18.

TYROSINE KINASE INHIBITORS AS ANTI-KINETOPLASTID AND ANTI-APICOMPLEXAN AGENTS

Номер патента: US20130072484A1. Автор: Mensa-Wilmot Kojo. Владелец: University of Georgia Research Foundation, Inc.. Дата публикации: 2013-03-21.

FtsZ INHIBITORS AS POTENTIATORS OF BETA-LACTAM ANTIBIOTICS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS

Номер патента: US20130203726A1. Автор: LEE Sang Ho,ROEMER TERRY,Jarantow Lisa Wang. Владелец: . Дата публикации: 2013-08-08.

USE OF TAM RECEPTOR INHIBITORS AS ANTIMICROBIALS

Номер патента: US20130251734A1. Автор: YOUNG John A.T.,Rothlin Carla V.,Lemke Greg E.,Bhattacharyya Suchita. Владелец: The Salk Institute for Biological Studies. Дата публикации: 2013-09-26.

HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS

Номер патента: US20180016243A1. Автор: Botta Maurizio,Martinez Javier,MEYERHANS Andreas,MARTINEZ DE LA SIERRA Miguel-Angel,BRAI Annalaura,FAZI Roberta,TINTORI Cristina,ARAQUE Jose-Este. Владелец: . Дата публикации: 2018-01-18.

ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS

Номер патента: US20210015807A1. Автор: Michaud Joris,POYDENOT PAULINE,FLAENDER MÉLANIE,DUCHEMIN-PELLETIER EVE,SELIG LUC. Владелец: . Дата публикации: 2021-01-21.

FIRST-IN-CLASS OF SHMT2 AND MTHFD2 INHIBITORS AS ANTITUMOR AGENTS

Номер патента: US20210047332A1. Автор: Gangjee Aleem,Matherly Larry H.. Владелец: . Дата публикации: 2021-02-18.

POLYAMINE TRANSPORT INHIBITORS AS ANTIVIRALS

Номер патента: US20220071928A1. Автор: Phanstiel,IV Otto,Connor John. Владелец: . Дата публикации: 2022-03-10.

POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Номер патента: US20190055203A1. Автор: Lawrence Harshani R.,Lawrence Nicholas J.,SCHÖNBRUNN Ernst. Владелец: . Дата публикации: 2019-02-21.

USE OF ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Номер патента: US20170100368A1. Автор: Cox David,KREMER Alton,MCGONIGLE Sharon,WU Jiayi. Владелец: . Дата публикации: 2017-04-13.

HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS

Номер патента: US20200140398A1. Автор: Botta Maurizio,Martinez Javier,MEYERHANS Andreas,MARTINEZ DE LA SIERRA Miguel-Angel,BRAI Annalaura,FAZI Roberta,TINTORI Cristina,ARAQUE Jose-Este. Владелец: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE. Дата публикации: 2020-05-07.

Bcl6 inhibitors as anticancer agents

Номер патента: US20160166549A1. Автор: Fengtian Xue,Alexander D. Mackerell,Ari Melnick,Leandro Carlos A. Cerchietti,Mariano G. Cardenas. Владелец: University of Maryland at Baltimore. Дата публикации: 2016-06-16.

COMPOSITION FOR PROLIFERATION, DIFFERENTIATION PROMOTION, OR SENESCENCE INHIBITION OF STEM CELLS, CONTAINING JAK1 INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20190183900A1. Автор: Kim Sang-Yoon,KIM Seong-Who,LEE Hyang-Ju. Владелец: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION. Дата публикации: 2019-06-20.

Highly potent tacc3 inhibitor as a novel anticancer drug candidate

Номер патента: US20210220369A1. Автор: Ozge Akbulut,Ozgur Sahin,Erden BANOGLU,Burcu CALISKAN,Deniz LENGERLI. Владелец: A2A Pharmaceuticals Inc. Дата публикации: 2021-07-22.

POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Номер патента: US20170226065A1. Автор: Lawrence Harshani R.,Lawrence Nicholas J.,SHÖNBRUNN Ernst. Владелец: . Дата публикации: 2017-08-10.

Composition comprising flt3 inhibitor as effective ingredient for inhibiting drug resistance in chronic myelogenous leukemia

Номер патента: US20210252009A1. Автор: Hyun Woo Park,Jieun Shin. Владелец: Industry Academic Cooperation Foundation of Yonsei University. Дата публикации: 2021-08-19.

PERFORIN-2 ACTIVATORS AND INHIBITORS AS DRUG TARGETS FOR INFECTIOUS DISEASE AND GUT INFLAMMATION

Номер патента: US20160250303A1. Автор: Podack Eckhard R.,McCormack Ryan. Владелец: . Дата публикации: 2016-09-01.

PHARMACEUTICAL COMPOSITION FOR TREATING THYROID CANCER COMPRISING TYROSINE KINASE ACTIVITY INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20200246341A1. Автор: AHN Byeong Cheol,OH Ji Min. Владелец: Kyungpook National University Industry-Academic Cooperation Foundation. Дата публикации: 2020-08-06.

Selective c-FLIP Inhibitors as Anticancer Agents

Номер патента: US20190282563A1. Автор: GUILLAUDEUX THIERRY,Bonnet Pascal,Daniellou Richard,YAACOUB Katherine,LAFITE Pierre,ACI-SECHE Samia. Владелец: . Дата публикации: 2019-09-19.

NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF

Номер патента: US20170342049A1. Автор: Kumar Suresh,Mondhe Dilip Manikrao,NARGOTRA Amit,MAHAJAN Priya,VISHWAKARMA Ram Asrey,MAHAJAN Girish,SINGH Parvinder Pal,Thatikonda Thanusha,Singh Umed,Malik Fayaz. Владелец: . Дата публикации: 2017-11-30.

Pharmaceutical Composition comprising c-Met kinase inhibitor as active ingredient for preventing or treating toxoplasma gondii infection

Номер патента: KR102304573B1. Автор: 남호우. Владелец: 가톨릭대학교 산학협력단. Дата публикации: 2021-09-27.

The bicyclic dihydropyrimidinonesand and its purposes of the inhibitor as Neutrophil elastase activity being substituted

Номер патента: CN104995186B. Автор: C·格纳姆,T·奥斯特,S·彼得斯,H·霍希,U·J·赖斯. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2017-06-20.

Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy

Номер патента: US20040053900A1. Автор: Jaime Masferrer. Владелец: Pharmacia LLC. Дата публикации: 2004-03-18.

Use of tam receptor inhibitors as antimicrobials

Номер патента: EP2902494A1. Автор: John A. T. Young,Greg E. Lemke,Carla V. Rothlin,Suchita Bhattacharyya. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 2015-08-05.

Skp2 inhibitor as a novel anti-cancer agent

Номер патента: KR101769911B1. Автор: 임현석,오미숙. Владелец: 포항공과대학교 산학협력단. Дата публикации: 2017-08-21.

Pharmaceutical Composition comprising VEGFR2 inhibitor as active ingredient for preventing or treating toxoplasma gondii infection

Номер патента: KR102301217B1. Автор: 남호우. Владелец: 가톨릭대학교 산학협력단. Дата публикации: 2021-09-10.

Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation

Номер патента: US20020037276A1. Автор: Gillian M. Beattie,Alberto Hayek,Andrzej Ptasznik. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2002-03-28.

A composition for inhibiting tolerance of a drug for cml comprising an flt3 inhibitor as an active ingredient

Номер патента: KR102282304B1. Автор: 박현우,신지은. Владелец: 연세대학교 산학협력단. Дата публикации: 2021-07-28.

Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes

Номер патента: CA2496292A1. Автор: Frank Wunder,Martin Hendrix,Frank-Gerhard Boess,Christina Erb,Marja Van Kampen. Владелец: Individual. Дата публикации: 2004-04-01.

Selective c-FLIP inhibitors as anticancer agents

Номер патента: AU2017360029A1. Автор: Pascal Bonnet,Samia ACI-SECHE,Richard Daniellou,Thierry Guillaudeux,Pierre LAFITE,Katherine YAACOUB. Владелец: Universite dOrleans. Дата публикации: 2019-05-23.

Medicament for prevention or treatment of fibrosis having chymase inhibitor as effective ingredient

Номер патента: CA2368366A1. Автор: Harukazu Fukami,Hideki Okunishi,Eiichi Kakizoe. Владелец: Individual. Дата публикации: 2001-08-30.

Novel 1,3,5 -triazine based pi3k inhibitors as anticancer agents and a process for the preparation thereof

Номер патента: EP3221307A1. Автор: Suresh Kumar,Ram Asrey Vishwakarma,Thanusha THATIKONDA,Umed SINGH,Priya MAHAJAN,Girish Mahajan,Amit NARGOTRA,Fayaz Malik,Dilip Manikrao Mondhe,Parvinder Pal SINGH. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2017-09-27.

Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents

Номер патента: CA2783701A1. Автор: Li-An Yeh,John Scott,Alfred Williams,Matthew R. Redinbo,Sridhar Mani,Bret David Wallace,Kimberly Terry Lane. Владелец: NORTH CAROLINA CENTRAL UNIVERSITY. Дата публикации: 2011-06-16.

The piperidine derivative of the spiro-condensed of inhibitor as kidney medulla externa potassium channel

Номер патента: CN104540826B. Автор: 于洋,顾新,唐海峰,江金龙,丁法祥,董书志,J.弗里,A.帕斯特纳克,吴志才,T.苏祖基. Владелец: Schering Corp. Дата публикации: 2018-04-20.

Use of eribulin and poly (adp ribose) polymerase (parp) inhibitors as combination therapy for the treatment of cancer

Номер патента: WO2015184145A1. Автор: David Cox,Jiayi Wu,Alton KREMER,Sharon MCGONIGLE. Владелец: Eisai R&D Management Co., Ltd.. Дата публикации: 2015-12-03.

Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient

Номер патента: CA2701880A1. Автор: Yoshikazu Sugimoto,Kazuki Sakamoto. Владелец: Kazuki Sakamoto. Дата публикации: 2009-04-16.

Alk5 inhibitors as skeletal muscle hypertrophy inducers

Номер патента: WO2019180269A1. Автор: Pauline POYDENOT,Joris MICHAUD,Mélanie FLAENDER,Eve DUCHEMIN-PELLETIER,Luc Selig. Владелец: Cytoo. Дата публикации: 2019-09-26.

The substitution chromene derivative of selective double inhibitor as PI3 δ and γ protein kinase

Номер патента: CN106661029B. Автор: 斯瓦鲁普·库马尔·文卡塔·萨蒂亚·瓦卡拉恩卡,普拉尚特·卡希纳特·巴瓦. Владелец: Rhizen Pharmaceuticals SA. Дата публикации: 2019-04-05.

Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient

Номер патента: EP2204192A4. Автор: Yoshikazu Sugimoto,Kazuki Sakamoto. Владелец: Taiho Pharmaceutical Co Ltd. Дата публикации: 2011-12-21.

Use of DDX3 inhibitors as antiproliferative agents

Номер патента: US11000512B2. Автор: Maurizio Botta,Annalaura BRAI,Cristina TINTORI,Giovanni Maga. Владелец: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE. Дата публикации: 2021-05-11.

First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents

Номер патента: US11384084B2. Автор: Aleem Gangjee,Larry H. Matherly. Владелец: Duquesne Univ of Holy Spirit. Дата публикации: 2022-07-12.

The Pyrazolopyrimidine derivative of inhibitor as bruton's tyrosine kinase

Номер патента: CN106661035B. Автор: 马修·考尔德,尼古拉斯·E·S·格伊索特. Владелец: Limited By Share Ltd Roxo Oncology. Дата публикации: 2019-11-19.

Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents

Номер патента: WO2004017950A2. Автор: Michael Waterfield,Peter Parker. Владелец: Piramed Limited. Дата публикации: 2004-03-04.

New hif-1-alpha inhibitor, method for production thereof, and pharmaceutical composition for preventing or treating angiogenesis-associated eye diseases, containing said inhibitor as an active component

Номер патента: RU2770027C1. Автор: Ёнгер СО,Сонпом ЛИ,Чонхун КИМ. Владелец: СЕУЛЬСКИЙ НАЦИОНАЛЬНЫЙ УНИВЕРСИТЕТ РэндДБ ФАУНДЕЙШН. Дата публикации: 2022-04-14.

Use of tam receptor inhibitors as antimicrobials

Номер патента: CA2703621C. Автор: John A. T. Young,Greg E. Lemke,Carla V. Rothlin,Suchita Bhattacharyya. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 2022-03-22.

E-protein channel blockers and ORF3 inhibitors as anti-COVID-19agents

Номер патента: CN115867265A. Автор: I·阿尔金,P·P·辛格托马,M·克鲁格利亚克. Владелец: Yissum Research Development Co of Hebrew University of Jerusalem. Дата публикации: 2023-03-28.

E protein channel blockers and orf3 inhibitors as anti-covid-19 agents

Номер патента: CA3177537A1. Автор: Isaiah Arkin,Prabhat Pratap SINGH TOMAR,Miriam KRUGLIAK. Владелец: Exonhit SA. Дата публикации: 2021-11-04.

Use of stat-6 inhibitors as therapeutic agents

Номер патента: AU2001294515A1. Автор: Dennis A. Carson,Lorenzo M. Leoni,Howard B Cottam,Sylvie Barchechath. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2002-02-25.

Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient

Номер патента: CN101820914A. Автор: 坂本一树,杉本芳一. Владелец: Taiho Pharmaceutical Co Ltd. Дата публикации: 2010-09-01.

Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents

Номер патента: AU2003255845A1. Автор: Michael Waterfield,Peter Parker. Владелец: Piramed Ltd. Дата публикации: 2004-03-11.

Composition for proliferation, differentiation promotion, or senescence inhibition of stem cells, containing jak1 inhibitor as active ingredient

Номер патента: WO2017155325A1. Автор: 김상윤,이향주,김승후. Владелец: 울산대학교 산학협력단. Дата публикации: 2017-09-14.

Use of tam receptor inhibitors as antimicrobials

Номер патента: US20100247554A1. Автор: Greg E. Lemke,Carla V. Rothlin,Suchita Bhattacharyya,John A.T. Young. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 2010-09-30.

Perforin-2 activators and inhibitors as drug targets for infectious disease and gut inflammation

Номер патента: KR20160061423A. Автор: 엑카드 포닥,라이안 맥코르맥. Владелец: 더 유니버시티 오브 마이애미. Дата публикации: 2016-05-31.

Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient

Номер патента: EP1192950A1. Автор: Naohiro Watanabe,Harukazu Fukami,Yoshiaki Fukuda,Yoshiaki Tomimori. Владелец: Suntory Ltd. Дата публикации: 2002-04-03.

Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents

Номер патента: US9334288B2. Автор: Matthew R. Redinbo. Владелец: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL. Дата публикации: 2016-05-10.

Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents

Номер патента: US8557808B2. Автор: Li-An Yeh,John Scott,Alfred Williams,Matthew R. Redinbo,Sridhar Mani,Bret David Wallace,Kimberly Terry Lane. Владелец: NORTH CAROLINA CENTRAL UNIVERSITY. Дата публикации: 2013-10-15.

Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes

Номер патента: US8455502B2. Автор: Frank Wunder,Martin Hendrix,Christina Erb,Marja Van Kampen,Frank-Gerhard Boss. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2013-06-04.

5- (N- [6,5]-fused bicyclic aryl tetrahydroisoquinoline -6- bases) pyridin-3-yl acetogenin of inhibitor as human immunodeficiency virus replication

Номер патента: CN108137553A. Автор: 汪涛,J.F.卡多,B.N.奈杜,尹志伟,张钟兴. Владелец: ViiV Healthcare UK No 5 Ltd. Дата публикации: 2018-06-08.

Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient

Номер патента: EP1192950A4. Автор: Naohiro Watanabe,Harukazu Fukami,Yoshiaki Fukuda,Yoshiaki Tomimori. Владелец: Suntory Ltd. Дата публикации: 2003-01-22.

Pharmaceutical composition for preventing, improving or treating atopic dermatitis comprising novel inflammasome inhibitor as an active ingredient

Номер патента: KR20230043774A. Автор: 성승용. Владелец: (주)샤페론. Дата публикации: 2023-03-31.

Novel BRAF inhibitors as paradox blockers

Номер патента: JP2023505300A. Автор: コジモ ドレンテ，,デーヴィッド スティーブン ヘウィングス，,ダニエル フンツィカー，,ダニエラ クルメナッハ，,ピエルジョルジョ フランチェスコ トンマゾ ペッタッツォーニ，,ユルゲン ヴィヒマン，. Владелец: エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト. Дата публикации: 2023-02-08.

Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes

Номер патента: WO2004026286A3. Автор: Kampen Marja Van,Frank Wunder,Martin Hendrix,Frank-Gerhard Boess,Christina Erb. Владелец: Christina Erb. Дата публикации: 2004-06-03.

Antiviral composition containing epidermal growth factor receptor inhibitor as active ingredient

Номер патента: WO2022005204A1. Автор: 황인수,김성준,신혜진,이선희,김해수,정지욱,김범태,권영찬,안대균,김천생,김균도,구근본,윤건영. Владелец: 한국화학연구원. Дата публикации: 2022-01-06.

Ezh2 and androgen receptor signaling inhibitors as tools for targeting prostate cancer

Номер патента: WO2020139943A1. Автор: Patrick Trojer,William D. Bradley,John McGrath,Adrian SENDEROWICZ. Владелец: CONSTELLATION PHARMACEUTICALS, INC.. Дата публикации: 2020-07-02.

Highly potent tacc3 inhibitor as a novel anticancer drug candidate

Номер патента: US20210220369A1. Автор: Ozge Akbulut,Ozgur Sahin,Erden BANOGLU,Burcu CALISKAN,Deniz LENGERLI. Владелец: A2A Pharmaceuticals Inc. Дата публикации: 2021-07-22.

Highly potent tacc3 inhibitor as a novel anticancer drug candidate

Номер патента: EP3801529B1. Автор: Ozge Akbulut,Ozgur Sahin,Erden BANOGLU,Burcu CALISKAN,Deniz LENGERLI. Владелец: A2A Pharmaceuticals Inc. Дата публикации: 2023-10-11.

Neurotrophic tyrosine receptor kinase inhibitors as therapeutics for liver disease

Номер патента: WO2023230454A1. Автор: SHUANG Wang,Scott Friedman. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2023-11-30.

New braf inhibitors as paradox breakers

Номер патента: ZA202204092B. Автор: Daniel Hunziker,Juergen Wichmann,Cosimo Dolente,David Stephen HEWINGS,Daniela Krummenacher,Piergiorgio Francesco Tommaso PETTAZZONI. Владелец: Hoffmann La Roche. Дата публикации: 2022-12-21.

New braf inhibitors as paradox breakers

Номер патента: IL292349A. Автор: . Владелец: Hoffmann La Roche. Дата публикации: 2022-06-01.

Pharmaceutical composition for preventing or treating cancer comprising naphthoquinone-based compound and immune checkpoint inhibitor as active ingredients

Номер патента: EP4180034A4. Автор: Tae Hwan Kwak,Hong Seob So. Владелец: Nadianbio Ltd. Дата публикации: 2024-01-03.

Therapeutic agent used for graft-versus-host disease, containing interleukin-6 receptor inhibitor as active ingredient

Номер патента: RU2490025C2. Автор: Масахико МИХАРА,Йоитиро МОРИЯ. Владелец: Чугаи Сейяку Кабусики Кайся. Дата публикации: 2013-08-20.

Pharmaceutical composition for preventing or treating cancer, containing cd300e inhibitor as active ingredient

Номер патента: EP3805258A1. Автор: Joo-Yeon Chung,Areum Jeong,Youn Kyung Houh,Jinyoung Sohn,Yun Yeon Kim,Suro Lee,Kyoung Wan YOON,Bu-Nam JEON. Владелец: Genome and Co. Дата публикации: 2021-04-14.

Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient

Номер патента: US09752151B2. Автор: Jin Sun Kim,Jai Hee Moon,Bong Cheol Kim,Eun kyung Choi,Tae Won Kim,Seung Woo Hong,Ky Youb Nam,Dong Hoon Jin,Jae Sik Shin,Yong Sang HONG,Kyung Ah Jung,Jung Shin Lee,Jae Lyun Lee,Kyu Pyo Kim. Владелец: Asan Foundation. Дата публикации: 2017-09-05.

Reversible method for sustainable human cognitive enhancement

Номер патента: US20220000988A1. Автор: John Lawrence Mee. Владелец: Individual. Дата публикации: 2022-01-06.

Methods for sustainable human cognitive enhancement

Номер патента: US20210393796A1. Автор: John Lawrence Mee. Владелец: Cognigenics Inc. Дата публикации: 2021-12-23.

Adjustable method for sustainable human cognitive enhancement

Номер патента: WO2019226476A1. Автор: John Mee. Владелец: John Mee. Дата публикации: 2019-11-28.

Composition for preventing or treating cancer comprising msh2 or msh6 inhibitor as active ingredient

Номер патента: EP4385524A1. Автор: Suk-Woo Nam,Min Jeong NA. Владелец: Neornat. Дата публикации: 2024-06-19.

Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer

Номер патента: EP4427755A1. Автор: Jung-Joon Min,Yeongjin Hong,Sung-Hwan YOU,Nguyen Dinh Huy. Владелец: Cncure Biotech Inc. Дата публикации: 2024-09-11.

Production of organoid derived from ctc of small cell lung cancer patient, and igf1r inhibitor as a molecular target drug for small cell lung cancer

Номер патента: EP4403186A1. Автор: Hiroyuki Yasuda,Toshiro Sato,Takahiro Fukushima,Koichi Fukunaga,Toshiki EBISUDANI,Junko HAMAMOTO. Владелец: KEIO UNIVERSITY. Дата публикации: 2024-07-24.

Pharmaceutical composition for preventing or treating fabry disease, containing TSP1 protein inhibitor as active ingredient

Номер патента: AU2019352379A1. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2021-05-06.

Composition for preventing or treating diseases caused by overexpression of chemokine cx3cl1, containing death receptor inhibitor as active ingredient

Номер патента: US20230159650A1. Автор: Donghyun Kim,Eugene C. Yi,Min Jueng Kang,Doo Hyun CHUNG,Dongjin Jeong. Владелец: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION. Дата публикации: 2023-05-25.

Composition for preventing or treating diseases caused by overexpression of chemokine CX3CL1, containing death receptor inhibitor as active ingredient

Номер патента: US12091465B2. Автор: Donghyun Kim,Eugene C. Yi,Min Jueng Kang,Doo Hyun CHUNG,Dongjin Jeong. Владелец: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION. Дата публикации: 2024-09-17.

Compositions and particles containing cellulosic fibers and stabilized- and/or activated-urease inhibitors, as well as methods of making and using the same

Номер патента: CA2687995C. Автор: Gopal C. Goyal,Zheng Tan,Linnea J. Shaver. Владелец: International Paper Co. Дата публикации: 2015-04-21.

Pharmaceutical composition for preventing and treating metabolic disease comprising MKRN1 expression or activity inhibitor as an active ingredient

Номер патента: US10696970B2. Автор: Jae Whan SONG,Min Sik LEE. Владелец: Industry Academic Cooperation Foundation of Yonsei University. Дата публикации: 2020-06-30.

Pharmaceutical composition for preventing or treating cancer comprising LRIT2 inhibitor as active ingredient

Номер патента: US11787870B2. Автор: Joo-Yeon Chung,Areum Jeong,Youn Kyung Houh,Jinyoung Sohn,Yun Yeon Kim,Suro Lee,Kyoung Wan YOON,Bu-Nam JEON. Владелец: Genome and Co. Дата публикации: 2023-10-17.

Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer

Номер патента: AU2022382621A1. Автор: Jung-Joon Min,Yeongjin Hong,Sung-Hwan YOU,Nguyen Dinh Huy. Владелец: Cncure Biotech Inc. Дата публикации: 2024-05-30.

Use of composition for enhancing anticancer effect, comprising err.gamma. inhibitor as active ingredient

Номер патента: CA3159428C. Автор: Mi Jin Kim,Sung Jin Cho,Dong Su Kim,In Kyu Lee,Yong Hyun Jeon,Hoe Yune Jung,Jin A Kim,Yeon Kyung Choi,Keun Gyu Park,Jung Wook Chin. Владелец: Novmetapharma Co Ltd. Дата публикации: 2024-05-28.

Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer

Номер патента: CA3236831A1. Автор: Jung-Joon Min,Yeongjin Hong,Sung-Hwan YOU,Nguyen Dinh Huy. Владелец: Individual. Дата публикации: 2023-05-11.

Pharmaceutical composition for preventing or treating fabry disease, containing tsp1 protein inhibitor as active ingredient

Номер патента: EP3848039A1. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2021-07-14.

Pharmaceutical composition for preventing or treating fabry disease, containing tsp1 protein inhibitor as active ingredient

Номер патента: CA3114875A1. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2020-04-09.

Anticancer agent containing rhoa peptide inhibitor as an active ingredient

Номер патента: US20230086119A1. Автор: Jae Gyu Kim,Jae Bong PARK. Владелец: El Med. Дата публикации: 2023-03-23.

Composition for treating retinal or choroidal diseases, containing acta2 inhibitor as active ingredient

Номер патента: US20230392150A1. Автор: Soo Jin Kim,Junyeop LEE. Владелец: Asan Foundation. Дата публикации: 2023-12-07.

Histone deacetylase inhibitors as therapeutic agents for Niemann-Pick type C disease

Номер патента: US9333222B2. Автор: Olaf Wiest,Frederick R. Maxfield,Paul Helquist. Владелец: University of Notre Dame . Дата публикации: 2016-05-10.

Heparanase Inhibitor as Anti-Viral and Immunomodulatory Therapy

Номер патента: US20220401468A1. Автор: Jingyu XIANG,Katherine Weilbaecher. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2022-12-22.

Hyaluronidase inhibitors as anti-cancer agents

Номер патента: WO2008140500A8. Автор: Vinata B Lokeshwar. Владелец: Vinata B Lokeshwar. Дата публикации: 2009-02-05.

PHARMACEUTICAL COMPOSITION INCLUDING AN HIF-2 ALPHA INHIBITOR AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ARTHRITIS

Номер патента: US20130236531A1. Автор: Chun Jang-Soo,Yang Si Young. Владелец: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY. Дата публикации: 2013-09-12.

Nkx2.2 inhibitors as drugs

Номер патента: US20140005249A1. Автор: Dominique Joubert,Rosette Lidereau,Jean-Philippe Hugnot,Ivan Bieche,Luc Bauchet,Valerie Rigau,Pierre-Olivier Guichet,Marisa Teigell. Владелец: Centre Hospitalier Universitaire de Montpellier CHUM. Дата публикации: 2014-01-02.

ENDOMUCIN INHIBITOR AS AN ANTI-ANGIOGENIC AGENT

Номер патента: US20210163955A1. Автор: "DAmore Patricia A.",Saint-Geniez Magali,Park-Windhol Cindy. Владелец: . Дата публикации: 2021-06-03.

Heparanase Inhibitor as Anti-Viral and Immunomodulatory Therapy

Номер патента: US20220401468A1. Автор: XIANG Jingyu,Weilbaecher Katherine. Владелец: WASHINGTON UNIVERSITY. Дата публикации: 2022-12-22.

Endomucin inhibitor as an anti-angiogenic agent

Номер патента: US10883108B2. Автор: Patricia A. D'Amore,Magali Saint-Geniez,Cindy Park-Windhol. Владелец: Schepens Eye Research Institute Inc. Дата публикации: 2021-01-05.

Nkx2.2 inhibitors as drugs

Номер патента: EP2596013A1. Автор: Dominique Joubert,Rosette Lidereau,Jean-Philippe Hugnot,Luc Bauchet,Valerie Rigau,Pierre-Olivier Guichet,Marisa Teigell,Yvan Bieche. Владелец: Centre Hospitalier Universitaire de Montpellier CHUM. Дата публикации: 2013-05-29.

Endomucin inhibitor as an anti-angiogenic agent

Номер патента: WO2017173327A1. Автор: Patricia A. D'Amore,Magali Saint-Geniez,Cindy Park-Windhol. Владелец: The Schepens Eye Research Institute, Inc.. Дата публикации: 2017-10-05.

Hyaluronidase inhibitors as anti-cancer agents

Номер патента: WO2008140500A3. Автор: Vinata B Lokeshwar. Владелец: Vinata B Lokeshwar. Дата публикации: 2008-12-31.

Orthosiphon stamineus extracts with beneficial use as cognition enhancer

Номер патента: EP2515923A1. Автор: Matthias Gehling,Philipp Wabnitz,Joachim Hans,Torsten Grothe,Tengku Shahrir Tengku Adnan,Rozita Zamri,Annie George V.K. George. Владелец: BIOTROPICS MALAYSIA BERHAD. Дата публикации: 2012-10-31.

Orthosiphon stamineus extracts with beneficial use as cognition enhancer

Номер патента: WO2011078652A1. Автор: Matthias Gehling,Philipp Wabnitz,Joachim Hans,Torsten Grothe,Tengku Shahrir Tengku Adnan,Rozita Zamri,Annie George V.K. George. Владелец: BIOTROPICS MALAYSIA BERHAD. Дата публикации: 2011-06-30.

Gsno reductase inhibitor as an adjunct therapy with remote ischemic conditioning and thrombolytic reperfusion therapies in stroke

Номер патента: US20220062264A1. Автор: Farid Ahmed,Syed Kashif Zaidi,Md. Nasrul Hoda,Muhammad Hussain Al-Qahtani,Heba Al Khatabi. Владелец: KING ABDULAZIZ UNIVERSITY. Дата публикации: 2022-03-03.

Gsno reductase inhibitor as an adjunct therapy with remote ischemic conditioning and thrombolytic reperfusion therapies in stroke

Номер патента: US20220062262A1. Автор: Syed Kashif Zaidi,Md. Nasrul Hoda,Muhammad Hussain Al-Qahtani. Владелец: KING ABDULAZIZ UNIVERSITY. Дата публикации: 2022-03-03.

Histone deacetylase inhibitors as therapeutics for neurological diseases

Номер патента: EP1951656A1. Автор: Ryan Burnett,Joel M. Gottesfeld,David M. Herman,Kai Jenssen,C. James Chou. Владелец: Scripps Research Institute. Дата публикации: 2008-08-06.

Methods for Alzheimer'S disease treatment and cognitive enhancement

Номер патента: US9446020B2. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2016-09-20.

Methods for Alzheimer's Disease treatment and cognitive enhancement

Номер патента: US6825229B2. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2004-11-30.

Cdki pathway inhibitors as selective inhibitors of tumor cell growth

Номер патента: WO2007133772A3. Автор: Donald Porter,Bey-Dih Chang,Igor B Roninson. Владелец: Igor B Roninson. Дата публикации: 2008-11-20.

Development and optimization of thiochromenothiazole-based msut2 inhibitors as candidates for the treatment of tauopathy

Номер патента: US20240342139A1. Автор: Brian Kraemer. Владелец: US Department of Veterans Affairs VA. Дата публикации: 2024-10-17.

Aromatase inhibitors as novel veterinary drugs

Номер патента: EP1399158A1. Автор: Kalevi Heinonen. Владелец: VETCARE OY. Дата публикации: 2004-03-24.

Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases

Номер патента: EP1330240A2. Автор: Masakazu Sato,Shigeru Okuyama,Kazuya Kameo,Noriyuki Miyata,Richard J. Roman,David R. Harder. Владелец: Medical College of Wisconsin Research Foundation Inc. Дата публикации: 2003-07-30.

Aromatase inhibitors as novel veterinary drugs

Номер патента: WO2002087571A1. Автор: Kalevi Heinonen. Владелец: VETCARE OY. Дата публикации: 2002-11-07.

Novel drp-1 inhibitors as therapeutic agents

Номер патента: US20240294481A1. Автор: Adel Nefzi,Stephen Black,Kim TIEU. Владелец: Florida International University FIU. Дата публикации: 2024-09-05.

Polyamine transport inhibitors as novel therapeutics

Номер патента: US09730902B2. Автор: Otto Phanstiel, Iv,Jennifer J. Archer. Владелец: University of Central Florida Research Foundation Inc UCFRF. Дата публикации: 2017-08-15.

A brd4 inhibitor as well as a preparative method and use thereof

Номер патента: CA3107895C. Автор: Fei Wang,Yuanwei Chen,Lei Fan,Xiaoquan WU,Kexin Xu,Tongchuan LUO,Shaohua Zhang,Yongxu HUO,Xinghai Li,Ke Chen,Zhilin TU. Владелец: Hinova Pharmaceuticals Inc. Дата публикации: 2024-01-02.

GSNO reductase inhibitor as an adjunct therapy in cerebral thrombosis and/or thromboembolic stroke

Номер патента: US11260051B1. Автор: Syed Kashif Zaidi,Md. Nasrul Hoda,Muhammad Hussain Al-Qahtani. Владелец: KING ABDULAZIZ UNIVERSITY. Дата публикации: 2022-03-01.

A brd4 inhibitor as well as a preparative method and use thereof

Номер патента: CA3107895A1. Автор: Fei Wang,Yuanwei Chen,Lei Fan,Xiaoquan WU,Kexin Xu,Tongchuan LUO,Shaohua Zhang,Yongxu HUO,Xinghai Li,Ke Chen,Zhilin TU. Владелец: Hinova Pharmaceuticals Inc. Дата публикации: 2020-01-30.

METHODS FOR ALZHEIMER'S DISEASE TREATMENT AND COGNITIVE ENHANCEMENT

Номер патента: US20130281522A1. Автор: Alkon Daniel L.,Etcheberrigaray Rene. Владелец: . Дата публикации: 2013-10-24.

METHODS FOR ALZHEIMER'S DISEASE TREATMENT AND COGNITIVE ENHANCEMENT

Номер патента: US20160051509A1. Автор: Alkon Daniel L.,Etcheberrigaray Rene. Владелец: . Дата публикации: 2016-02-25.

ANIMAL TRAINING USING COGNITIVE ENHANCEMENT

Номер патента: US20170181408A1. Автор: Rahman Muhit. Владелец: . Дата публикации: 2017-06-29.

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Номер патента: US20160199356A1. Автор: Abraham Brent D.,Copp Richard R.,Farnham James G.,Hanson Seth A.,Hendrickson Michael L.,Ockuly Jeffrey C.,Twose Trevor M.,Verdone Melinda L.. Владелец: . Дата публикации: 2016-07-14.

COMPOUNDS FOR COGNITIVE ENHANCEMENT AND METHODS OF USE THEREOF

Номер патента: US20160272587A1. Автор: WANG Tong,Huentelman Matthew,Dunckley Travis. Владелец: . Дата публикации: 2016-09-22.

Compounds and Compositions for Cognition-Enhancement, Methods of Making, and Methods of Treating

Номер патента: US20170313687A1. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: NEUROSOLIS Inc. Дата публикации: 2017-11-02.

Azaindolizinone derivatives and cognitive enhancers comprising the same as effective components

Номер патента: CA2387719C. Автор: Naoki Fukuda,Yoshimasa Yamaguchi,Toshiyuki Matsuno,Seiichiro Kawashima,Kenichi Saitoh,Masaya Higashi. Владелец: Zenyaku Kogyo KK. Дата публикации: 2010-04-27.

Azaindolizinone derivatives and cognitive enhancers comprising the same as effective components

Номер патента: CA2387719A1. Автор: Naoki Fukuda,Yoshimasa Yamaguchi,Toshiyuki Matsuno,Seiichiro Kawashima,Kenichi Saitoh,Masaya Higashi. Владелец: Individual. Дата публикации: 2001-02-08.

Methods for Alzheimer's Disease Treatment and Cognitive Enhancement

Номер патента: US20100029744A1. Автор: Daniel Alkon. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2010-02-04.

Medicament for the inducement of cognition enhancement

Номер патента: EP1245228A3. Автор: George Edward Morris Husbands,Eric Anthony Muth,Magid Abdel-Megid Abou-Gharbia,John Allen Moyer. Владелец: WYETH LLC. Дата публикации: 2002-10-09.

Compounds and compositions for cognition-enhancement, methods of making, and methods of treating

Номер патента: US8853219B2. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: NEUROSOLIS Inc. Дата публикации: 2014-10-07.

Methods for Alzheimer's Disease treatment and cognitive enhancement

Номер патента: US20050037984A1. Автор: Daniel Alkon,Rene Etcheberrigaray. Владелец: Rene Etcheberrigaray. Дата публикации: 2005-02-17.

Cognitive enhancing compositions containing d-cycloserine

Номер патента: IL88531A. Автор: . Владелец: Searle & Co. Дата публикации: 1993-02-21.

Compounds for cognitive enhancement and methods of use thereof

Номер патента: WO2015070170A1. Автор: Tong Wang,Matthew Huentelman,Travis Dunckley. Владелец: Td2 Inc.. Дата публикации: 2015-05-14.

Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

Номер патента: EP1478399A1. Автор: Rango Dietrich,Hartmut Ney,Klaus Eistetter. Владелец: ALTANA PHARMA AG. Дата публикации: 2004-11-24.

Methods for alzheimer's disease treatment and cognitive enhancement

Номер патента: AU2003220096A1. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2003-09-22.

Compounds and compositions for cognition-enhancement, methods of making, and methods of treating

Номер патента: WO2011085406A1. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: MITHRIDION, INC.. Дата публикации: 2011-07-14.

Method for alzheimer's disease treatment and cognitive enhancement

Номер патента: JP2013010767A. Автор: Daniel L Alkon,ダニエル・エル．・アルコン. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2013-01-17.

Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient

Номер патента: CA2827869C. Автор: Kazuo Tsubota,Miho Maeda,Hideyuki Okano,Akiyoshi Kishino,Shigeto Shimmura,Masahiro Omoto. Владелец: Sumitomo Dainippon Pharma Co Ltd. Дата публикации: 2019-04-02.

Methods for Alzheimer's Disease treatment and cognitive enhancement

Номер патента: US9345685B2. Автор: Daniel Alkon. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2016-05-24.

Medicament for the inducement of cognition enhancement

Номер патента: EP1245228A2. Автор: George Edward Morris Husbands,Eric Anthony Muth,Magid Abdel-Megid Abou-Gharbia,John Allen Moyer. Владелец: WYETH LLC. Дата публикации: 2002-10-02.

Foam cell specific Liver X Receptor (LXR) alpha agonist, SIRT1 inhibitors as well as p300 inhibitors as pharmaceutically active agents

Номер патента: EP2759295A1. Автор: Sascha Sauer,Radmila Feldmann,Anne Geikowski,Susanne Holzhauser. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2014-07-30.

Methods for alzheimer's disease treatment and cognitive enhancement

Номер патента: EP1490050A2. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2004-12-29.

Orthosiphon stamineus extracts for use as a cognition enhancer

Номер патента: TW201125569A. Автор: Matthias Gehling,Philipp Wabnitz,Joachim Hans,Torsten Grothe,K George Annie George V,Adnan Tengku Shahrir Tengku,Rozita Zamri. Владелец: BIOTROPICS MALAYSIA BERHAD. Дата публикации: 2011-08-01.

Azaindolizinone derivatives and cognitive enhancers comprising the same as effective components

Номер патента: EP1219621B1. Автор: Seiichiro Kenkyusho Of Zenyaku K.K.K. Kawashima,Toshiyuki Kenkyusho Of Zenyaku K.K.K. Matsuno,Naoki Kenkyusho Of Zenyaku Kogyo K.K. Fukuda,Kenichi Kenkyusho Of Zenyaku Kogyo K.K. Saitoh,Yoshimasa Kenkyusho Of Zenyaku Kogyo Kk Yamaguchi,Masaya Kenkyusho Of Zenyaku Kogyo K.K. Higashi. Владелец: Zenyaku Kogyo KK. Дата публикации: 2003-10-22.

Use of fatty acid oxidation inhibitors as antimicrobials

Номер патента: US20240000774A1. Автор: Kathryn Moore,Pallavi Chandra,Jennifer A. Philips,Mireille Ouimet. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2024-01-04.

BRD4 inhibitor as well as a preparative method and use thereof

Номер патента: US20210147419A1. Автор: Fei Wang,Yuanwei Chen,Lei Fan,Xiaoquan WU,Kexin Xu,Tongchuan LUO,Shaohua Zhang,Yongxu HUO,Xinghai Li,Ke Chen,Zhilin TU. Владелец: Hinova Pharmaceuticals Inc. Дата публикации: 2021-05-20.

Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient

Номер патента: US20130345265A1. Автор: DIETRICH Rango,NEY Hartmut,EISTETTER Klaus. Владелец: TAKEDA GMBH. Дата публикации: 2013-12-26.

Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient

Номер патента: US20140031396A1. Автор: DIETRICH Rango,NEY Hartmut,EISTETTER Klaus. Владелец: TAKEDA GMBH. Дата публикации: 2014-01-30.

Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient

Номер патента: US20140031397A1. Автор: Rango Dietrich,Hartmut Ney,Klaus Eistetter. Владелец: TAKEDA GMBH. Дата публикации: 2014-01-30.

Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient

Номер патента: US20150290178A1. Автор: DIETRICH Rango,NEY Hartmut,EISTETTER Klaus. Владелец: . Дата публикации: 2015-10-15.

Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient

Номер патента: US20150290179A1. Автор: DIETRICH Rango,NEY Hartmut,EISTETTER Klaus. Владелец: . Дата публикации: 2015-10-15.

Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient

Номер патента: US20150290180A1. Автор: DIETRICH Rango,NEY Hartmut,EISTETTER Klaus. Владелец: . Дата публикации: 2015-10-15.

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

Номер патента: US20060269600A1. Автор: Rango Dietrich,Hartmut Ney,Klaus Eistetter. Владелец: ALTANA PHARMA AG. Дата публикации: 2006-11-30.

Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

Номер патента: KR101253033B1. Автор: 디트리히랑고,아이스테터클라우스,나이하르트무트. Владелец: 다케다 게엠베하. Дата публикации: 2013-04-11.

pharmaceutical composition comprising a dpp-iv inhibitor, as well as a process for its preparation

Номер патента: BRPI0911273B8. Автор: Braun Michael,FRIEDL Thomas,NISHIOKA Takaaki,EGUSA Kenji,FUJITA Hikaru,MARUYAMA Megumi. Владелец: Boehringer Ingelheim Int. Дата публикации: 2021-05-25.

A pharmaceutical composition comprising a DPP-IV inhibitor as well as a process for its preparation.

Номер патента: BRPI0911273B1. Автор: Megumi Maruyama,Thomas Friedl,Michael Braun,Kenji Egusa,Hikaru Fujita,Takaaki Nishioka. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2019-07-16.

Indoleamine 2,3-dioxygenase inhibitor as well as preparation method and application thereof

Номер патента: CN106883193B. Автор: 包如迪,喻红平,徐耀昌,赵志明,黄志强,李凯龙,吴盛华,郭凤英,潘忠宗. Владелец: Shanghai Hansoh Biomedical Co Ltd. Дата публикации: 2021-10-15.

Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

Номер патента: KR101386843B1. Автор: 랑고 디트리히,클라우스 아이스테터,하르트무트 나이. Владелец: 다케다 게엠베하. Дата публикации: 2014-04-17.

Benzofuroxan histone deacetylase inhibitor as well as preparation method and application thereof

Номер патента: CN104592145B. Автор: 张颖杰,徐文方,段文文. Владелец: Shandong University. Дата публикации: 2017-05-17.

Oral pharmaceutical form containing a PDE 4 inhibitor as active ingredient and polyvinylpyrrolidone as an excipient

Номер патента: ES2384378T3. Автор: Rango Dietrich,Hartmut Ney,Klaus Eistetter. Владелец: NYCOMED GMBH. Дата публикации: 2012-07-04.

Protein complex acid phosphatase inhibitor as well as preparation method and purpose of protein complex acid phosphatase inhibitor

Номер патента: CN102675199B. Автор: 张军,罗都强. Владелец: Hebei University. Дата публикации: 2013-09-11.

APPLICATION OF ERIBULIN AND mTOR INHIBITORS AS A COMBINED THERAPY FOR TREATMENT OF MALIGNANT NORMAL FORMATION

Номер патента: RU2016136504A. Автор: Ясухиро ФУНАХАСИ,Тосимицу УЕНАКА,Брюс Э. ЛИТТЛФИЛД. Владелец: Эйсай Ар Энд Ди Менеджмент Ко., Лтд.. Дата публикации: 2018-04-03.

1,2-di(cyclic) substituted benzene compounds, drug comprising them, therapeutic agent, cell adhesion inhibitor, as well as their use

Номер патента: BRPI0418152B8. Автор: KAWAHARA Tetsuya,Kotake Makoto,Hirota Shinsuke,YONEDA Naoki,Ohkuro Masayoshi. Владелец: Eisai R&D Man Co Ltd. Дата публикации: 2021-05-25.

process for making granules of moisture sensitive therapeutic compound and dpp-iv inhibitor, as well as immediate release pharmaceutical composition for oral administration comprising granules thus obtained

Номер патента: BRPI0514682B8. Автор: Joshi Yatindra,Kowalski James,KALB Oskar,T M Serajuddin Abu. Владелец: NOVARTIS AG. Дата публикации: 2021-05-25.

Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

Номер патента: US6071949A. Автор: Marti Jett,James L. Mulshine. Владелец: US Department of Health and Human Services. Дата публикации: 2000-06-06.

Ferritin nanoparticle loaded with Survivin double inhibitors as well as preparation method and application thereof

Номер патента: CN111544598A. Автор: 刘畅,郭伟,马兴元,张瑞环,晏婷,郑文云,胡发彪. Владелец: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY. Дата публикации: 2020-08-18.

Polyamine transport inhibitors as novel therapeutics

Номер патента: WO2010148390A3. Автор: Otto Phanstiel,Jennifer J. Archer. Владелец: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.. Дата публикации: 2011-04-21.

Polyamine transport inhibitors as novel therapeutics

Номер патента: US20160151312A1. Автор: Otto Phanstiel, Iv,Jennifer J. Archer. Владелец: University of Central Florida Research Foundation Inc UCFRF. Дата публикации: 2016-06-02.

Use of an angiogenesis inhibitor as a lead compound in drug development

Номер патента: US20010011100A1. Автор: Roy Wuthier,Daotai Nie. Владелец: Individual. Дата публикации: 2001-08-02.

Polyamine transport inhibitors as novel therapeutics

Номер патента: US20120172449A1. Автор: Otto Phanstiel,Jennifer J. Archer. Владелец: University of Central Florida Research Foundation Inc UCFRF. Дата публикации: 2012-07-05.

Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen

Номер патента: US20120009282A1. Автор: Yung-Chi Cheng,Shwu-Huey Liu,Zaoli Jiang,Robert Tilton. Владелец: PhytoCeutica Inc. Дата публикации: 2012-01-12.

Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen

Номер патента: WO2009152228A9. Автор: Yung-Chi Cheng,Shwu-Huey Liu,Zaoli Jiang,Robert Tilton. Владелец: Phytoceutica, Inc.. Дата публикации: 2010-08-05.

Phosphatase inhibitors as nk cells modulators for the treatment of cancer

Номер патента: CA3237288A1. Автор: Michel L. Tremblay,Chu-han FENG. Владелец: Kanyr Pharma Inc. Дата публикации: 2023-05-11.

Protease inhibitors as antivirals

Номер патента: US11987554B2. Автор: XIAO Xu,Long Mao,Namir SHAABANI,Can JIN. Владелец: Vivasor Inc. Дата публикации: 2024-05-21.

Protease inhibitors as antivirals

Номер патента: IL308694A. Автор: XIAO Xu,Long Mao,Namir SHAABANI,Can JIN. Владелец: Can JIN. Дата публикации: 2024-01-01.

2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis

Номер патента: US20170166867A1. Автор: Christina Li Lin Chai,Steve Oh,Joo Leng LOW,Qixing ZHONG,Filip LACO. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2017-06-15.

No synthetase inhibitors as medicinal products intended to reduce alcohol consumption or to prevent excessive alcohol consumption

Номер патента: US5639792A. Автор: Francoise Beauge. Владелец: Pernod Ricard SA. Дата публикации: 1997-06-17.

Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunsuppressor and anti-inflammatory agent

Номер патента: WO2003061702A9. Автор: Francois Mach. Владелец: Francois Mach. Дата публикации: 2003-11-27.

Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular disease

Номер патента: US20050153871A1. Автор: Masakazu Sato,Shigeru Okuyama,Kazuya Kameo,Noriyuki Miyata,Richard Roman,David Harder. Владелец: Medical College of Wisconsin Research Foundation Inc. Дата публикации: 2005-07-14.

Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases

Номер патента: AU8879801A. Автор: Masakazu Sato,Shigeru Okuyama,Kazuya Kameo,Noriyuki Miyata,Richard J Roman,David R Harder. Владелец: Medical College of Wisconsin Research Foundation Inc. Дата публикации: 2002-05-15.

USE OF β-LACTAMASE INHIBITORS AS NEUROPROTECTANTS

Номер патента: WO2002063954A3. Автор: Gary A Koppel. Владелец: Revaax Pharmaceuticals Llc. Дата публикации: 2002-12-05.

USE OF β-LACTAMASE INHIBITORS AS NEUROPROTECTANTS

Номер патента: WO2002063954A2. Автор: Gary A. Koppel. Владелец: Revaax Pharmaceuticals, LLC. Дата публикации: 2002-08-22.

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

Номер патента: US8802733B2. Автор: Michael A. White,Anand Ganesan,Patrick J. Farmer. Владелец: University of Texas System. Дата публикации: 2014-08-12.

2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis

Номер патента: EP3102207A1. Автор: Christina Li Lin Chai,Steve Oh,Joo Leng LOW,Qixing ZHONG,Filip LACO. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2016-12-14.

Pharmaceutical composition for preventing or treating ovary granulosa cell tumors containing glycogen synthase kinase-3 beta inhibitor as active ingredient, and functional health food composition

Номер патента: EP2979696A4. Автор: Jaehong Kim,Kangseok Lee,Jeehyeon BAE. Владелец: Industry Academic Cooperation Foundation of Chung Ang University. Дата публикации: 2017-01-04.

Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent

Номер патента: EP1467764A1. Автор: Francois Mach. Владелец: Novimmune SA. Дата публикации: 2004-10-20.

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

Номер патента: US20140314698A1. Автор: Michael A. White,Anand Ganesan,Patrick J. Farmer. Владелец: University of Texas System. Дата публикации: 2014-10-23.

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

Номер патента: US9889081B2. Автор: Michael A. White,Anand Ganesan,Patrick J. Farmer. Владелец: University of Texas System. Дата публикации: 2018-02-13.

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

Номер патента: US20130101535A1. Автор: Michael A. White,Anand Ganesan,Patrick J. Farmer. Владелец: University of Texas System. Дата публикации: 2013-04-25.

Caspase inhibitors as coating material for medical products for inhibiting restenosis

Номер патента: ZA200603110B. Автор: Hoffmann Erika,Horres Roland,Hoffman Michael. Владелец: HEMOTEQ AG. Дата публикации: 2007-12-27.

Caspase inhibitors as coating materiel for medical products for inhibiting restenosis

Номер патента: WO2005039629A2. Автор: Erika Hoffmann,Roland Horres,Michael Hoffmann. Владелец: Hemoteq GmbH. Дата публикации: 2005-05-06.

Valbenazine, a vmat2 inhibitor, as a free base a tosylate or ditosylate salt, for use in the treatment of chorea associated with huntington's disease

Номер патента: IL315181A. Автор: Grace S Liang,Dietrich HAUBENBERGER. Владелец: Dietrich HAUBENBERGER. Дата публикации: 2024-10-01.

Valbenazine, a vmat2 inhibitor, as a free base a tosylate or ditosylate salt, for use in the treatment of chorea associated with huntington's disease

Номер патента: AU2023232134A1. Автор: Grace S. LIANG,Dietrich HAUBENBERGER. Владелец: Neurocrine Biosciences Inc. Дата публикации: 2024-10-03.

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

Номер патента: US09889081B2. Автор: Michael A. White,Anand Ganesan,Patrick J. Farmer. Владелец: University of Texas System. Дата публикации: 2018-02-13.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders

Номер патента: US20120302621A1. Автор: Veena Viswanath,Alan C. FOSTER,Yong-xin LI,Ursula V. Staubli,Lauren M. Luhrs. Владелец: Allergan Inc. Дата публикации: 2012-11-29.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders

Номер патента: US20120329851A1. Автор: Veena Viswanath,Ursula Staubli,Alan C. FOSTER,Yong-xin LI,Lauren Luhrs. Владелец: Allergan Inc. Дата публикации: 2012-12-27.

ALDEHYDE DEHYDROGENASE INHIBITORS AS NOVEL DEPIGMENTING AGENTS

Номер патента: US20130101535A1. Автор: Ganesan Anand,White Michael A.,Farmer Patrick J.. Владелец: . Дата публикации: 2013-04-25.

USE OF HISTONE ACETYLTRANSFERASE INHIBITORS AS NOVEL ANTI-CANCER THERAPIES

Номер патента: US20130142887A1. Автор: Alani Rhoda Myra,Cole Philip A.,Yan Gai,Bowers Erin M.. Владелец: THE JOHNS HOPKINS UNIVERSITY. Дата публикации: 2013-06-06.

NOVEL SEROTONIN REUPTAKE INHIBITORS AS DRUGS HAVING PERIPHERAL-SYSTEM-RESTRICTED ACTIVITY

Номер патента: US20130143960A1. Автор: REHAVI Moshe,Gurwitz David. Владелец: Ramot at Tel-Aviv University Ltd.. Дата публикации: 2013-06-06.

Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient

Номер патента: US20140018416A1. Автор: Kazuo Tsubota,Miho Maeda,Hideyuki Okano,Akiyoshi Kishino,Shigeto Shimmura,Masahiro Omoto. Владелец: Sumitomo Dainippon Pharma Co Ltd. Дата публикации: 2014-01-16.

Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor

Номер патента: US20140039010A1. Автор: Su Jin Lee,Ji Hyun Lee,Gyu Yong Song,Bum Joon Park,Nam Chul Ha,Youn Sang Jung. Владелец: University Industry Cooperation Foundation of Pusan National University. Дата публикации: 2014-02-06.

COMPOSITION FOR PREVENTION OR TREATMENT OF BRONCHIAL ASTHMA COMPRISING PKR INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20180000794A1. Автор: Lee Yong Chul,KIM So Ri. Владелец: . Дата публикации: 2018-01-04.

USE OF FATTY ACID OXIDATION INHIBITORS AS ANTIMICROBIALS

Номер патента: US20210000821A1. Автор: Philips Jennifer A.,Moore Kathryn,Chandra Pallavi,Ouimet Mireille. Владелец: . Дата публикации: 2021-01-07.

ARGINASE INHIBITORS AS THERAPEUTICS

Номер патента: US20170000808A1. Автор: Van Zandt Michael,Jagdmann Gunnar E.. Владелец: . Дата публикации: 2017-01-05.

GSNO REDUCTASE INHIBITOR AS AN ADJUNCT THERAPY WITH REMOTE ISCHEMIC CONDITIONING AND THROMBOLYTIC REPERFUSION THERAPIES IN STROKE

Номер патента: US20220062262A1. Автор: ZAIDI Syed Kashif,HODA Md. Nasrul,AL-QAHTANI Muhammad Hussain. Владелец: . Дата публикации: 2022-03-03.

GSNO REDUCTASE INHIBITOR AS AN ADJUNCT THERAPY WITH REMOTE ISCHEMIC CONDITIONING AND THROMBOLYTIC REPERFUSION THERAPIES IN STROKE

Номер патента: US20220062264A1. Автор: ZAIDI Syed Kashif,HODA Md. Nasrul,AL-QAHTANI Muhammad Hussain,Ahmed Farid,Al Khatabi Heba. Владелец: . Дата публикации: 2022-03-03.

Pharmaceutical composition for preventing or treating ovary granulosa cell tumors containing glycogen synthase kinase-3 beta inhibitor as active ingredient, and functional health food composition

Номер патента: US20160058738A1. Автор: Jaehong Kim,Kangseok Lee,Jeehyeon BAE. Владелец: Industry Academic Cooperation Foundation of Chung Ang University. Дата публикации: 2016-03-03.

ARGINASE INHIBITORS AS THERAPEUTICS

Номер патента: US20190054101A1. Автор: Van Zandt Michael,Jagdmann Gunnar E.. Владелец: . Дата публикации: 2019-02-21.

COMBINED MODALITIES FOR NUCLEOSIDES AND/OR NADPH OXIDASE (NOX) INHIBITORS AS MYELOID-SPECIFIC ANTIVIRAL AGENTS

Номер патента: US20210060051A1. Автор: SCHINAZI RAYMOND F.,Cox Bryan,Amblard Franck,Gavegnano Christina,Mengshetti Seema. Владелец: . Дата публикации: 2021-03-04.

Lsd1 inhibitors as skeletal muscle hypertrophy inducers

Номер патента: US20200054578A1. Автор: Pauline POYDENOT,Joris MICHAUD,Mélanie FLAENDER,Eve DUCHEMIN-PELLETIER,Luc Selig. Владелец: Cytoo. Дата публикации: 2020-02-20.

USE OF ERIBULIN AND MTOR INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Номер патента: US20170071903A1. Автор: Uenaka Toshimitsu,Funahashi Yasuhiro,LITTLEFIELD Bruce A.. Владелец: . Дата публикации: 2017-03-16.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders

Номер патента: US20140200254A1. Автор: Veena Viswanath,Ursula Staubli,Alan C. FOSTER,Yong-xin LI,Lauren Luhrs. Владелец: Allergan Inc. Дата публикации: 2014-07-17.

D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS

Номер патента: US20140221453A1. Автор: Viswanath Veena,Foster Alan C.,Luhrs Lauren M.,Li Yong-Xin,Staubli Ursula V.. Владелец: ALLERGAN, INC.. Дата публикации: 2014-08-07.

Polyamine transport inhibitors as novel therapeutics

Номер патента: US20160151312A1. Автор: Otto Phanstiel, Iv,Jennifer J. Archer. Владелец: University of Central Florida Research Foundation Inc UCFRF. Дата публикации: 2016-06-02.

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING VACCINIA VIRUS AND GRANULOPOIESIS INHIBITOR AS ACTIVE INGREDIENTS

Номер патента: US20220288143A1. Автор: Kim Jae-Joon,CHO Mong,HWANG Tae-Ho. Владелец: . Дата публикации: 2022-09-15.

EphA4 INHIBITORS AS NEUROPROTECTIVE AGENTS

Номер патента: US20160152618A1. Автор: Ip Fanny Chui Fun,Fu Kit Yu,IP Nancy Yuk Yu,GU Shuo,Huagn Xuhui,HUNG Kwok. Владелец: . Дата публикации: 2016-06-02.

Mi-2beta Inhibitor as an Immunotherapy Agent

Номер патента: US20220304990A1. Автор: Hong-Yu Li,Zhengyu Wang,Jingwei Shao,Rutao CUI. Владелец: BioVentures LLC. Дата публикации: 2022-09-29.

D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Номер патента: US20170172957A1. Автор: Viswanath Veena,Staubli Ursula,Foster Alan C.,Li Yong-Xin,LUHRS LAUREN. Владелец: . Дата публикации: 2017-06-22.

Arginase inhibitors as therapeutics

Номер патента: US20150191492A1. Автор: Michael Van Zandt,Gunnar E. Jagdmann. Владелец: Individual. Дата публикации: 2015-07-09.

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES OR FATTY LIVER CONTAINING A CYP4A INHIBITOR AS AN ACTIVE INGREDIENT

Номер патента: US20140275198A1. Автор: Kim Soohyun,CHOI Jong-Soon,Kim Gun-Hwa,Kim Seung II,Park Edmond Changkyun. Владелец: KOREA BASIC SCIENCE INSTITUTE. Дата публикации: 2014-09-18.

Proteasome Inhibitors as Ovoprotective Agents to Shield the Ovary from Chemotherapy Toxicity

Номер патента: US20140315859A1. Автор: Salih Sana M.,Roti Roti Elon Christiane. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2014-10-23.

USE OF PROLYL HYDROXYLASE INHIBITORS AS A RADIOPROTECTIVE DRUG FOR THE LOWER GASTROINTESTINAL TRACT

Номер патента: US20140315999A1. Автор: Giaccia Amato,Taniguchi Cullen. Владелец: . Дата публикации: 2014-10-23.

Methods of Using Androgen Receptor Inhibitors as Cancer Therapeutics

Номер патента: US20210251966A1. Автор: NATALE Christopher,Ridky Todd,AGUIRRE PORTOLÉS Cristina. Владелец: . Дата публикации: 2021-08-19.

Arginase Inhibitors as Therapeutics

Номер патента: US20200246362A1. Автор: Van Zandt Michael,Jagdmann Gunnar E.. Владелец: . Дата публикации: 2020-08-06.

TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY

Номер патента: US20180265531A1. Автор: Black Cameron,Kennedy Brian,TREMBLAY Michel L.,PENAFUERTE Claudia,FELDHAMMER Matthew,ZOGOPOULOS George. Владелец: . Дата публикации: 2018-09-20.

VINFLUNINE AND PD1 AND/OR PDL1 INHIBITOR AS PHARMACEUTICAL COMBINATION

Номер патента: US20190307741A1. Автор: KRUCZYNSKI Anna,FERRE Pierre,VANDENBERGHE Isabelle. Владелец: PIERRE FABRE MEDICAMENT. Дата публикации: 2019-10-10.

LDH INHIBITORS AS TREATMENT FOR FIBROSIS AND FIBROTIC-RELATED DISORDERS

Номер патента: US20150335674A1. Автор: PHIPPS Richard P.,Kottmann Robert M.,Sime Patricia J.. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2015-11-26.

MEVALONATE PATHWAY INHIBITOR AS HIGHLY-EFFICIENT VACCINE ADJUVANT

Номер патента: US20190321465A1. Автор: Wang Ke,Li Xin,Zhang Yonghui,Zhao Meng,Xia Yun,LI Liping,ZHOU Xiaoying,XIE Yonghua,YU Zhengsen,Yang Yunyun,Gao Kanzhao,Liu Wanli. Владелец: . Дата публикации: 2019-10-24.

PI 4-KINASE INHIBITOR AS A THERAPEUTIC FOR VIRAL HEPATITIS, CANCER, MALARIA. AUTOIMMUNE DISORDERS AND INFLAMMATION, AND A RADIOSENSITIZER AND IMMUNOSUPPRESSANT

Номер патента: US20190358196A1. Автор: Toyang Ngeh J.,Lowe Henry C.. Владелец: . Дата публикации: 2019-11-28.

Pharmaceutical composition of the prevention or treatment of allergic diseases comprising pdks inhibitor as an effective component

Номер патента: KR101783306B1. Автор: 이상우,이호원,전용현,이인규,이재태,오슬기. Владелец: 경북대학교병원. Дата публикации: 2017-09-29.

Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia

Номер патента: US20030225150A1. Автор: Jaime Masferrer. Владелец: Pharmacia LLC. Дата публикации: 2003-12-04.

N1- (tri- fluoro- 2- hydroxy-2-methyls propionos of 3,3,3-)-piperidine derivative of inhibitor as pyruvic dehydrogenase kinase

Номер патента: CN108779093A. Автор: H-P.布赫施塔勒. Владелец: Merck Patent GmBH. Дата публикации: 2018-11-09.

Drugs containing chymase inhibitor and ace inhibitor as the active ingredients

Номер патента: KR100902799B1. Автор: 하세나오끼,우라따히데노리,쯔찌야나오끼. Владелец: 데이진 가부시키가이샤. Дата публикации: 2009-06-12.

Methods and compositions of parp inhibitors as potentiators in cancer therapy

Номер патента: WO2007051119A1. Автор: Jie Zhang,Jia-He Li,Dana Victor Ferraris,Vincent Kalish. Владелец: Mgi Gp, Inc.. Дата публикации: 2007-05-03.

Use of COMT inhibitors as analgesics

Номер патента: JP2003526663A. Автор: アホ、ペイビ,リンデン、インゲ−ブリット. Владелец: オリオン コーポレーション. Дата публикации: 2003-09-09.

Use of aryl and heteroaryl urea Chkl inhibitors as radiosensitizers and chemical sensitizers

Номер патента: JP4222833B2. Автор: キャサリン エス． キーガン，,エドワード エイ． ケシクキ，,ジョン ジョセフ ガウディノ，,アダム ウェイド クック，,スコット ダグラス コーウェン，,ローレンス エドワード バージェス，. Владелец: Icos Corp. Дата публикации: 2009-02-12.

Pharmaceutical composition for prevention or treatment of cancer containing an emtol signaling inhibitor as an active ingredient

Номер патента: JP2023514717A. Автор: キム，セユン,イ，ボア,ジュ パク，スン. Владелец: コリア アドヴァンスド インスティテュート オブ サイエンス アンド テクノロジー. Дата публикации: 2023-04-07.

Pharmaceutical composition of the prevention or treatment of allergic diseases comprising pdks inhibitor as an effective component

Номер патента: KR20170071996A. Автор: 이상우,이호원,전용현,이인규,이재태,오슬기. Владелец: 경북대학교병원. Дата публикации: 2017-06-26.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders

Номер патента: CA2837382A1. Автор: Veena Viswanath,Ursula Staubli,Alan C. FOSTER,Yong-xin LI,Lauren Luhrs. Владелец: Allergan Inc. Дата публикации: 2012-12-06.

Composition for preventing, improving or treating atopic dermatitis containing proteasome inhibitor as effective component

Номер патента: KR101953671B1. Автор: 김용은,김기광. Владелец: 충남대학교산학협력단. Дата публикации: 2019-03-04.

Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient

Номер патента: AU8336898A. Автор: Wilfried Fischer,Karin Klokkers,Renate Oppelt. Владелец: HEXAL AG. Дата публикации: 1998-12-30.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: TWI309649B. Автор: Alan Cooper,Hugh Zhu,Jagdish Desai,James J-S Wang. Владелец: Schering Corp. Дата публикации: 2009-05-11.

Quinone reductase 2 inhibitors as neuroprotective agents

Номер патента: CN112823006A. Автор: C·D·拉斯科拉,J·K·菲茨帕特里克. Владелец: Duke University. Дата публикации: 2021-05-18.

Enkephalinase and endorphinase inhibitors as anti-craving compositions

Номер патента: CA1321146C. Автор: Kenneth Blum. Владелец: Individual. Дата публикации: 1993-08-10.

Pharmaceutical composition for preventing or treating allergic diseases, containing pdk inhibitor as active ingredient

Номер патента: WO2017104887A1. Автор: 이상우,이호원,전용현,이인규,이재태,오슬기. Владелец: 경북대학교병원. Дата публикации: 2017-06-22.

Trk inhibitor as anti-cancer drug

Номер патента: EP3848365A4. Автор: Guangming Chen,Boyu Zhong,Tony Yantao Zhang,Yiju CAO. Владелец: Tyligand Bioscience Shanghai Ltd. Дата публикации: 2022-06-01.

cxcr1 / 2 inhibitors as adjuvants in pancreatic islet transplantation

Номер патента: BR112012007991A2. Автор: Allegretti Marcello,Piemonti Lorenzo,Daffonchio Luisa. Владелец: Dompe Spa. Дата публикации: 2017-07-25.

Monoamine oxidase inhibitors as modifiers of beta cell vulnerability in type 1 diabetes

Номер патента: CA3174673A1. Автор: Peng Yi,Stephan KISSLER. Владелец: Joslin Diabetes Center Inc. Дата публикации: 2021-07-01.

Use of pla2 inhibitors as treatment for alzheimer's disease

Номер патента: CA2179649A1. Автор: Michael Joseph Sofia,James Allen Clemens,Diane Teresa Stephenson. Владелец: Individual. Дата публикации: 1995-06-29.

Melanocyte tyrosinase inhibitor as a brightener of topical skin types

Номер патента: DE60143135D1. Автор: Thomas P Dooley,Ernest V Curto. Владелец: MediQuest Therapeutics Inc. Дата публикации: 2010-11-04.

Use of comt inhibitors as analgesics

Номер патента: CA2403352C. Автор: Inge-Britt Linden,Paivi Aho. Владелец: Orion Oyj. Дата публикации: 2009-05-05.

Use of eribulin and mtor inhibitors as combination therapy for the treatment of cancer

Номер патента: CA2940983A1. Автор: Yasuhiro Funahashi,Toshimitsu Uenaka,Bruce A. Littlefield. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2015-09-11.

Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents

Номер патента: CA2464256A1. Автор: David Michael Evans,Andre Tartar. Владелец: Andre Tartar. Дата публикации: 2003-05-01.

A Composition for Inhibiting Lipid Absorption Comprising mGluR5 Inhibitors as Active Ingredients

Номер патента: KR20220096338A. Автор: 김철훈,왕혜진. Владелец: 연세대학교 산학협력단. Дата публикации: 2022-07-07.

Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity

Номер патента: CN101506188A. Автор: 莫什·雷哈维,大卫·格威茨. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2009-08-12.

Serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity

Номер патента: US9221779B2. Автор: Moshe Rehavi,David Gurwitz. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2015-12-29.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders

Номер патента: CA2837381C. Автор: Veena Viswanath,Ursula Staubli,Alan C. FOSTER,Yong-xin LI,Lauren Luhrs. Владелец: Allergan Inc. Дата публикации: 2021-01-12.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders

Номер патента: CA2837381A1. Автор: Veena Viswanath,Ursula Staubli,Alan C. FOSTER,Yong-xin LI,Lauren Luhrs. Владелец: Allergan Inc. Дата публикации: 2012-12-06.

Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient

Номер патента: CA2827869A1. Автор: Kazuo Tsubota,Miho Maeda,Hideyuki Okano,Akiyoshi Kishino,Shigeto Shimmura,Masahiro Omoto. Владелец: Sumitomo Dainippon Pharma Co Ltd. Дата публикации: 2013-08-19.

Use of mek1 inhibitors as protective agents against damage due to ischemia

Номер патента: WO2002028388A2. Автор: Joseph Bonventre,Michael Moskowitz,Alessandro Alessandrini,Shobu Namura. Владелец: The General Hospital Corporation. Дата публикации: 2002-04-11.

Use of pde4 inhibitors as adjunct therapy for psychiatric disorders

Номер патента: US20060069115A1. Автор: Edward Scolnick. Владелец: Individual. Дата публикации: 2006-03-30.

NEW DIPEPTIDYL PEPTIDASE IV INHIBITORS AS ANTI-DIABETIC AGENTS

Номер патента: RU2004110055A. Автор: Дейвид Майкл ИВАНЗ,Андре ТАРТАР,Дейвид Майкл ИВАНЗ (GB),Андре ТАРТАР (FR). Владелец: Ферринг Бв (Nl). Дата публикации: 2005-10-20.

LDH inhibitors as treatment for fibrosis and fibrotic-related disorders

Номер патента: US9750761B2. Автор: Richard P. Phipps,Patricia J. Sime,Robert M. Kottmann. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2017-09-05.

Controlled release pharmaceutical preparation with ACE inhibitor as active agent and two outer coatings at a 2 to 1 ratio

Номер патента: NZ501726A. Автор: Wilfried Fischer,Karin Klokkers,Renate Oppelt. Владелец: HEXAL AG. Дата публикации: 2001-09-28.

Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents

Номер патента: US20040198800A1. Автор: Geoffrey Allan,Glen Kelley. Владелец: Insmed Inc. Дата публикации: 2004-10-07.

Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists

Номер патента: CA2064574A1. Автор: Andrew Thurkauf,Richard B. Rothman,Kenner C. Rice,Andrea Mele,Nigel H. Greig,Agu Pert,Audrey A. Reid,Hyacinth C. C. Akunne. Владелец: Individual. Дата публикации: 1991-02-04.

Use of eribulin and Mtor inhibitors as combination therapy for the treatment of cancer

Номер патента: CN106029070A. Автор: T.尤纳卡,B.A.利特尔菲尔德,Y.富纳哈施. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2016-10-12.

Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents

Номер патента: CA2510295A1. Автор: Geoffrey Allan,Glen Kelley. Владелец: Individual. Дата публикации: 2004-07-15.

CINESINE INHIBITORS AS A THERAPEUTIC PRODUCT FOR CANCER

Номер патента: CO6290651A2. Автор: Annette Walter,David Duhl,Michel Faure,Tinya Abrams,Paul A Renhowe,Paul A Barsanti. Владелец: NOVARTIS AG. Дата публикации: 2011-06-20.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: CA2591705A1. Автор: Alan Cooper,Hugh Zhu,Jagdish Desai,James J-S Wang. Владелец: James J-S Wang. Дата публикации: 2006-06-29.

Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient

Номер патента: AU736357B2. Автор: Wilfried Fischer,Karin Klokkers,Renate Oppelt. Владелец: HEXAL AG. Дата публикации: 2001-07-26.

Arginase Inhibitors as Therapeutic Agents

Номер патента: ES2794006T3. Автор: Zandt Michael Van,Jagdmann, Jr. Владелец: Mars Inc. Дата публикации: 2020-11-17.

Use of MEK1 inhibitors as protective agents against damage due to ischemia

Номер патента: US6319955B1. Автор: Joseph Bonventre,Michael A. Moskowitz,Alessandro Alessandrini,Shobu Namura. Владелец: General Hospital Corp. Дата публикации: 2001-11-20.

Pharmaceutical composition comprising iu1-lineage ubiquitin-specific protease 14 inhibitor as active ingredient for enhancing anticancer effect of protac

Номер патента: WO2022250363A1. Автор: 이병훈,문성현. Владелец: 재단법인대구경북과학기술원. Дата публикации: 2022-12-01.

Novel cxcr4 inhibitors as anti-hiv agents

Номер патента: WO2011154580A1. Автор: Jordi Teixido Closa,Raimon Puig De La Bellacasa Cazorla,Jose Ignacio Borrell Bilbao,José ESTÉ ARAQUE. Владелец: Irsicaixa (Institut De Recerca De La Sida). Дата публикации: 2011-12-15.

Kinesin inhibitors as cancer therapeutics

Номер патента: CA2708822A1. Автор: David Duhl,Paul Barsanti,Michel Faure,Tinya Abrams,Paul A. Renhowe,Annette Olga Walter. Владелец: Individual. Дата публикации: 2009-06-25.

Use of adam9 inhibitor as immunomodulator

Номер патента: WO2020216319A1. Автор: 佘玉萍,杨颛丞,刘璟霈,黄裕锴. Владелец: 中国医药大学. Дата публикации: 2020-10-29.

Mevalonate pathway inhibitor as a high-efficiency vaccine adjuvant

Номер патента: KR102116528B1. Автор: 케 왕,신 리,리핑 리,용휘 장,연 샤,용화 시에,젱센 유,시오잉 조우,연연 양,칸자오 가오,왕리 리우,멩 자오. Владелец: 칭화 유니버시티. Дата публикации: 2020-05-28.

Pharmaceutical composition for enhancing the anticancer effect of PROTAC, comprising the IU1 series of USP14 inhibitors as active ingredients

Номер патента: KR20220158629A. Автор: 이병훈,문성현. Владелец: 재단법인대구경북과학기술원. Дата публикации: 2022-12-01.

Use of comt inhibitors as analgesics

Номер патента: CA2403352A1. Автор: Inge-Britt Linden,Paivi Aho. Владелец: Paivi Aho. Дата публикации: 2001-09-20.

A pharmaceutical composition for preventing or treating diabetes or fatty liver, comprising a CYP4A inhibitor as an active ingredient.

Номер патента: JP5901770B2. Автор: スヒョン キム,グン−ファ キム,ジョン−ソン チェ,スンイル キム,エドモンド チャンギュン パク,エドモンド チャンギュン パク. Владелец: Korea Basic Science Institute KBSI. Дата публикации: 2016-04-13.

2-cyclooxygenase inhibitors as antiangiogenic agents

Номер патента: RU2268716C2. Автор: Джэйм Л. МАСФЕРРЕР,Амирам РАЗ,Джэйм Л. МАСФЕРРЕР (US),Амирам РАЗ (IL). Владелец: Джи. Ди. Сирл Энд Ко. Дата публикации: 2006-01-27.

Composition for Preventing or Treating of Degenerative Brain Disease Comprising Prolyl Oligopeptidase Inhibitor as Active Ingredient

Номер патента: KR101913506B1. Автор: 이근우,김명옥. Владелец: 경상대학교산학협력단. Дата публикации: 2018-10-30.

Use of adam9 inhibitor as immune modulator

Номер патента: TW202038948A. Автор: 佘玉萍,楊顓丞,劉璟霈,黃裕鍇. Владелец: 中國醫藥大學. Дата публикации: 2020-11-01.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders

Номер патента: ES2632437T3. Автор: Veena Viswanath,Ursula Staubli,Alan C. FOSTER,Yong-xin LI,Lauren Luhrs. Владелец: Allergan Inc. Дата публикации: 2017-09-13.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: TW200634004A. Автор: Alan Cooper,Hugh Zhu,Jagdish Desai,James J-S Wang. Владелец: Schering Corp. Дата публикации: 2006-10-01.

Use of sphk2 inhibitor as drug for repairing bone marrow hematopoietic system injury or treating bone marrow hematopoietic dysfunction

Номер патента: WO2019210866A1. Автор: 赵萌. Владелец: 中山大学. Дата публикации: 2019-11-07.

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders

Номер патента: AU2012262533A1. Автор: Veena Viswanath,Ursula Staubli,Alan C. FOSTER,Yong-xin LI,Lauren Luhrs. Владелец: Allergan Inc. Дата публикации: 2013-12-19.

Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia

Номер патента: HU0104747A3. Автор: . Владелец: G D Searle & Co Skokie. Дата публикации: 2002-12-28.

Kinesin inhibitors as cancer therapeutics

Номер патента: GEP20125647B. Автор: David Duhl,Paul Barsanti,Michel Faure,Tinya Abrams,Paul A Renhowe,Annette Olga Walter. Владелец: NOVARTIS AG. Дата публикации: 2012-09-25.

Use of seh inhibitors as analgesics

Номер патента: CA2619768A1. Автор: Bruce Hammock,Ahmet Bora Inceoglu. Владелец: Ahmet Bora Inceoglu. Дата публикации: 2007-02-22.

2-h-indazole derived inhibitors as cyclin dependent kinase (cdk) and their therapeutic uses

Номер патента: BR112017001058A2. Автор: Zhang Don,Peng Jirong,Nicholas Greco Michael,John Costanzo Michael,Lynn Wilde Victoria. Владелец: Beta Pharma, Inc. Дата публикации: 2018-06-26.

USE OF COX-2 INHIBITORS AS IMMUNOSTIMULANTS FOR THE TREATMENT OF HIV OR AIDS

Номер патента: DE60129330T2. Автор: Jo Klaveness,Kjetil Tasken,Vidar Hansson,Einar Martin Aandahl,Pal Aukrust,Michel Moutschen,Souad Rahmouni-Piette,Stig S. Froland,Christian Carl Johansson. Владелец: Lauras AS. Дата публикации: 2008-04-10.

Dihydroorotate - dehydrogenase inhibitors as virostatic compounds

Номер патента: NZ596014A. Автор: Roland Baumgärtner,Johann Leban,Daniel Vitt,Manfred GROEPPEL. Владелец: 4SC Discovery GmbH. Дата публикации: 2013-06-28.

Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia

Номер патента: PL349216A1. Автор: Gary Gordon,Jaime L Masferrer,John P Mckearn,James J Cunningham,Stephen T Gately,Alane T Koki. Владелец: Searle & Co. Дата публикации: 2002-07-01.

Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents.

Номер патента: TR199901703T2. Автор: L. Masferrer Jaime,Raz Amiram. Владелец: G.D. Searle & Co.. Дата публикации: 2000-07-21.

Use of pla2 inhibitors as treatment for alzheimer's disease

Номер патента: WO1995017183A1. Автор: Michael Joseph Sofia,James Allen Clemens,Diane Teresa Stepenson. Владелец: ELI LILLY AND COMPANY. Дата публикации: 1995-06-29.

Use of quinoxalines in combination with protease inhibitors as medicaments for treating aids and/or hiv infections

Номер патента: CA2170222A1. Автор: Arnold Paessens,Gunther Riess,Manfred Rosner,Martin Blunck,Jorg-Peter Kleim. Владелец: Bayer AG. Дата публикации: 1996-08-28.

Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents

Номер патента: IL129604A0. Автор: . Владелец: Searle & Co. Дата публикации: 2000-02-29.

Pharmaceutical compositions containing aromatic acetylcholinesterase inhibitors as active ingredient

Номер патента: IL109863A. Автор: . Владелец: Merrell Dow Pharma. Дата публикации: 1998-12-27.

Pharmaceutical composition and health functional food composition for prevention or treatment of ovarian granule cell tumor comprising glycogen synthase kinase 3β inhibitor as an active ingredient

Номер патента: JP5973108B2. Автор: ジェホン キム，,ジ ヒョン ペ，,ジ ヒョン ペ，,カン ソク イ，,カン ソク イ，. Владелец: Industry Academic Cooperation Foundation of Chung Ang University. Дата публикации: 2016-08-23.

Use of beta-lactamase inhibitors as neuroprotectants

Номер патента: US20020002159A1. Автор: Gary Koppel. Владелец: Revaax Pharmaceuticals Llc. Дата публикации: 2002-01-03.

Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases

Номер патента: WO2002036108A2. Автор: Masakazu Sato,Shigeru Okuyama,Kazuya Kameo,Noriyuki Miyata,Richard J. Roman,David R. Harder. Владелец: MCW RESEARCH FOUNDATION, INC.. Дата публикации: 2002-05-10.

Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids

Номер патента: PT1303265E. Автор: Jo Klaveness,Kjetil Tasken,Vidar Hansson,Einar Martin Aandahl,Pal Aukrust,Michel Moutschen,Souad Rahmouni-Piette,Christian Carl Johansson,Stig S Froland. Владелец: Lauras AS. Дата публикации: 2007-10-09.

Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents

Номер патента: US20100105729A1. Автор: Steven P. Govek,James W. Malecha,Stewart A. Noble,Andrew K. Shiau,Guy Oshiro. Владелец: Kalypsys Inc. Дата публикации: 2010-04-29.

Histone deacetylase inhibitors as skin lightening agents

Номер патента: WO2009064421A1. Автор: Satoru Yokoyama,David E. Fisher,Erez Feige. Владелец: Dana-Farber Cancer Institute, Inc.. Дата публикации: 2009-05-22.

Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia

Номер патента: WO2004058302A1. Автор: Jaime L. Masferrer. Владелец: Pharmacia Corporation. Дата публикации: 2004-07-15.

Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents

Номер патента: WO2004058240A1. Автор: Geoffrey Allan,Glen Kelley. Владелец: Insmed Incorporated. Дата публикации: 2004-07-15.

Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient

Номер патента: WO2012115182A1. Автор: 一男 坪田,岡野　栄之,美穂 前田,岸野　晶祥,重人 榛村,雅弘 大本. Владелец: 学校法人慶應義塾. Дата публикации: 2012-08-30.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: CA3152973A1. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2021-03-04.

Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

Номер патента: CA2185448A1. Автор: Marti Jett,James L. Mulshine. Владелец: Individual. Дата публикации: 1995-09-21.

HDAC inhibitors as anti-cancer agents

Номер патента: US9469656B2. Автор: Pravin Bhansali,L. M. Viranga Tillekeratne,Jehad Almaliti,Ayad Al-Hamashi. Владелец: UNIVERSITY OF TOLEDO. Дата публикации: 2016-10-18.

Combination modes of nucleoside and/or nadph oxidase (nox) inhibitors as myellis-specific antiviral agents

Номер патента: CN111971284A. Автор: 雷蒙德·F·斯基那兹,弗兰克·安布拉尔,克里斯蒂娜·加维根那诺,西玛·门斯赫蒂,布莱恩·考克斯. Владелец: EMORY UNIVERSITY. Дата публикации: 2020-11-20.

Kinesin inhibitors as cancer therapeutics

Номер патента: EA018014B1. Автор: Пол БАРСАНТИ,Мишель ФОРЕ,Тиниа Абрамс,Дейвид Дул,Пол А. Ренхау,Аннетте Ольга Вальтер. Владелец: НОВАРТИС АГ. Дата публикации: 2013-04-30.

Kinesin inhibitors as cancer therapeutics

Номер патента: CN101939005A. Автор: T·阿布拉姆斯,M·福雷,D·达尔,P·A·伦豪威,P·巴尔桑尼,A·O·瓦尔特. Владелец: NOVARTIS AG. Дата публикации: 2011-01-05.

Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients

Номер патента: WO2003066052A1. Автор: Jong-Won Lee,Sung-Hwan Park,Sun-Ha Lim,Hong-Tae Kim,Hun-Suk Suh,Yang-Il Kim. Владелец: Hypoxi Co., Ltd.. Дата публикации: 2003-08-14.

Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids

Номер патента: AU6094098A. Автор: Arnold Paessens,Manfred Rosner,Martin Blunck,Jorg-Peter Kleim,Gunter Riess. Владелец: Bayer AG. Дата публикации: 1998-08-18.

Mevalonate pathway inhibitor as highly-effective vaccine adjuvant

Номер патента: EP3348269B1. Автор: Meng Zhao,Yonghui Zhang,Xin Li,Ke Wang,Liping Li,Yun Xia,Wanli Liu,Xiaoying Zhou,Yonghua XIE,Zhengsen YU,Yunyun YANG,Kanzhao GAO. Владелец: TSINGHUA UNIVERSITY. Дата публикации: 2023-11-15.

Monoamine oxidase inhibitors as modifiers of beta cell vulnerability in type 1 diabetes

Номер патента: EP4081197A4. Автор: Peng Yi,Stephan KISSLER. Владелец: Joslin Diabetes Center Inc. Дата публикации: 2024-01-10.

Novel anandamide amidase inhibitors as analgesic agents

Номер патента: EP1021406A1. Автор: Alexandros Makriyannis,Sonyan Lin,William Adam Hill. Владелец: University of Connecticut. Дата публикации: 2000-07-26.

Profilin1:actin inhibitor as an anti-angiogenic compound

Номер патента: US20230293490A1. Автор: Xavier Guillonneau,Lee Mcdermott,Partha ROY,Abigail E. Allen,David Koes,David M. Gau,Paul G. Francoeur. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2023-09-21.

Proteasome inhibitors as ovoprotective agents to shield the ovary from chemotherapy toxicity

Номер патента: US9333212B2. Автор: Sana M. Salih,Elon Christiane Roti Roti. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2016-05-10.

Use of histone acetyltransferase inhibitors as novel anti-cancer therapies

Номер патента: US20130142887A1. Автор: Rhoda Myra Alani,Philip A. Cole,Erin M. Bowers,Gai Yan. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2013-06-06.

Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients

Номер патента: AU2003208037A1. Автор: Jong-Won Lee,Sung-Hwan Park,Sun-Ha Lim,Hong-Tae Kim,Hun-Suk Suh,Yang-Il Kim. Владелец: Hypoxi Co Ltd. Дата публикации: 2003-09-02.

Use of phosphodiesterase-4 inhibitors as enhancers of cognition

Номер патента: AU2003286024A8. Автор: Yves Girard,Anthony Mastracchio,Bernard Cote,Yves Ducharme,Richard Frenette,Richard Friesen,Evelyn Martins,Daniel Guay,Marc Blouin,Patrick Lacombe,Daniel Dube,Mario Girard,Sebastien Laliberte,Michel Gallant,Dwight Macdonald,Helene Perrier,Annette Robichaud. Владелец: Merck Frosst Canada and Co. Дата публикации: 2004-06-18.

Pharmaceutical composition for enhancing anticancer effect of protac, including iu1-series ubiquitin-specific protease 14 inhibitor as active ingredient

Номер патента: US20240108612A1. Автор: Byung-Hoon Lee,Seonghyeon MOON,Thuy Thi Thanh TRAN. Владелец: DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY. Дата публикации: 2024-04-04.

Valbenazine, a vmat2 inhibitor, as a free base a tosylate or ditosylate salt, for use in the treatment of chorea associated with huntington's disease

Номер патента: WO2023172849A1. Автор: Grace S. LIANG,Dietrich HAUBENBERGER. Владелец: NEUROCRINE BIOSCIENCES, INC.. Дата публикации: 2023-09-14.

G9a inhibitors and ezh2 inhibitors as multifaceted covid-19 therapeutics

Номер патента: WO2022104190A1. Автор: Xian Chen. Владелец: The University of North Carolina at Chapel Hill. Дата публикации: 2022-05-19.

Hdac inhibitors as anti-cancer agents

Номер патента: WO2015175770A1. Автор: Pravin Bhansali,Jehad Almaliti,Ayad Al-Hamashi,Viranga L.M. TILLEKERATNE. Владелец: The University of Toledo. Дата публикации: 2015-11-19.

Glycine cleavage system inhibitors as potential antipsychotics

Номер патента: PL353180A1. Автор: Gerd Bartoszyk,Michael Arlt. Владелец: Merck Patent GmBH. Дата публикации: 2003-11-03.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: EP4023235A4. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2023-03-29.

Quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids

Номер патента: IL130877A0. Автор: . Владелец: Bayer AG. Дата публикации: 2001-01-28.

Protease inhibitors as antivirals

Номер патента: EP4347034A1. Автор: XIAO Xu,Long Mao,Namir SHAABANI,Can JIN. Владелец: Acea Therapeutics Inc. Дата публикации: 2024-04-10.

Human helicase ddx3 inhibitors as therapeutic agents

Номер патента: US20200140398A1. Автор: Javier Martinez,Maurizio Botta,Andreas Meyerhans,Annalaura BRAI,Cristina TINTORI,Roberta Fazi,José-Esté Araque,Miguel-Angel MARTINEZ DE LA SIERRA. Владелец: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE. Дата публикации: 2020-05-07.

Novel lipoxygenase inhibitors as neuroprotective agents

Номер патента: WO2009017825A3. Автор: Eng H Lo,Matthew P Jacobson,Leyen Klaus Van,Theodore R Holman,David W Howells. Владелец: David W Howells. Дата публикации: 2009-03-26.

Novel anandamide amidase inhibitors as analgesic agents

Номер патента: US20020091153A1. Автор: William Hill,Alexandros Makriyannis,Sonyan Lin. Владелец: Individual. Дата публикации: 2002-07-11.

Novel anandamide amidase inhibitors as analgesic agents

Номер патента: AU3229097A. Автор: Alexandros Makriyannis,Sonyan Lin,William Adam Hill. Владелец: CONNECTICUT THE, University of. Дата публикации: 1998-01-05.

Novel anandamide amidase inhibitors as analgesic agents

Номер патента: EP1021406B1. Автор: Alexandros Makriyannis,Sonyan Lin,William Adam Hill. Владелец: University of Connecticut. Дата публикации: 2006-11-29.

Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen

Номер патента: WO2009152228A3. Автор: Yung-Chi Cheng,Shwu-Huey Liu,Zaoli Jiang,Robert Tilton. Владелец: Phytoceutica, Inc.. Дата публикации: 2010-03-25.

Methods of using androgen receptor inhibitors as cancer therapeutics

Номер патента: US11992478B2. Автор: Todd RIDKY,Christopher Natale,Cristina AGUIRRE PORTOLES. Владелец: University of Pennsylvania Penn. Дата публикации: 2024-05-28.

Proteasome Inhibitors as Ovoprotective Agents to Shield the Ovary from Chemotherapy Toxicity

Номер патента: US20140315859A1. Автор: Sana M. Salih,Elon Christiane Roti Roti. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2014-10-23.

G9a inhibitors and ezh2 inhibitors as multifaceted covid-19 therapeutics

Номер патента: US20230414619A1. Автор: Xian Chen. Владелец: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL. Дата публикации: 2023-12-28.

Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis

Номер патента: US20100093985A1. Автор: Lhousseine Touqui,Fariel Dif. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2010-04-15.

Heterocyclic compounds and cognitive enhancers comprising the same as effective components

Номер патента: CA2436589C. Автор: Naoki Fukuda,Yoshimasa Yamaguchi,Toshiyuki Matsuno,Seiichiro Kawashima,Kenichi Saitoh,Masaya Higashi. Владелец: Zenyaku Kogyo KK. Дата публикации: 2010-10-19.

Reversible method for sustainable human cognitive enhancement

Номер патента: WO2019245776A2. Автор: John Mee. Владелец: John Mee. Дата публикации: 2019-12-26.

p38 MAPK Pathway Inhibitors as Female-Specific Therapeutics

Номер патента: US20140127231A1. Автор: Rincon Mercedes,Teuscher Cory,Krementsov Dimitry,Noubade Rajkumar. Владелец: UNIVERSITY OF VERMONT. Дата публикации: 2014-05-08.

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Номер патента: US20160199356A1. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: NEUROSOLIS Inc. Дата публикации: 2016-07-14.

Txa2 inhibitor as stimulator or inducer of mhc class i cross-presentation

Номер патента: WO2016102352A1. Автор: Jost Enninga,Alexandre Bobard. Владелец: INSTITUT PASTEUR. Дата публикации: 2016-06-30.

S6K1 protein kinase inhibitors as cancer therapeutics

Номер патента: US11912660B2. Автор: Jayalakshmi Sridhar,Melyssa BRATTON,Rajesh KOMATI. Владелец: XAVIER UNIVERSITY OF LOUISIANA. Дата публикации: 2024-02-27.

S6k1 protein kinase inhibitors as cancer therapeutics

Номер патента: US20240158351A1. Автор: Jayalakshmi Sridhar,Melyssa BRATTON,Rajesh KOMATI. Владелец: XAVIER UNIVERSITY OF LOUISIANA. Дата публикации: 2024-05-16.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: EP4433095A1. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2024-09-25.

Protease inhibitors as modulators of periodontal wound healing

Номер патента: EP1227835A1. Автор: Clive Leighton Bunn,Phillip John Sharp,Yin c/o The University of Queensland XIAO,Peter Mark The University of Queensland BARTOLD. Владелец: Biotech Australia Pty Ltd. Дата публикации: 2002-08-07.

The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors

Номер патента: WO2004064713A2. Автор: Peter Schotte,Rudi Beyaert. Владелец: VIB VZW. Дата публикации: 2004-08-05.

Method for sustainable human cognitive enhancement

Номер патента: US20190336585A1. Автор: Mee John Lawrence. Владелец: . Дата публикации: 2019-11-07.

Adjustable method for sustainable human cognitive enhancement

Номер патента: US20190359985A1. Автор: John Lawrence Mee. Владелец: Individual. Дата публикации: 2019-11-28.

Compound and its use as a pde-5 inhibitor, as well as a pharmaceutical preparation comprising said compound

Номер патента: BR112015025033B1. Автор: Chutian Shu,Yongqian Wu. Владелец: XUANZHU PHARMA CO., LTD. Дата публикации: 2022-04-19.

Cognitive enhancing dietary supplement

Номер патента: WO2023084508A1. Автор: Inon Moshe ZEEVI. Владелец: Zeevi Inon Moshe. Дата публикации: 2023-05-19.

Peptide inhibitors as novel anti-hiv therapeutics

Номер патента: WO2013128418A3. Автор: Ravishankar RAMACHANDRAN,Raj Kamal TRIPATHI,Balawant KUMAR,Jitendra Kumar TRIPATHI,Smriti BHADAURIA,Jimut Kanti GHOSH. Владелец: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH. Дата публикации: 2014-01-30.

Peptide inhibitors as novel anti-hiv therapeutics

Номер патента: US20150182581A1. Автор: Ravishankar RAMACHANDRAN,Raj Kamal TRIPATHI,Balawant KUMAR,Jitendra Kumar TRIPATHI,Smriti BHADAURIA,Jimut Kanti GHOSH. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2015-07-02.

Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient

Номер патента: US20130131123A1. Автор: DIETRICH Rango,NEY Hartmut,EISTETTER Klaus. Владелец: NYCOMED GMBH. Дата публикации: 2013-05-23.

Compositions and particles containing cellulosic fibers and stabilized- and/or activated- urease inhibitors, as well as methods of making and using the same

Номер патента: WO2008153753A3. Автор: Zheng Tan,Gopal C Goyal,Linnea J Shaver. Владелец: Linnea J Shaver. Дата публикации: 2009-02-05.

Use of biological protease-inhibitors as deodorants

Номер патента: GB1286011A. Автор: Guenter Schmidt-Kastner,Franz-Josef Geks. Владелец: Bayer AG. Дата публикации: 1972-08-16.

Compositions and particles containing cellulosic fibers and stabilized and / or activated urease inhibitors, as well as methods of manufacturing and using them

Номер патента: ES2538481T3. Автор: Gopal C. Goyal,Zheng Tan,Linnea J. Shaver. Владелец: International Paper Co. Дата публикации: 2015-06-22.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: US20230416331A1. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2023-12-28.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: AU2022390891A1. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2024-06-06.

Methods of use for tripeptidyl peptidase ii inhibitors as anticancer agents

Номер патента: WO2003105835A1. Автор: Karl Munger,Stefan M. Duensing. Владелец: President and Fellows of Harvard College. Дата публикации: 2003-12-24.

Lipopeptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: US20240226304A1. Автор: Cyrille Mathieu,Branka Horvat,Matteo Porotto,Anne Moscona,Rik DE SWART,Rory DE VRIES. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2024-07-11.

Integrin inhibitors as therapy for metabolic disorders

Номер патента: WO2024047655A1. Автор: Dafna Benayahu,Nadav KISLEV. Владелец: Ramot at Tel-Aviv University Ltd.. Дата публикации: 2024-03-07.

Peptide deformylase inhibitors as novel antibiotics

Номер патента: US20050026821A1. Автор: Dehua Pei. Владелец: Ohio State University Research Foundation. Дата публикации: 2005-02-03.

Lipopeptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: EP4228673A1. Автор: Cyrille Mathieu,Branka Horvat,Matteo Porotto,Anne Moscona,Rik DE SWART,Rory DE VRIES. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2023-08-23.

Pharmaceutical composition for preventing or treating cancer containign recepto tyrosine kinase inhibitor as active ingredient

Номер патента: GB202001368D0. Автор: . Владелец: Korea Inst Radiological & Medical Sciences. Дата публикации: 2020-03-18.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: IL312884A. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2024-07-01.

Composition for treating retinal or choroidal diseases, containing acta2 inhibitor as active ingredient

Номер патента: EP4230226A4. Автор: Soo Jin Kim,Junyeop LEE. Владелец: Asan Foundation. Дата публикации: 2024-09-11.

Protease inhibitors as modulators of periodontal wound healing

Номер патента: AU1119501A. Автор: Yin Xiao,Clive Leighton Bunn,Phillip John Sharp,Peter Mark Bartold. Владелец: Biotech Australia Pty Ltd. Дата публикации: 2001-05-14.

Protease inhibitors as modulators of periodontal wound healing

Номер патента: EP1227835A4. Автор: Yin Xiao,Clive Leighton Bunn,Phillip John Sharp,Peter Mark Bartold. Владелец: Biotech Australia Pty Ltd. Дата публикации: 2003-05-14.

Lipid-peptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: EP4139330A4. Автор: ZHEN Yu,Samuel Gellman,Matteo Porotto,Anne Moscona,Victor OUTLAW. Владелец: Columbia University in the City of New York. Дата публикации: 2024-10-23.

Composition comprising osteopontin inhibitor as active ingredient for prevention, alleviation, or treatment of neurodegenerative disease

Номер патента: EP4159223A4. Автор: Jung Eun Lee,Jung Yeon Lim,Seung Ho Yang,Sung Won Kim,Sin-Soo JEUN,Soon A PARK. Владелец: Industry Academic Cooperation Foundation of Catholic University of Korea. Дата публикации: 2024-07-17.

TC-PTP inhibitors as APC activators for immunotherapy

Номер патента: US09828399B2. Автор: Cameron Black,Brian Kennedy,Michel L. Tremblay,Claudia PENAFUERTE,Matthew FELDHAMMER,George ZOGOPOULOS. Владелец: Royal Institution for the Advancement of Learning. Дата публикации: 2017-11-28.

ANTI-DESPR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20130177500A1. Автор: Ruiz-Opaz Nelson,Herrera Victoria L.M.. Владелец: Trustee of Boston University. Дата публикации: 2013-07-11.

PROLYL HYDROXYLASE INHIBITORS AS RADIATION MITIGATORS AND RADIATION PROTECTORS

Номер патента: US20130267594A1. Автор: SUN Yingli,Price Brendan D.. Владелец: Dana-Farber Cancer Institute Inc.. Дата публикации: 2013-10-10.

TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY

Номер патента: US20170015690A1. Автор: Black Cameron,Kennedy Brian,TREMBLAY Michel L.,PENAFUERTE Claudia,FELDHAMMER Matthew,ZOGOPOULOS George. Владелец: THE ROYAL INSTITUTE FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIVERSITY. Дата публикации: 2017-01-19.

Pharmaceutical composition for preventing or treating fabry disease, containing tsp1 protein inhibitor as active ingredient

Номер патента: US20220034908A1. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2022-02-03.

Composition for Treatment or Metastasis Suppression of Cancers Which Includes P34 Expression Inhibitor or Activity Inhibitor as Active Ingredient

Номер патента: US20160040168A1. Автор: Jin Sun Kim,Jai Hee Moon,Bong Cheol Kim,Eun kyung Choi,Tae Won Kim,Seung Woo Hong,Ky Youb Nam,Dong Hoon Jin,Jae Sik Shin,Yong Sang HONG,Kyung Ah Jung,Jung Shin Lee,Jae Lyun Lee,Kyu Pyo Kim. Владелец: Asan Foundation. Дата публикации: 2016-02-11.

PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING PULMONARY METASTASIS OF CANCER INCLUDING CHI3L1 INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20210046151A1. Автор: Kim Do-Hyun,CHOI Je-Min. Владелец: Industry-University Cooperation Foundation Hanyang University. Дата публикации: 2021-02-18.

BACTERIAL PHOSPHOLIPASE INHIBITORS AS MODULATOR OF COLONIC BACTERIAL FLORA

Номер патента: US20170043026A1. Автор: STREMMEL Wolfgang. Владелец: . Дата публикации: 2017-02-16.

TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY

Номер патента: US20180072763A1. Автор: Black Cameron,Kennedy Brian,TREMBLAY Michel L.,PENAFUERTE Claudia,FELDHAMMER Matthew,ZOGOPOULOS George. Владелец: . Дата публикации: 2018-03-15.

ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20190092865A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2019-03-28.

Composition comprising asm inhibitor as active ingredient for preventing or treating degenerative neurological disorders

Номер патента: US20160101070A1. Автор: Hee Kyung Jin,Jae Sung BAE,Jong Kil Lee. Владелец: Industry Academic Cooperation Foundation of KNU. Дата публикации: 2016-04-14.

ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20160108124A1. Автор: Herrera Victoria L.M.,Ruiz-Opazo Nelson. Владелец: . Дата публикации: 2016-04-21.

ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20210155700A1. Автор: Herrera Victoria L.M.,Ruiz-Opazo Nelson. Владелец: TRUSTEES OF BOSTON UNIVERSITY. Дата публикации: 2021-05-27.

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20210163608A1. Автор: Ishibashi Tatsuro,OHGURO Nobuyuki,TANO Yasuo,SONODA Kohei. Владелец: . Дата публикации: 2021-06-03.

Tumor Deliverable Iron and Protein Synthesis Inhibitors as a New Class of Drugs for the Diagnosis and Treatment of Cancer

Номер патента: US20180140724A1. Автор: Deng Changchun,Lipstein Mark,"OConnor Owen A.". Владелец: The Trustees of Columbia University in the City of New York. Дата публикации: 2018-05-24.

BACTERIAL PHOSPHOLIPASE INHIBITORS AS MODULATOR OF COLONIC BACTERIAL FLORA

Номер патента: US20170173165A1. Автор: STREMMEL Wolfgang. Владелец: . Дата публикации: 2017-06-22.

PEPTIDE INHIBITORS AS NOVEL ANTI-HIV THERAPEUTICS

Номер патента: US20150182581A1. Автор: Tripathi Raj Kamal,Kumar Balawant,Ramachandran Ravishankar,Tripathi Jitendra Kumar,Bhadauria Smriti,Ghosh Jimut Kanti. Владелец: . Дата публикации: 2015-07-02.

THERAPEUTIC AGENT FOR MENTAL ILLNESS COMPRISING IL-6 INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20180186887A1. Автор: Wakabayashi Chisato,KUNUGI Hiroshi. Владелец: . Дата публикации: 2018-07-05.

Pharmaceutical composition for inhibiting resistance against anticancer drugs of patient suffering from ovarian cancer comprising nag-1 inhibitor as active ingredient

Номер патента: US20180200283A1. Автор: Ki Hyung Kim,Yuseok MOON. Владелец: University Industry Cooperation Foundation of Pusan National University. Дата публикации: 2018-07-19.

ALDEHYDE DEHYDROGENASE INHIBITORS AS NOVEL DEPIGMENTING AGENTS

Номер патента: US20140314698A1. Автор: Ganesan Anand,White Michael A.,Farmer Patrick J.. Владелец: . Дата публикации: 2014-10-23.

BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Номер патента: US20180290984A1. Автор: Lawrence Harshani R.,Lawrence Nicholas J.,SCHÖNBRUNN Ernst. Владелец: . Дата публикации: 2018-10-11.

PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION AND TREATMENT, CONTAINING NDRG3 EXPRESSION OR ACTIVITY INHIBITOR AS ACTIVE INGREDIENT, OR NDRG3 PROTEIN-SPECIFIC ANTIBODY AND USE THEREOF

Номер патента: US20170306047A1. Автор: Lee Dong Chul,KANG Min Ho,YEOM Young II,RARK Kyung Chan,SOHN Hyun Ahm. Владелец: Korea Research Institute of Bioscience and Biotechnology. Дата публикации: 2017-10-26.

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20160326255A1. Автор: Ishibashi Tatsuro,OHGURO Nobuyuki,TANO Yasuo,SONODA Kohei. Владелец: . Дата публикации: 2016-11-10.

BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Номер патента: US20200407328A1. Автор: Lawrence Harshani R.,Lawrence Nicholas J.,SCHÖNBRUNN Ernst. Владелец: . Дата публикации: 2020-12-31.

JNK INHIBITORS AS ANTICANCER AGENTS

Номер патента: US20220411398A1. Автор: Salem Aliasger K.,Abdelrahman Somaya Ali Mohammed Elsaid. Владелец: . Дата публикации: 2022-12-29.

Pharmaceutical Compositions for Preventing or Treating Arthritis Comprising HIF-2α Inhibitor as an Active Ingredient

Номер патента: KR101223660B1. Автор: 양시영,전장수. Владелец: 광주과학기술원. Дата публикации: 2013-01-17.

Composition for treatment and metastasis inhibition of panceratic cancer including CTHRC1 expression and activation inhibitor as an active ingredient

Номер патента: KR20140144934A. Автор: 송시영,김석호,박은혜,조지윤,고상석,황연실. Владелец: 한국생명공학연구원. Дата публикации: 2014-12-22.

Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient

Номер патента: EP1854481B1. Автор: Tetsuya Matsumoto,Junkoh Yamashita,Kiyonobu Ikeda,Kouji Matsushima. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2014-07-16.

Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient

Номер патента: WO2009014263A1. Автор: Nobuyuki Ohguro,Yasuo Tano,Kohei Sonoda,Tatsuro Ishibashi. Владелец: Kyushu University, National University Corporation. Дата публикации: 2009-01-29.

Anti-Despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: AU2011280969A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2013-02-07.

A composition comprising cathepsin B inhibitor as active ingredient for functional cosmetics

Номер патента: KR100692951B1. Автор: 심재희,이계준. Владелец: 주식회사 비엠리서치. Дата публикации: 2007-03-12.

Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient

Номер патента: EP1854481A2. Автор: Tetsuya Matsumoto,Junkoh Yamashita,Kiyonobu Ikeda,Kouji Matsushima. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2007-11-14.

Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient

Номер патента: WO2009044774A1. Автор: Masahiko Mihara,Yoichiro Moriya. Владелец: Chugai Seiyaku Kabushiki Kaisha. Дата публикации: 2009-04-09.

Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient

Номер патента: EP3246045A1. Автор: Nobuyuki Ohguro,Yasuo Tano,Kohei Sonoda,Tatsuro Ishibashi. Владелец: Kyushu University NUC. Дата публикации: 2017-11-22.

Pharmaceutical composition including an hif-2α inhibitor as an active ingredient for preventing or treating arthritis

Номер патента: WO2011145777A1. Автор: 양시영,전장수. Владелец: 광주과학기술원. Дата публикации: 2011-11-24.

ANTI-DEsupR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: WO2012012750A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: TRUSTEES OF BOSTON UNIVERSITY. Дата публикации: 2012-01-26.

Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: EP3696195A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2020-08-19.

Mental illness therapeutic agent having il-6 inhibitor as active ingredient

Номер патента: EP3305325A4. Автор: Hiroshi Kunugi,Chisato Wakabayashi. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2019-01-16.

ANTITUMOR AGENT AND ANTIMETASTATIC AGENT CONTAINING A RIBONUCLEASE INHIBITOR AS AN ACTIVE COMPONENT

Номер патента: FR2647017A1. Автор: Koji Fukushima,Haruhisa Fujita,Tsutomu Honjo,Tomonobu Fujita,Toshiharu Sakurai. Владелец: Morinaga and Co Ltd. Дата публикации: 1990-11-23.

Expression and export of angiogenesis inhibitors as immunofusins

Номер патента: CA2339331C. Автор: Yue Li,Stephen D. Gillies,Kin-Ming Lo. Владелец: Merck Patent GmBH. Дата публикации: 2011-03-01.

Pharmaceutical composition for preventing or treating cancer comprising lrit2 inhibitor as active ingredient

Номер патента: KR102200428B1. Автор: 정아름,손진영,정주연,전부남,허윤경,김윤연,이수노,윤경완. Владелец: 주식회사 지놈앤컴퍼니. Дата публикации: 2021-01-08.

Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists

Номер патента: WO2007095113A2. Автор: Elly Nedivi. Владелец: Massachusetts Institute of Technology. Дата публикации: 2007-08-23.

Pharmaceutical composition for preventing or treating inflammatory diseases, containing inositol polyphosphate multikinase inhibitor as active ingredient

Номер патента: WO2018128429A1. Автор: 김은하,김세윤,변지윤. Владелец: 한국과학기술원. Дата публикации: 2018-07-12.

Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient.

Номер патента: MX2010003139A. Автор: Masahiko Mihara,Yoichiro Moriya. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2010-04-07.

Thromboresistant materials incorporating pyrazinone protease inhibitors as thromboresistant surfaces and for medical devices

Номер патента: AU2003213524B2. Автор: Tianbao Lu,Thomas P. Markotan,Bruce E. Tomczuk. Владелец: 3 Dimensional Pharmaceuticals Inc. Дата публикации: 2006-05-18.

Use of peptide PHPFLFVY (renin inhibitor) as a therapeutic agent

Номер патента: JP5384501B2. Автор: ベヴェック，ドリアン,カヴァリ，ファビオ,カヴァリ，ヴェラ,バッヒャー，ゲラルド. Владелец: モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト. Дата публикации: 2014-01-08.

Tc-ptp inhibitors as apc activators for immunotherapy

Номер патента: CA2977839A1. Автор: Cameron Black,Brian Kennedy,Michel L. Tremblay,Vouy-Linh Truong,Sheldon Crane,Claudia PENAFUERTE,Matthew FELDHAMMER,George ZOGOPOULOS. Владелец: Royal Institution for the Advancement of Learning. Дата публикации: 2015-09-03.

Neutral endopeptidase inhibitors as agents for diuresis, natriuresis and thus lowering of blood pressure

Номер патента: GB2207351B. Автор: Eric Michael Gordon,David Wayne Cushman,Norma Gail Delaney,Jack Martin Deforrest. Владелец: ER Squibb and Sons LLC. Дата публикации: 1991-09-18.

Bacterial phospholipase inhibitors as modulator of colonic bacterial flora

Номер патента: US10155041B2. Автор: Wolfgang Stremmel. Владелец: Universitaetsklinikum Heidelberg. Дата публикации: 2018-12-18.

Slimming cosmetic composition comprising a metalloproteinase inhibitor as an active agent

Номер патента: CA2558940A1. Автор: Olivier Courtin. Владелец: Olivier Courtin. Дата публикации: 2005-09-22.

COSMETIC COMPOSITION FOR REMOVING WITH A METAL PROTEINASE INHIBITOR AS AN ACTIVE SUBSTANCE

Номер патента: DE602005014542D1. Автор: Olivier Courtin. Владелец: Laboratoires Clarins SAS. Дата публикации: 2009-07-02.

Inhibitor as PARP1, PARP2 and/or tubulin can be used for the phthalazine derivatives for the treatment of cancer

Номер патента: CN109843874A. Автор: 乔鲍·J·佩托,戴维·M·雅布隆斯,特塞·曾,哈桑·莱姆贾巴尔-阿拉维. Владелец: Atlas Max Co Ltd. Дата публикации: 2019-06-04.

Secretory leukocyte protease inhibitor as an inhibitor of tryptase

Номер патента: CA2199746A1. Автор: Daniel K. Muller,Elise Brownell,Katherine A. Delaria. Владелец: Individual. Дата публикации: 1996-03-21.

Expression and export of angiogenesis inhibitors as immunofusins

Номер патента: US8703908B2. Автор: Yue Li,Stephen D. Gillies,Kin-Ming Lo. Владелец: Merck Patent GmBH. Дата публикации: 2014-04-22.

Pharmaceutical compositions to preventing or treating inflammatory disease comprising HAX1 inhibitor as an active ingredient, and screening method using thereof

Номер патента: KR101735422B1. Автор: 김정훈,김선홍,박병철,박성구,지승욱,최진선,배광희. Владелец: 한국생명공학연구원. Дата публикации: 2017-05-15.

Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient

Номер патента: EP2174667B1. Автор: Nobuyuki Ohguro,Yasuo Tano,Kohei Sonoda,Tatsuro Ishibashi. Владелец: Kyushu University NUC. Дата публикации: 2017-01-04.

Prostate-specific membrane antigen (PSMA) inhibitors as diagnostic and radionuclide therapeutic agents

Номер патента: AU2020262961A1. Автор: Hank F. Kung,Seok Rye Choi,Karl Ploessl,Zhihao ZHA. Владелец: Five Eleven Pharma Inc. Дата публикации: 2021-12-16.

Pharmaceutical composition for preventing or treating retinal neurodegenerative disease comprising Prox1 inhibitor as active ingredient

Номер патента: CN114945387A. Автор: 金镇佑,李恩汀. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2022-08-26.

Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: CA2806921A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2012-01-26.

Intermediates for the production of thrombin inhibitors as anticoagulants

Номер патента: DE69725354D1. Автор: Michael Robert Wiley,Valentine Joseph Klimkowski,Aaron Leith Schacht. Владелец: Eli Lilly and Co. Дата публикации: 2003-11-06.

Use of a composition containing an ERRγ inhibitor as an active ingredient for enhancing anticancer effects

Номер патента: JP2023504786A. Автор: ギュウ パーク クン,キュウ リー イン,ジン チョウ サン,キョン チョイ ヨン,ジン キム ミ,ウック チン ジャン,ヒュン ジョン ヨン,エー キム ジン,スー キム ドン,ユン ジャン ホ. Владелец: ノブメタファーマ カンパニー リミテッド. Дата публикации: 2023-02-07.

nc886 and/or PKR inhibitors as ancillary agents for anti-cancer drugs and methods to provide improved regimens for them

Номер патента: KR102143701B1. Автор: 이연수,이용선,김인후. Владелец: 국립암센터. Дата публикации: 2020-08-11.

Medicament for inducing tolerance to antigens, e.g. those causing autoimmune disease, allergy or infections, containing the antigen together with steroid sulfatase inhibitor as adjuvant to improve tolerance induction

Номер патента: DE10005643A1. Автор: Thomas Wickens. Владелец: BIONETWORKS GmbH. Дата публикации: 2001-08-16.

Matrix metalloproteinase inhibitors as targeting components in diagnostic agents

Номер патента: WO2001060416A2. Автор: Milind Rajopadhye,Alan P. Carpenter, Jr.. Владелец: Bristol-Myers Squibb Pharma Company. Дата публикации: 2001-08-23.

A therapeutic agent for psychiatric disorders comprising an IL-6 inhibitor as an active ingredient

Номер патента: JPWO2016195088A1. Автор: 浩 功刀,千里 若林. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2018-03-29.

Treatment of graft-versus-host disease with an interstitial-6 receptor inhibitor as an active ingredient

Номер патента: TWI468173B. Автор: Masahiko Mihara,Yoichiro Moriya. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2015-01-11.

Heart failure therapeutic agent containing an ASK1 inhibitor as an active ingredient and screening method thereof

Номер патента: JPWO2005009470A1. Автор: 修 山口,和彦 西田,秀憲 一條,山口　修,西田　和彦,欣也 大津,義治 樋口,一條　秀憲. Владелец: OSAKA FOUNDATION FOR TRADE AND INDUSTRY. Дата публикации: 2006-09-28.

Nitrocatecholderivater comt inhibitors as

Номер патента: DK1907382T3. Автор: Palma Pedro Nuno Leal,David Alexander Learmonth,Laszlo Erno Kiss,Santos Ferreira Humberto Dos,Jo Soares Da Silva Patrã Cio Manuel Vieira Araã. Владелец: Bial Portela & Ca Sa. Дата публикации: 2015-08-31.

Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient

Номер патента: US20100129355A1. Автор: Nobuyuki Ohguro,Yasuo Tano,Kohei Sonoda,Tatsuro Ishibashi,Ryoko Tano. Владелец: Kyushu University NUC. Дата публикации: 2010-05-27.

Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders

Номер патента: EP1399471A2. Автор: Torsten Hoffmann,Hans-Ulrich Demuth,Ulrich Heiser,Konrad Glund,Stephan Von Horsten. Владелец: PROBIODRUG AG. Дата публикации: 2004-03-24.

Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same

Номер патента: US20070167386A1. Автор: Yoshiharu Higuchi,Kazuhiko Nishida,Osamu Yamaguchi,Hidenori Ichijo,Kinya Otsu. Владелец: Osaka Industrial Promotion Organization. Дата публикации: 2007-07-19.

Bacterial phospholipase inhibitors as modulator of colonic bacterial flora

Номер патента: WO2015144737A1. Автор: Wolfgang Stremmel. Владелец: Universitaetsklinikum Heidelberg. Дата публикации: 2015-10-01.

Composition for preventing or treating cancer comprising miR-BART1-3p inhibitor as active ingredient

Номер патента: KR101985067B1. Автор: 이숙경,김효지,최호윤. Владелец: 가톨릭대학교 산학협력단. Дата публикации: 2019-05-31.

Cancer cell metastasis inhibitor containing ribonuclease inhibitor as active ingredient

Номер патента: JP2842888B2. Автор: 晴久 藤田,勉 本庄,敏晴 桜井,紘司 福島,知信 藤田. Владелец: MORINAGA SEIKA KK. Дата публикации: 1999-01-06.

Remedy for cardiac failure comprising ask1 inhibitor as the active ingredient and method of screening the same

Номер патента: WO2005009470A1. Автор: Yoshiharu Higuchi,Kazuhiko Nishida,Osamu Yamaguchi,Hidenori Ichijo,Kinya Otsu. Владелец: Osaka Industrial Promotion Organization. Дата публикации: 2005-02-03.

Therapeutic agents for graft-versus-host disease comprising interleukin 6 receptor inhibitor as active ingredient

Номер патента: CA2701155A1. Автор: Masahiko Mihara,Yoichiro Moriya. Владелец: Yoichiro Moriya. Дата публикации: 2009-04-09.

Use of biological protease inhibitors as deodorants

Номер патента: CH529560A. Автор: Geks Franz-Josef,Schmidt-Kastner Guenter. Владелец: Bayer AG. Дата публикации: 1972-10-31.

METALOCARBOXIPEPTIDASES AND MOLECULES DERIVED INHIBITORS AS ANTITUMORAL AGENTS.

Номер патента: ES2122912B1. Автор: Enrique Querol,Francesc X Aviles,Rafael Llorens,Marsha L Frazier,Carmen Blanco,Vila Miguel Angel Molina. Владелец: UVIVERSITAT AUTONOMA DE BARCEL. Дата публикации: 2000-10-01.

Composition comprising osteopontin inhibitor as active ingredient for prevention, alleviation, or treatment of neurodegenerative disease

Номер патента: WO2021246744A1. Автор: 이정은,김성원,임정연,양승호,전신수,박순아. Владелец: 가톨릭대학교 산학협력단. Дата публикации: 2021-12-09.

Agents comprising midkine or its inhibitor as active ingredient

Номер патента: CA2296409C. Автор: Kazuhiro Toriyama,Takashi Muramatsu,Tohru Takada,Hisako Muramatsu. Владелец: Medical Therapies Ltd. Дата публикации: 2010-05-18.

Use of protein inhibitors as antithrombotic agents

Номер патента: US20040244062A1. Автор: Ann Graybiel,David Housman,Jill Crittenden. Владелец: Massachusetts Institute of Technology. Дата публикации: 2004-12-02.

Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives

Номер патента: CA2542967A1. Автор: Thorsten A. Kirschberg,Aesop Cho,Maria Fardis,Lee S. Chong,Will Watkins. Владелец: Will Watkins. Дата публикации: 2005-05-06.

Pharmaceutical composition for enhancing the sensitivity of p97 target anticancer agent comprising a RepID inhibitor as an active ingredient

Номер патента: KR20220109536A. Автор: 장상민. Владелец: 충북대학교 산학협력단. Дата публикации: 2022-08-05.

Ribosome inhibitors as inhibitors of tyrosyl-dna-phosphodiesterase

Номер патента: WO2006099095A2. Автор: Yves Pommier,Zhi-Yong Liao. Владелец: The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services. Дата публикации: 2006-09-21.

Drugs containing enzyme inhibitors as the active ingredient

Номер патента: CA2284094A1. Автор: Naoyuki Kamatani,Hiroshi Osada,Takashi Dan. Владелец: Individual. Дата публикации: 1998-09-17.

Slimming cosmetic composition comprising a metalloproteinase inhibitor as an active agent

Номер патента: CA2558940C. Автор: Olivier Courtin. Владелец: Laboratoires Clarins SAS. Дата публикации: 2013-05-07.

Expression and export of angiogenesis inhibitors as immunofusins

Номер патента: CA2339331A1. Автор: Yue Li,Stephen D. Gillies,Kin-Ming Lo. Владелец: Individual. Дата публикации: 2000-03-02.

USE OF PHPFHLFVY PEPTIDE (RENIN INHIBITOR) AS A THERAPEUTIC

Номер патента: RU2010113970A. Автор: Дориан БЕВЕК,Фабио КАВАЛЛИ,Вера КАВАЛЛИ,Геральд БАХЕР,Дориан БЕВЕК (DE),Фабио КАВАЛЛИ (CH),Вера КАВАЛЛИ (CH),Геральд БАХЕР (DE). Владелец: Мондобайотек Лабораториз Аг (Li). Дата публикации: 2011-10-20.

Pharmaceutical composition for preventing or treating cancer, comprising LRIT2 inhibitor as active ingredient

Номер патента: TW202003578A. Автор: 朴漢洙,鄭朱然,許允景,孫珍英,金允淵,李洙魯,尹京婉,全富男,鄭亞凜. Владелец: 南韓商韓國億諾生物有限公司. Дата публикации: 2020-01-16.

USE OF HER2 PERTUSUMUB INHIBITOR INHIBITOR AS AN INDUSTRIAL PRODUCT AND INDUSTRIAL PRODUCT INCLUDING THE HER2 DIMMERIZATION INHIBITOR

Номер патента: EA201490779A1. Автор: Лукас К. АМЛЕР,Сридхара Алаваттам,Кристина Х. Де Толедо Пелизон,Марк К. Беньюнс,Эмма Л. Кларк,Зефаниа В. Квонг Гловер,Лада Митчелл,Джаянтха Ратнаяк,Грэхам А. Росс,Ру-Амир Уокер. Владелец: Дженентек, Инк.. Дата публикации: 2015-11-30.

Pharmaceutical composition for preventing or treating diseases caused by excessive release of steroid hormones, containing pdk4 activity inhibitor as active ingredient, and method for screening for same

Номер патента: WO2017179744A1. Автор: 고영훈,이인규,박근규,배귀현. Владелец: 경북대학교 산학협력단. Дата публикации: 2017-10-19.

Use of protease inhibitors as antiexudative, antiphlogistic and antimicrobial agents

Номер патента: EP0420600A2. Автор: Jitka C/O Czechosl. Academy Of Sciences Cejkova,Jiri C/O Czechosl. Academy Of Sciences Vacik,Zdenek C/O Czechosl. Academy Of Sciences Lojda. Владелец: Czech Academy of Sciences CAS. Дата публикации: 1991-04-03.

Pharmaceutical Compositions for Preventing or Treating Th1-mediated or Th2-mediated Immune diseases Comprising IGSF4 inhibitor as an Active Ingredient

Номер патента: KR101472089B1. Автор: 김혜란,전창덕. Владелец: 광주과학기술원. Дата публикации: 2014-12-16.

Production of organoid derived from ctc of small cell lung cancer patient, and igf1r inhibitor as a molecular target drug for small cell lung cancer

Номер патента: WO2023042901A1. Автор: 浩之 安田,俊朗 佐藤,興壱 福永,俊樹 胡谷,貴大 福島,純子 浜本. Владелец: 慶應義塾. Дата публикации: 2023-03-23.

Lipid-peptide fusion inhibitors as SARS-COV-2 antivirals

Номер патента: KR20230028719A. Автор: 젠 유,마테오 포로토,안느 모스코나,사무엘 겔만,빅터 아우트로. Владелец: 위스콘신 얼럼나이 리서어치 화운데이션. Дата публикации: 2023-03-02.

LIPID-PEPTIDE FUSION INHIBITORS AS SARS-COV-2 ANTIVIRALS

Номер патента: BR112022021528A2. Автор: Yu Zhen,Moscona Anne,Porotto Matteo,Gellman Samuel,Outlaw Victor. Владелец: Wisconsin Alumni Res Foundation Warf. Дата публикации: 2023-04-04.

Expression and export of angiogenesis inhibitors as immunofusins

Номер патента: US20030139365A1. Автор: Yue Li,Stephen Gillies,Kin-Ming Lo. Владелец: EMD Serono Research Center Inc. Дата публикации: 2003-07-24.

Use of composition for enhancing anticancer effect, comprising err.gamma.inhibitor as active ingredient

Номер патента: CA3159428A1. Автор: Mi Jin Kim,Sung Jin Cho,Dong Su Kim,In Kyu Lee,Yong Hyun Jeon,Hoe Yune Jung,Jin A Kim,Yeon Kyung Choi,Keun Gyu Park,Jung Wook Chin. Владелец: Choi Yeon Kyung. Дата публикации: 2021-06-03.

Direct and indirect effector cell protease receptor-1 (EPR-1) Inhibitors as antiplatelet agents

Номер патента: US20070031412A1. Автор: Javier Egea,Luis Catasus. Владелец: Thrombotargets Corp. Дата публикации: 2007-02-08.

Lipopeptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: CA3195563A1. Автор: Cyrille Mathieu,Branka Horvat,Matteo Porotto,Anne Moscona,Rik DE SWART,Rory DE VRIES. Владелец: Individual. Дата публикации: 2022-04-21.

Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: EP3696195B1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2024-02-14.

Pharmaceutical composition for preventing or treating fabry disease, containing tsp1 protein inhibitor as active ingredient

Номер патента: EP3848039A4. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2021-12-01.

Pharmaceutical composition for prevention or treatment of retinal neurodegenerative diseases, comprising prox1 inhibitor as active ingredient

Номер патента: EP4173641A4. Автор: Eun Jung Lee,Jin Woo Kim. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2024-04-17.

Use of composition for enhancing anticancer effect, comprising err-gamma inhibitor as active ingredient

Номер патента: EP4066835A4. Автор: Mi Jin Kim,Sung Jin Cho,Dong Su Kim,In Kyu Lee,Yong Hyun Jeon,Hoe Yune Jung,Jin A Kim,Yeon Kyung Choi,Keun Gyu Park,Jung Wook Chin. Владелец: Novmetapharma Co Ltd. Дата публикации: 2023-12-20.

Discovery of yeats2 yeats domain inhibitors as novel anti-cancer agents

Номер патента: US20230355705A1. Автор: Xin Li,Sha Liu,Xiang David Li. Владелец: University of Hong Kong HKU. Дата публикации: 2023-11-09.

Amino acid β-lyase enzyme inhibitors as deodorants

Номер патента: US5487886A. Автор: Hermes van der Lee,Sue B. Lyon,Clifford O'neal,Brian Rogers. Владелец: Gillette Co LLC. Дата публикации: 1996-01-30.

Methods of use for tripeptidyl peptidase ii inhibitors as anticancer agents

Номер патента: AU2003248710A1. Автор: Karl Munger,Stefan M. Duensing. Владелец: Harvard College. Дата публикации: 2003-12-31.

Lipid-peptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: WO2021216891A3. Автор: ZHEN Yu,Samuel Gellman,Matteo Porotto,Anne Moscona,Victor OUTLAW. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF). Дата публикации: 2021-12-09.

Lipid-peptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: IL297498A. Автор: . Владелец: Univ Columbia. Дата публикации: 2022-12-01.

Lipid-peptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: EP4139330A2. Автор: ZHEN Yu,Samuel Gellman,Matteo Porotto,Anne Moscona,Victor OUTLAW. Владелец: Columbia University in the City of New York. Дата публикации: 2023-03-01.

Lipid-peptide fusion inhibitors as sars-cov-2 antivirals

Номер патента: WO2021216891A2. Автор: ZHEN Yu,Samuel Gellman,Matteo Porotto,Anne Moscona,Victor OUTLAW. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF). Дата публикации: 2021-10-28.

Discovery of yeats2 yeats domain inhibitors as novel anti-cancer agents

Номер патента: EP4257196A1. Автор: Sha Liu,Xiang David Li,Xin Ll. Владелец: University of Hong Kong HKU. Дата публикации: 2023-10-11.

Peptide deformylase inhibitors as novel antibiotics

Номер патента: US20070259812A1. Автор: Dehua Pei. Владелец: Ohio State University Research Foundation. Дата публикации: 2007-11-08.

Disubstituted polycyclic systems as cognition enhancers

Номер патента: CA2128234A1. Автор: Wendell W. Wilkerson,Christopher A. Teleha. Владелец: Individual. Дата публикации: 1993-07-22.

Process for preparing Ó,Ó-disubstituted aromatics and¹heteroaromatics as cognition enhancers

Номер патента: IE940118L. Автор: . Владелец: Du Pont Pharm Co. Дата публикации: 1989-04-06.

Disubstituted polycyclic compounds as cognitive enhancers

Номер патента: JP2650786B2. Автор: ウイルカーソン，ウエンドル・ウイルキー,テレハ，クリストフアー・アラン. Владелец: DEYUHON MERUKU PHARM CO ZA. Дата публикации: 1997-09-03.

Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators

Номер патента: US4582838A. Автор: Donald E. Butler,James D. Leonard. Владелец: Warner Lambert Co LLC. Дата публикации: 1986-04-15.

Saturated tricyclic nitrogen-containing diones as cognition activators

Номер патента: PT79912A. Автор: . Владелец: Warner Lambert Co. Дата публикации: 1985-03-01.

Saturated tricyclic nitrogen-containing diones as cognition activators

Номер патента: PT79912B. Автор: . Владелец: Warner Lambert Co. Дата публикации: 1987-02-05.

Saturated tricyclic nitrogen containing diones as cognition activators

Номер патента: PH22525A. Автор: Donald E Butler,Italien Yvon J L. Владелец: Warner Lambert Co. Дата публикации: 1988-10-17.

System and method for cognitive enhancement based on electroencephalogram (eeg) signals

Номер патента: WO2024107111A1. Автор: Aung Aung Phyo Wai,Yi Ding,Cuntai Guan,Neethu ROBINSON,Kavitha PERUMPADAPPIL THOMAS,Thirukarthik B,Tushar CHOUHAN. Владелец: NANYANG TECHNOLOGICAL UNIVERSITY. Дата публикации: 2024-05-23.

Compound 7 - ([1,2,4] triazolo [1,5-a] pyridin-6-yl) -4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydroisoquinoline; a pharmaceutical composition comprising it; and use to treat diseases such as cognitive impairment, anxiety disorders, desire to smoke and consume alcohol, among others.

Номер патента: CL2011002810A1. Автор: Shuang Liu,Bruce F Molino,Kassoum Nacro. Владелец: Albany Molecular Res Inc. Дата публикации: 2012-03-23.

Tricyclic nitrogen-containing diones as cognition activators

Номер патента: ZA85444B. Автор: Donald E Butler,Yvon J L Italien. Владелец: Warner Lambert Co. Дата публикации: 1986-08-27.

(substituted-phenyl)-5-oxo-pyrrolidine-2-propanoic acids and derivatives as cognition activators

Номер патента: ZA852875B. Автор: Donald E Butler,Anthony J Thomas. Владелец: Warner Lambert Co. Дата публикации: 1986-11-26.

Novel neurotransmitter releasers useful for cognition enhancement

Номер патента: CA2128233A1. Автор: Matthew Ernst Voss,Wendell Wilkie Wilkerson,Richard Alan Earl. Владелец: Individual. Дата публикации: 1993-07-22.

Composition comprising oil palm phenolics for use in providing neuroprotective effects and cognitive-enhancement

Номер патента: WO2010087693A1. Автор: Yew Ai TAN,Ravigadevi Sambanthamurthi,Kalyana Sundram P. Manickam,Mohd Basri Wahid,Soon-Sen Leow. Владелец: Malaysian Palm Oil Board. Дата публикации: 2010-08-05.

Composition comprising oil palm phenolics for use in providing neuroprotective effects and cognitive-enhancement

Номер патента: US20120040029A1. Автор: Yew Ai TAN,Kalyana Sundram P. Manickam,Mohd Basri Wahid,Soon-Sen Leow,Ravigadevi S. Sambanthamurthi. Владелец: Palm Oil Research and Development Board. Дата публикации: 2012-02-16.

Cognitive enhancement using feedback

Номер патента: US09943698B2. Автор: Gerold Yonas,Charles J. Chase. Владелец: Lockheed Martin Corp. Дата публикации: 2018-04-17.

Composition comprising oil palm phenolics for use in providing neuroprotective effects and cognitive-enhancement

Номер патента: US09642389B2. Автор: Yew Ai TAN,Ravigadevi Sambanthamurthi,Kalyana Sundram P. Manickam,Mohd Basri Wahid,Soon-Sen Leow. Владелец: Palm Oil Research and Development Board. Дата публикации: 2017-05-09.

A 10h-phenothiazine ferroptosis inhibitor as well as the preparative method and the use thereof

Номер патента: CA3098219A1. Автор: Shengyong Yang,Linli Li. Владелец: Chengdu Henghao Investment Co Ltd. Дата публикации: 2019-10-31.

A 10h-phenothiazine ferroptosis inhibitor as well as the preparative method and the use thereof

Номер патента: CA3098219C. Автор: Shengyong Yang,Linli Li. Владелец: Chengdu Henghao Investment Co Ltd. Дата публикации: 2024-05-07.

Highly selective c-Met inhibitors as anticancer agents

Номер патента: US09695175B2. Автор: FENG Zhou,Chuan Shih,Boyu Zhong,Hongbin Yuan. Владелец: CB Therapeutics Inc Cayman Island. Дата публикации: 2017-07-04.

Compounds and compositions for cognition-enhancement, methods of making, and methods of treating

Номер патента: US20120046273A1. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: Mithridion Inc. Дата публикации: 2012-02-23.

DEVICE AND METHOD FOR COGNITIVE ENHANCEMENT OF A USER

Номер патента: US20130338738A1. Автор: GARCIA MOLINA Gary Nelson,TSONEVA Tsvetomira Kirova,Baldo Davide,Danhua Zhu,Gabrielsson Patrick Hans Arvid. Владелец: KONINKLIJKE PHILIPS N.V.. Дата публикации: 2013-12-19.

Personalized closed-loop pulsed transcranial stimulation system for cognitive enhancement

Номер патента: US20190021657A1. Автор: Michael D. Howard,Praveen K. PILLY,Iman Mohammadrezazadeh. Владелец: HRL LABORATORIES LLC. Дата публикации: 2019-01-24.

TRANSCUTANEOUS ELECTRICALLY AMPLIFIED COGNITIVE ENHANCEMENT SYSTEM

Номер патента: US20210052896A1. Автор: Howard Newton. Владелец: . Дата публикации: 2021-02-25.

Ultrasound Neuromodulation for Cognitive Enhancement

Номер патента: US20140194726A1. Автор: Mishelevich David J.,Sato Tomo,Tyler William J.,Wetmore Daniel Z.. Владелец: Neurotrek, Inc.. Дата публикации: 2014-07-10.

Cognitive Enhancement Using Feedback

Номер патента: US20150297108A1. Автор: Chase Charles J.,Yonas Gerold. Владелец: . Дата публикации: 2015-10-22.

TRANSCUTANEOUS ELECTRICALLY AMPLIFIED COGNITIVE ENHANCEMENT SYSTEM

Номер патента: US20190381314A1. Автор: Howard Newton. Владелец: . Дата публикации: 2019-12-19.

Reversible method for sustainable human cognitive enhancement

Номер патента: US20190390193A1. Автор: Mee John Lawrence. Владелец: . Дата публикации: 2019-12-26.

METHOD AND DEVICE FOR Personalized transcranial direct current stimulation PROTOCOL for cognitive enhancements

Номер патента: KR102312387B1. Автор: 김정윤,윤수정,홍가혜,류인균. Владелец: 이화여자대학교 산학협력단. Дата публикации: 2021-10-13.

Transcutaneous electrically amplified cognitive enhancement system

Номер патента: WO2019241795A1. Автор: Newton Howard. Владелец: Newton Howard. Дата публикации: 2019-12-19.

Compounds and compositions for cognition-enhancement,methods of making,and methods of treating

Номер патента: ZA201106577B. Автор: Trevor M Twose,Brent D Abraham,Richard R Copp,James G Farnham,Seth A Hanson,Michael L Hendrickson,Jeffrey C Ockuly,Melinda L Verdone. Владелец: Mithridion Inc. Дата публикации: 2013-02-27.

Cognitive enhancement through feedback

Номер патента: ES2899170T3. Автор: Gerold Yonas,Charles J Chase. Владелец: Lockheed Corp. Дата публикации: 2022-03-10.

Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders

Номер патента: US20030050316A1. Автор: Jerry Buccafusco,Alvin Terry,J. Beach,Rammamohanna Jonnala. Владелец: Individual. Дата публикации: 2003-03-13.

Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders

Номер патента: AU2002322562A1. Автор: J. W. Beach,Jerry J. Buccafusco,Rammamohanna R. Jonnala,Alvin V. Terry. Владелец: Medical College of Georgia Research Institute Inc. Дата публикации: 2003-03-03.

A personalized closed-loop pulsed transcranial stimulation system for cognitive enhancement

Номер патента: WO2019036082A2. Автор: Michael D. Howard,Praveen K. PILLY,Iman Mohammadrezazadeh. Владелец: HRL LABORATORIES, LLC. Дата публикации: 2019-02-21.

Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use

Номер патента: CA2700160A1. Автор: Sergey Sablin,S. Bachurin,B. Beznosko,V. Sokolov,A. Aksinenko. Владелец: D2E, Llc. Дата публикации: 2009-03-26.

Device and method for cognitive enhancement of a user

Номер патента: CN103392196A. Автор: G.N.加西亚莫里纳,T.K.特索内瓦,D.朱,D.巴多,P.H.A.加布里伊森. Владелец: KONINKLIJKE PHILIPS ELECTRONICS NV. Дата публикации: 2013-11-13.

Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders

Номер патента: US6881738B2. Автор: J. Warren Beach,Jerry J. Buccafusco,Rammamohanna R. Jonnala,Alvin V. Terry. Владелец: Medical College of Georgia Research Institute Inc. Дата публикации: 2005-04-19.

Cognitive enhancement using feedback

Номер патента: EP2939706A1. Автор: Gerold Yonas,Charles J. Chase. Владелец: Lockheed Corp. Дата публикации: 2015-11-04.

Fluoro-containing derivatives of hydrogented pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use

Номер патента: WO2009038764A1. Автор: Sergey Sablin,V Sokolov,S Bachurin,B Beznosko,A Aksinenko. Владелец: D2E, Llc. Дата публикации: 2009-03-26.

Method and device for generating personalized transcranial direct current stimulation protocol for cognitive enhancement

Номер патента: WO2021095995A1. Автор: 김정윤,윤수정,홍가혜,류인균. Владелец: 이화여자대학교 산학협력단. Дата публикации: 2021-05-20.

Device and method for cognitive enhancement of a user

Номер патента: WO2012117343A1. Автор: Danhua Zhu,Gary Nelson Garcia Molina,Tsvetomira Kirova TSONEVA,Davide BALDO,Patrick Hans Arvid GABRIELSSON. Владелец: KONINKLIJKE PHILIPS ELECTRONICS N.V.. Дата публикации: 2012-09-07.

Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders

Номер патента: WO2003008559A2. Автор: J. W. Beach,Jerry J. Buccafusco,Rammamohanna R. Jonnala,Alvin V. Terry. Владелец: Medical College Of Georgia Research Institute. Дата публикации: 2003-01-30.

System and method for non-invasive brain stimulation of cognitive enhancement

Номер патента: US20230398353A1. Автор: ShiNung Ching,Todd Braver,Matthew Singh,Jacob Wheelock. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2023-12-14.

COMPOSITIONS AND PARTICLES CONTAINING CELLULOSIC FIBERS AND STABILIZED- AND/OR ACTIVATED- UREASE INHIBITORS, AS WELL AS METHODS OF MAKING AND USING THE SAME

Номер патента: US20170087532A1. Автор: Tan Zheng,GOYAL GOPAL C.,SHAVER LINNEA J.. Владелец: . Дата публикации: 2017-03-30.

HDAC (Histone deacetylase) and CDK (CDK) double-target inhibitor as well as preparation method and application thereof

Номер патента: CN110194769B. Автор: 甘宗捷. Владелец: Chongqing Medical University. Дата публикации: 2021-12-10.

NEW FARNESIL PROTEIN TRANSFERASE INHIBITORS AS ANTITUMOR AGENTS

Номер патента: RU2006106768A. Автор: Ф. Джордж НЙОРОГЕ,Алан Б. КУПЕР,Ягдиш А. ДЕСАИ,Вийур М. ГИРИЯВАЛЛАБХАН,Хью Й. ЖУ,Джеймс Дж-С УОНГ,Дайнанат Ф. РЕЙН,Роналд Дж. ДОЛЛ,Ф. Джордж НЙОРОГЕ (US),Вийур М. ГИРИЯВАЛЛАБХАН (US),Хью Й. ЖУ (US),Алан Б. КУПЕР (US),Ягдиш А. ДЕСАИ (US),Джеймс Дж-С УОНГ (US),Дайнанат Ф. РЕЙН (US),Роналд Дж. ДОЛЛ (US). Владелец: Шеринг Корпорейшн (US). Дата публикации: 2007-09-20.

INDOL DERIVATIVES AS INDOL INHIBITORS AS INHIBITORS OF HISTAMINE RECEIVER 3 FOR THE PARKING OF SUENO DISORDERS AND COGNITIVES OBESITY AND OTHER SNC DISORDERS

Номер патента: AR056690A1. Автор: . Владелец: Athersys Inc. Дата публикации: 2007-10-17.

Cell adhesion inhibitor as well as pharmaceutical compositions containing it

Номер патента: NO20006023D0. Автор: Wen-Cherng Lee,Alan Gill. Владелец: Biogen Inc. Дата публикации: 2000-11-28.

DERIVATIVES OF BENZO [C] QUINOLYSIN AND THEIR APPLICATION AS 5H-REDUCTASE INHIBITORS AS THE INHIBITORS

Номер патента: EA200000697A1. Автор: Антонио Гуарна,Марио Серио. Владелец: Апплайд Резеч Системз Арс Холдинг Н.В.. Дата публикации: 2000-12-25.

Spak kinase inhibitors as neuroprotective agents

Номер патента: AU2019351731A1. Автор: Dandan SUN,Xianming Deng,Jinwei ZHANG,Bradley J. Molyneaux,Mohammad Iqbal Hossain Bhuiyan. Владелец: US Department of Veterans Affairs VA. Дата публикации: 2021-05-20.

Pyrrolidine main protease inhibitors as antiviral agents

Номер патента: WO2024081351A1. Автор: David A. Degoey,Eric R. Miller,Timothy R. HODGES,Michael R. Schrimpf,Gregory A. Gfesser,Andrew Bogdan,Robert G. Schmidt,Xenia B. Searle,Edgars JECS,David J. Hardee,Justin D. DIETRICH,Alberto Munoz,Jacob LUDWIG,Sarah J. PERLMUTTER,Haun-Qiu X. LI,Alvin JANG,Elizabeth L. NOEY,Boguslaw P. NOCEK. Владелец: AbbVie Inc.. Дата публикации: 2024-04-18.

Spak kinase inhibitors as neuroprotective agents

Номер патента: US20210261497A1. Автор: Dandan SUN,Xianming Deng,Jinwei ZHANG,Bradley J. Molyneaux,Mohammad Iqbal Hossain Bhuiyan. Владелец: US Department of Veterans Affairs VA. Дата публикации: 2021-08-26.

Spak kinase inhibitors as neuroprotective agents

Номер патента: US20200102266A1. Автор: Dandan SUN,Xianming Deng,Jinwei ZHANG,Bradley J. Molyneaux,Mohammad Iqbal Hossain Bhuiyan. Владелец: US Department of Veterans Affairs VA. Дата публикации: 2020-04-02.

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING LRIT2 INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20210009710A1. Автор: Houh Youn Kyung,JEON Bu-Nam,KIM Yun Yeon,LEE Suro,CHUNG Joo-Yeon,JEONG Areum,SOHN Jinyoung,YOON Kyoung Wan. Владелец: GENOME AND COMPANY. Дата публикации: 2021-01-14.

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING PLK1 INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20220033405A1. Автор: Lee Sang Jin,KIM Jin Sook,YOON Eun-Kyung,KIM Kyungtae,Park Minji,LEE Eun Sook,LEE Byung Il,LEE Su-Hyung,PARK Joong-Won,BONG Seoung Min,LEE Joo-Youn. Владелец: . Дата публикации: 2022-02-03.

FIRST-IN-CLASS OF SHMT2 AND MTHFD2 INHIBITORS AS ANTITUMOR AGENTS

Номер патента: US20190100524A1. Автор: Gangjee Aleem,Matherly Larry H.. Владелец: . Дата публикации: 2019-04-04.

SPAK KINASE INHIBITORS AS NEUROPROTECTIVE AGENTS

Номер патента: US20200102266A1. Автор: Molyneaux Bradley J.,Deng Xianming,Sun Dandan,Zhang Jinwei,Bhuiyan Mohammad Iqbal Hossain. Владелец: . Дата публикации: 2020-04-02.

Endomucin Inhibitor as an Anti-Angiogenic Agent

Номер патента: US20190112610A1. Автор: "DAmore Patricia A.",Saint-Geniez Magali,Park-Windhol Cindy. Владелец: The Schepens Eye Research Institute, Inc.. Дата публикации: 2019-04-18.

Myobacterium Tuberculosis-Thioredoxin Reductase Inhibitor as an Antitubercular Agent

Номер патента: US20200123130A1. Автор: KOCH OLIVER,Bering Luis. Владелец: . Дата публикации: 2020-04-23.

Heterocyclic wdr5 inhibitors as anti-cancer compounds

Номер патента: US20220289732A1. Автор: Ce Wang,Jianping Wu,Tao Wang,Qitao XIAO,Sing Yeung Frankie MAK,Kevin Kun Chin LIU,Counde Oyang,Lichao FANG,Zhenting GAO,Xiangqing JIANG,Wu YINGMING. Владелец: NOVARTIS AG. Дата публикации: 2022-09-15.

SPAK KINASE INHIBITORS AS NEUROPROTECTIVE AGENTS

Номер патента: US20210261497A1. Автор: Molyneaux Bradley J.,Deng Xianming,Sun Dandan,Zhang Jinwei,Bhuiyan Mohammad Iqbal Hossain. Владелец: . Дата публикации: 2021-08-26.

MICRORNA INHIBITORS AS ANTI-CANCER THERAPEUTICS

Номер патента: US20190300883A1. Автор: JR. Charles R.,Thomas,ANAND Sudarshan,Rana Shushan. Владелец: . Дата публикации: 2019-10-03.

1H- pyrazol-1-yl-the thiazole and its application method of inhibitor as lactic dehydrogenase

Номер патента: CN109996797A. Автор: 杨世明,戴维·J·马洛尼,亚历克斯·格雷戈里·沃特森,甘尼沙·拉伊·班图卡卢,凯勒·瑞恩·布里马科姆,普拉门·克里斯托夫,希·V·丹格,维克托·M·达利-乌斯马尔,马修·霍尔,胡新,阿吉特·贾达夫,索姆纳特·贾纳,金光镐,威廉·J·穆尔,布莱恩·T·莫特,伦纳德·M·内克斯,安东·西梅奥诺夫,加里·艾伦·苏利科夫斯基,丹尼尔·詹森·乌尔班. Владелец: Goverment Of United States, AS REPRESENTED BY SECRETARY D. Дата публикации: 2019-07-09.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: US20050059672A1. Автор: Ronald Doll,Viyyoor Girijavallabhan,James Wang,Alan Cooper,Hugh Zhu,Jagdish Desai,Dinanath Rane,F. Njoroge. Владелец: Schering Corp. Дата публикации: 2005-03-17.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: WO2005014577A1. Автор: F. George Njoroge,Viyyoor M. Girijavallabhan,Ronald J. Doll,Dinanath F. Rane,Alan B. Cooper,Hugh Y. Zhu,Jagdish A. Desai,James J-S. Wang. Владелец: Schering Corporation. Дата публикации: 2005-02-17.

Kinase inhibitors as therapeutic agents

Номер патента: EP1268481A2. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,David Calderwood,Stephen St.Gallay,Helen L. Twigger. Владелец: BASF SE. Дата публикации: 2003-01-02.

An analgesic containing a p75NTR inhibitor as an active ingredient

Номер патента: JPWO2007026567A1. Автор: 山下　俊英,俊英 山下,朋子 渡辺. Владелец: Chiba University NUC. Дата публикации: 2009-03-05.

Map-kinase inhibitors as regulators of tumor-associated antigen expression

Номер патента: WO2004087941A1. Автор: Paul J. Durda,James T. Kurnick. Владелец: The General Hospital Corporation. Дата публикации: 2004-10-14.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: CA2535210A1. Автор: F. George Njoroge,Viyyoor M. Girijavallabhan,Ronald J. Doll,Dinanath F. Rane,Alan B. Cooper,Hugh Y. Zhu,Jagdish A. Desai,James J.-S. Wang. Владелец: James J.-S. Wang. Дата публикации: 2005-02-17.

Kinase inhibitors as therapeutic agents

Номер патента: CA2385769A1. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,David Calderwood,Helen L. Twigger,Stephen St. Gallay. Владелец: Individual. Дата публикации: 2001-03-22.

Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents

Номер патента: EP2225207A2. Автор: Roger Frechette. Владелец: BIOTA SCIENTIFIC MANAGEMENT PTY LTD. Дата публикации: 2010-09-08.

Kinase inhibitors as therapeutic agents

Номер патента: CN1390220A. Автор: G·C·希尔斯特,K·里特,H·L·特维格,P·拉菲蒂,S·圣加莱,D·卡尔德伍德. Владелец: Abert & Co KG GmbH. Дата публикации: 2003-01-08.

Farnesyl: protein transferase inhibitors as anticancer agents

Номер патента: CN1045207C. Автор: D·M·斯特莫里克. Владелец: Merrell Dow Pharmaceuticals Inc. Дата публикации: 1999-09-22.

Kinase inhibitors as therapeutic agents

Номер патента: AU7491400A. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,David Calderwood,Helen L. Twigger,Stephen St. Gallay. Владелец: BASF SE. Дата публикации: 2001-04-17.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: US20040122018A1. Автор: Ray James,Ge Li,Timothy Guzi,Ronald Doll,Viyyoor Girijavallabhan,Carmen Alvarez,Kartik Keertikar,James Wang,Alan Cooper,Hugh Zhu,Jagdish Desai,John Baldwin,Chia-Yu Huang,Dinanath Rane,F. Njoroge,Bama Santhanam,Patrick Pinto,Bancha Vibulbhan,Keith Minor,W. Bishop. Владелец: Schering Corp. Дата публикации: 2004-06-24.

ANALGESIC AGENT COMPRISING p75NTR INHIBITOR AS ACTIVE INGREDIENT

Номер патента: WO2007026567A1. Автор: Tomoko Watanabe,Toshihide Yamashita. Владелец: NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY. Дата публикации: 2007-03-08.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: WO2005014577A9. Автор: Ronald J Doll,F George Njoroge,Viyyoor M Girijavallabhan,James J-S Wang,Dinanath F Rane,Alan B Cooper,Hugh Y Zhu,Jagdish A Desai. Владелец: Jagdish A Desai. Дата публикации: 2006-03-23.

Heterocyclic wdr5 inhibitors as anti-cancer compounds

Номер патента: WO2021028806A1. Автор: Ce Wang,Jianping Wu,Tao Wang,Qitao XIAO,Sing Yeung Frankie MAK,Kevin Kun Chin LIU,Counde Oyang,Lichao FANG,Zhenting GAO,Xiangqing JIANG,Wu YINGMING. Владелец: NOVARTIS AG. Дата публикации: 2021-02-18.

Farnesyl:protein transferase inhibitors as anticancer agents

Номер патента: HUT72647A. Автор: David Martin Stemerick. Владелец: Merrell Dow Pharma. Дата публикации: 1996-05-28.

Novel farnesyl protein transferase inhibitors as antitumor agents

Номер патента: EP1660477A1. Автор: F. George Njoroge,Viyyoor M. Girijavallabhan,Ronald J. Doll,Dinanath F. Rane,Alan B. Cooper,Hugh Y. Zhu,Jagdish A. Desai,James J-S. Wang. Владелец: Schering Corp. Дата публикации: 2006-05-31.

Highly selective c-Met inhibitors as anticancer agents

Номер патента: JP6106899B2. Автор: ブォユー ヂョン,チュェン シー,ホンビン ユェン,フォン ヂョウ. Владелец: Cb Therapeutics Inc. Дата публикации: 2017-04-05.

Farnesyl protein transferase inhibitors as antitumor agents

Номер патента: CN100537542C. Автор: R·J·多尔,T·J·古兹,P·A·平托,A·B·库珀,J·J·包德温,W·R·比肖普,李格,H·Y·朱,R·A·詹姆士,F·G·恩乔洛吉,D·F·拉恩,K·P·米诺尔,V·M·吉利加法拉布汗,B·圣珊纳,B·维布尔巴汉,K·M·基尔堤卡,C·S·阿尔瓦雷兹,黄家育,J·J·-S·王,J·A·德塞. Владелец: Pharmacopeia LLC. Дата публикации: 2009-09-09.

Farnesyl protein transferase inhibitors as anticancer agents

Номер патента: DK0686159T3. Автор: David M Stemerick. Владелец: Merrell Pharma Inc. Дата публикации: 1998-01-26.

New RAC1 inhibitors as potential pharmacological agents for heart failure treatment

Номер патента: EP2241555A1. Автор: Marita Hogberg,Nicola Ferri,Alberto CorsiniI,Carmelina Ruggiero,Weimin Tong,Andrea Anneliese Robitzki,Uko Maran,Sulev Sild,Alfonso Tlatoani Garcia-Sosa,Christine Batzl-Hartmann,Pia Bartholomae,Jouko Sakari Uusitalo,Ari Tapio Tolonen,Timo Rousu,Juho Kalevi Hokkanen,Miia Turpeinen. Владелец: Novamass. Дата публикации: 2010-10-20.

Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy

Номер патента: CA2422489A1. Автор: Jeannette M. Whitcomb. Владелец: Individual. Дата публикации: 2002-03-21.

Novel farnesyl protein transferase inhibitors as antitumor

Номер патента: CN1471524A. Автор: ,J·王,�Ф,��˹��ŵ��,��������ķ������,李革,R·J·多尔,ƽ,R·A·詹姆斯,ٿ���,P·A·平托,A·B·库珀,F·G·恩乔罗格,B·桑塔纳姆,��ղķ˹����Ƕ�,黄嘉瑜,F��G��ʩ�ܵ���,V·M·吉里亚瓦拉班,H·Y·朱,J·A·德赛,K·P·米诺尔,B·维布尔班,T·古兹,D·F·拉尼,K·M·凯尔蒂卡,C·S·阿瓦雷斯,J·J·巴尔德温,R·W·比肖普. Владелец: Pharmacopeia LLC. Дата публикации: 2004-01-28.

Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents

Номер патента: CA2707445A1. Автор: Roger Frechette. Владелец: Roger Frechette. Дата публикации: 2009-06-11.

Cd14 inhibitors as an effective treatment for hcv infection

Номер патента: WO2014122660A1. Автор: Romy Zemel,Larisa BACHMETOV,Ran Tur-Kaspa. Владелец: MOR RESEARCH APPLICATIONS LTD.. Дата публикации: 2014-08-14.

The sulfonamide of inhibitor as the intake of extracellular citrate

Номер патента: CN110325527A. Автор: J·克利,S·考希克,D·维登迈尔,A·帕奇. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2019-10-11.

FARNESIL PROTEIN TRANSFERASE INHIBITORS AS ANTITUMOR AGENTS

Номер патента: RU2004128465A. Автор: Рональд Дж. ДОЛЛ,Картик М. КИРТИКАР,Тимоти Дж. ГУЗИ,Алан Б. КУПЕР,Хью И. ЖУ,Джон Дж. БОЛДУИН,Бама САНТАНАМ,Патрик А. ПИНТО,Кармен С. АЛЬВАРЕЗ,Ге ЛИ,Ф. Джордж НЬЕРОЖ,Динанат Ф. РЕИН,Кэйт П. МАЙНОР,Вийур Мупиль ДЖИРИЯВАЛЛАБАН,Бауха ВИБУЛБАН,Рональд Дж. ДОЛЛ (US),Картик М. КИРТИКАР (US),Бама САНТАНАМ (US),Тимоти Дж. ГУЗИ (US),Патрик А. ПИНТО (US),Алан Б. КУПЕР (US),Хью И. ЖУ (US),Ф. Джордж НЬЕРОЖ (US),Динанат Ф. РЕИН (US),Кэйт П. МАЙНОР (US),Вийур Мупиль ДЖИРИЯВАЛЛАБАН (US),Бауха ВИБУЛБАН (US),Кармен С. АЛЬВАРЕЗ (US),Джон Дж. БОЛДУИН (US),Ге ЛИ (CN). Владелец: Фармакопие Драг Дискавери, Инк. (US). Дата публикации: 2005-09-27.

Kinase inhibitors as therapeutic agents.

Номер патента: ZA200202122B. Автор: Kurt Ritter,Paul Rafferty,David Calderwood,Gavin C Hirst,Helen L Twigger,Stephen St Gallay. Владелец: Abbott Gmbh & Co Kg. Дата публикации: 2003-08-27.

Farnesyl protein transferase inhibitors as antitumor agents

Номер патента: NO20044053L. Автор: Ge Li,Chia-Yu Huang,Ronald J Doll,Timothy J Guzi,Walter Robert Bishop,John J Baldwin,Viyyoor Moopil Girijavallabhan,Bama Santhanam,Kartik M Keertikar,Bancha Vibulbhan,F George Njoroge,Ray Anthony James,Dinanath F Rane,Patrick A Pinto,Alan Bruce Cooper,Keith P Minor,Carmen S Alvarez,Hugh Y Zhu,Jagdish A Desai,James J S Wang. Владелец: Schering Corp. Дата публикации: 2004-11-26.

Pim kinase inhibitors as cancer chemotherapeutics

Номер патента: US20080161578A1. Автор: Thomas D. Penning,Vincent L. Giranda,Sheela A. Thomas. Владелец: ABBOTT LABORATORIES. Дата публикации: 2008-07-03.

Protease inhibitors as antivirals

Номер патента: CA3220847A1. Автор: XIAO Xu,Long Mao,Namir SHAABANI,Can JIN. Владелец: Acea Therapeutics Inc. Дата публикации: 2022-12-08.

Protease inhibitors as antivirals

Номер патента: US20230322668A1. Автор: XIAO Xu,Long Mao,Namir SHAABANI,Can JIN. Владелец: Acea Therapeutics Inc. Дата публикации: 2023-10-12.

Protease inhibitors as antivirals

Номер патента: AU2022283816A1. Автор: XIAO Xu,Long Mao,Namir SHAABANI,Can JIN. Владелец: Acea Therapeutics Inc. Дата публикации: 2024-01-04.

Myobacterium Tuberculosis-Thioredoxin Reductase Inhibitor as an Antitubercular Agent

Номер патента: US20200123130A1. Автор: Oliver Koch,Luis BERING. Владелец: TECHNISCHE UNIVERSITAET DORTMUND. Дата публикации: 2020-04-23.

Mycobacterium tuberculosis—thioredoxin reductase inhibitor as an antitubercular agent

Номер патента: US11078185B2. Автор: Oliver Koch,Luis BERING. Владелец: TECHNISCHE UNIVERSITAET DORTMUND. Дата публикации: 2021-08-03.

Cognitive enhancement training method and system based on neural regulation

Номер патента: US20230260605A1. Автор: SHA Li,Xiaoyi Wang,Zhujiang MA. Владелец: Beijing Wispirit Technology Co Ltd. Дата публикации: 2023-08-17.

Screening methods for cognitive enhancers

Номер патента: US09863934B2. Автор: Rusiko Bourtchouladze,Timothy P. Tully,Roderick E. M. Scott. Владелец: Dart Neuroscience Cayman Ltd. Дата публикации: 2018-01-09.

Method and Apparatus for Teaching and Cognitive Enhancement

Номер патента: US20140287386A1. Автор: Kenneth Wesson. Владелец: Individual. Дата публикации: 2014-09-25.

Method and Apparatus for Teaching and Cognitive Enhancement

Номер патента: US20170206801A1. Автор: Kenneth Wesson. Владелец: Individual. Дата публикации: 2017-07-20.

Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury

Номер патента: US5464843A. Автор: Joseph B. Monahan,Donald W. Hansen, Jr.,Karen B. Peterson. Владелец: GD Searle LLC. Дата публикации: 1995-11-07.

Novel hyperbranched polyesters and their use as wax inhibitor, as pour point depressant, as lubricant or in lubricating oils

Номер патента: EP3774996A1. Автор: Edward Bohres,XIAO Fu,Radoslaw Kierat,Stefan Frenzel,Anna Maria MUELLER-CRISTADORO,Felix Alexander WESTERHAUS,Tina NOACK. Владелец: BASF SE. Дата публикации: 2021-02-17.

Novel hyperbranched polyesters and their use as wax inhibitor, as pour point depressant, as lubricant or in lubricating oils

Номер патента: CA3092527A1. Автор: Edward Bohres,XIAO Fu,Radoslaw Kierat,Stefan Frenzel,Anna Maria MUELLER-CRISTADORO,Felix Alexander WESTERHAUS,Tina NOACK. Владелец: BASF SE. Дата публикации: 2019-10-03.

Soybean transformation using hppd inhibitors as selection agents

Номер патента: EP2531601A1. Автор: Bernard Pelissier,Yannick Favre,Flavie Coulombier,Hélène ECKERT. Владелец: Bayer CropScience AG. Дата публикации: 2012-12-12.

Composition for inducing dedifferentiation into cancer stem cells comprising ribosome-activating inhibitor as active ingredient, cancer organoid culture method and anticancer drug screening platform based thereon

Номер патента: US20180355323A1. Автор: Seung Joon Lee,Yuseok MOON. Владелец: University Industry Cooperation Foundation of Pusan National University. Дата публикации: 2018-12-13.

Composition for inducing dedifferentiation into cancer stem cells comprising ribosome-activating inhibitor as active ingredient, cancer organoid culture method and anticancer drug screening platform based thereon

Номер патента: US11091740B2. Автор: Seung Joon Lee,Yuseok MOON. Владелец: University Industry Cooperation Foundation of Pusan National University. Дата публикации: 2021-08-17.

Digital cognition enhancement training apparatus and method for cognitive reserve enhancement

Номер патента: US20230260414A1. Автор: Junyoung Lee,Bo Hee Kim,Hyunjin Cho,Museok Kang,Geonha KIM,Yoonyoung KANG,Minkyoung SO,Hanna CHUNG. Владелец: Haii Corp. Дата публикации: 2023-08-17.

Animal model of cholinergic dysfunction to evaluate cognitive enhancers and drugs that improve myasthenia

Номер патента: US20080052785A1. Автор: Marc Caron,Vania Prado,Marco Prado,Raul Gainetdinov,Grace Pereira,Braulio Castro,Cristina Silva,Ivan Izquierdo. Владелец: Individual. Дата публикации: 2008-02-28.

Natural oxidation inhibitor containing plant extracts, and preparation method and application of natural oxidation inhibitor, as well as processing method of minced pork

Номер патента: CN105341136A. Автор: 张忠超,李鹏程,范鑫,余年,戴清源,朱秀灵,潘汇,申屹,胡龙平,汪家龙. Владелец: ANHUI POLYTECHNIC UNIVERSITY. Дата публикации: 2016-02-24.

CONTRACTABLE MATERIALS CONTAINING PRINCIPALLY FATTY SUGAR INHIBITORS AS A MEANS OF BITTLE TREATMENT, OR CONTAINS MAINLY TANKS OF BITTERNESS AS A REDUCTURE MEANS

Номер патента: YU47534B. Автор: M.D.R.J. Kurtz,W.D. Fuller. Владелец: Bioresearch Inc.. Дата публикации: 1995-10-03.

CELLULOSE SYNTHASE INHIBITORS AS A NEW CLASS OF HERBICIDE AND NON-GMO CROPS THAT ARE RESISTANT TO THE HERBICIDE

Номер патента: US20200290959A1. Автор: Zhang Chunhua. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2020-09-17.

Plant hormone / auxin biosynthesis inhibitor, phytochemical regulator, herbicide containing the inhibitor as an active ingredient, and method of use thereof

Номер патента: JPWO2008150031A1. Автор: 秀樹 郷田,忠男 浅見,幸久 嶋田,巴 立川,貴広 石井,和雄 添野,昭三 藤岡. Владелец: RIKEN Institute of Physical and Chemical Research. Дата публикации: 2010-08-26.

Auxin transport inhibitors as potentiators or enhancers of herbicides.

Номер патента: ZA936743B. Автор: Richard James Anderson,Ian Stuart Cloudsdale,Jost Harr,Robert James Lamoreaux,Kristine Joyce Peters Schaefer. Владелец: SANDOZ Ltd. Дата публикации: 1995-03-13.

Inhibitor of biosynthesis of plant hormone auxin, chemical plant regulator comprising the inhibitor as active ingredient, herbicidal agent, and use thereof

Номер патента: WO2008150031A1. Автор: Shozo Fujioka,Takahiro Ishii,Yukihisa Shimada,Tadao Asami,Hideki Goda,Tomoe Tachikawa,Kazuo Soeno. Владелец: RIKEN. Дата публикации: 2008-12-11.

Isoxazole pyrazoloindane derivatives as cognition enhancing GABA-A alpha 5 subtype ligands

Номер патента: US20040006226A1. Автор: Angus Macleod,Tamara Ladduwahetty,Kevin Merchant,Francine Sternfeld. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2004-01-08.

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Номер патента: US20130274299A1. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: Mithridion Inc. Дата публикации: 2013-10-17.

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Номер патента: US20160340348A1. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: NEUROSOLIS Inc. Дата публикации: 2016-11-24.

Cognition enhancing compounds and compositions, methods of making, and methods of treating

Номер патента: US09738633B2. Автор: Richard R. Copp,Michael L. Hendrickson,Jeffrey C. Ockuly,Trevor M. Twose,Melinda L. Verdone,Brent D. Abraham,James G. Farnham,Seth A. Hanson. Владелец: NEUROSOLIS Inc. Дата публикации: 2017-08-22.

5-oxo-2-pyrrolidinepropanoic acid and derivatives as cognition activators

Номер патента: CA1240329A. Автор: Donald E. Butler. Владелец: Warner Lambert Co LLC. Дата публикации: 1988-08-09.

Adaptive vehicle illumination utilizing visual pattern learning and cognitive enhancing

Номер патента: US20190031085A1. Автор: Bo Zhang,Changrui Ren,Lin TANG,Yu Tao BA. Владелец: International Business Machines Corp. Дата публикации: 2019-01-31.

Methods for identifying cognitive enhancers

Номер патента: WO2021130746A1. Автор: Shira KNAFO. Владелец: Fundacion Biofisica Bizkaia/Biofisika Bizkaia Fundazioa. Дата публикации: 2021-07-01.

1-substituted oxindoles and azaoxindoles as novel cognition enhancers

Номер патента: ZA937453B. Автор: Christopher Allan Teleha. Владелец: Du Pont Merck Pharma. Дата публикации: 1995-04-07.

1-substituted oxindoles and azaoxindoles as novel cognition enhancers

Номер патента: AU5292893A. Автор: Christopher Allan Teleha. Владелец: DuPont Merck Pharmaceutical Co. Дата публикации: 1994-04-26.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: WO2008014916A1. Автор: Alwin Krämer. Владелец: Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts. Дата публикации: 2008-02-07.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: US20090264310A1. Автор: Alwin Krämer. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2009-10-22.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: EP2047255A1. Автор: Alwin Krämer. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2009-04-15.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: WO2008014916A9. Автор: Alwin Kraemer. Владелец: Alwin Kraemer. Дата публикации: 2009-02-26.

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Номер патента: US20130274299A1. Автор: Abraham Brent D.,Copp Richard R.,Farnham James G.,Hanson Seth A.,Hendrickson Michael L.,Ockuly Jeffrey C.,Twose Trevor M.,Verdone Melinda L.. Владелец: . Дата публикации: 2013-10-17.

NOVEL HYPERBRANCHED POLYESTERS AND THEIR USE AS WAX INHIBITOR, AS POUR POINT DEPRESSANT, AS LUBRICANT OR IN LUBRICATING OILS

Номер патента: US20210017466A1. Автор: Bohres Edward,FRENZEL Stefan,KIERAT Radoslaw,Fu Xiao,MUELLER-CRISTADORO Anna Maria,WESTERHAUS Felix Alexander,NOACK Tina. Владелец: . Дата публикации: 2021-01-21.

Adaptive vehicle illumination utilizing visual pattern learning and cognitive enhancing

Номер патента: US20190031084A1. Автор: Bo Zhang,Changrui Ren,Lin TANG,Yu Tao BA. Владелец: International Business Machines Corp. Дата публикации: 2019-01-31.

ADAPTIVE VEHICLE ILLUMINATION UTILIZING VISUAL PATTERN LEARNING AND COGNITIVE ENHANCING

Номер патента: US20190031085A1. Автор: ZHANG BO,Tang Lin,Ren Changrui,Ba Yu Tao. Владелец: . Дата публикации: 2019-01-31.

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Номер патента: US20180099956A1. Автор: Abraham Brent D.,Copp Richard R.,Farnham James G.,Hanson Seth A.,Hendrickson Michael L.,Ockuly Jeffrey C.,Twose Trevor M.,Verdone Melinda L.. Владелец: . Дата публикации: 2018-04-12.

SCREENING METHODS FOR COGNITIVE ENHANCERS

Номер патента: US20160139111A1. Автор: Tully Timothy P.,Bourtchouladze Rusiko,Scott Roderick E.M.. Владелец: . Дата публикации: 2016-05-19.

Method and Apparatus for Teaching and Cognitive Enhancement

Номер патента: US20180174479A1. Автор: Wesson Kenneth. Владелец: . Дата публикации: 2018-06-21.

COGNITIVE ENHANCEMENT OF COMMUNICATION WITH TACTILE STIMULATION

Номер патента: US20200168205A1. Автор: JR. John M.,Rakshit Sarbajit K.,Bostick James E.,Ganci,Keen Martin G.. Владелец: . Дата публикации: 2020-05-28.

Method and Apparatus for Teaching and Cognitive Enhancement

Номер патента: US20140287386A1. Автор: Wesson Kenneth. Владелец: . Дата публикации: 2014-09-25.

Method and Apparatus for Teaching and Cognitive Enhancement

Номер патента: US20170206801A1. Автор: Wesson Kenneth. Владелец: . Дата публикации: 2017-07-20.

Mobile Platform Designed For Hosting Brain Rehabilitation Therapy And Cognitive Enhancement Sessions

Номер патента: US20140330576A1. Автор: Bauer James Dean. Владелец: . Дата публикации: 2014-11-06.

SCREENING METHODS FOR COGNITIVE ENHANCERS

Номер патента: US20140342943A1. Автор: Tully Timothy P.,Bourtchouladze Rusiko,Scott Roderick E.M.. Владелец: . Дата публикации: 2014-11-20.

Cognitive Enhanced Oil Recovery Advisor System Based on Digital Rock Simulator

Номер патента: US20180252076A1. Автор: Rodrigo Neumann Barros Ferreira,Ronaldo Giro,Mathias B. Steiner,Peter William Bryant. Владелец: International Business Machines Corp. Дата публикации: 2018-09-06.

COGNITIVE ENHANCEMENT TO MEETING SCHEDULING

Номер патента: US20180293549A1. Автор: Liang Qian,Pan Che,Yue Zhiyu. Владелец: . Дата публикации: 2018-10-11.

COGNITIVE ENHANCEMENT TO MEETING SCHEDULING

Номер патента: US20180293550A1. Автор: Liang Qian,Pan Che,Yue Zhiyu. Владелец: . Дата публикации: 2018-10-11.

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Номер патента: US20160340348A1. Автор: Abraham Brent D.,Copp Richard R.,Farnham James G.,Hanson Seth A.,Hendrickson Michael L.,Ockuly Jeffrey C.,Twose Trevor M.,Verdone Melinda L.. Владелец: . Дата публикации: 2016-11-24.

ROUTE NAVIGATION SYSTEM, METHOD, AND RECORDING MEDIUM FOR COGNITIVE ENHANCEMENT

Номер патента: US20170343363A1. Автор: Goldberg Itzhack,PICKOVER Clifford A.,Kozloski James Robert. Владелец: . Дата публикации: 2017-11-30.

Cognition enhancing derivatives of isoxazole triazoloindane GABA-A alpha 5 receptor subunit ligands

Номер патента: US20040058970A1. Автор: Angus Macleod,Amanda Boase,Tamara Ladduwahetty,Kevin Merchant. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2004-03-25.

Compounds having cognition enhancer activity, a process for the preparation thereof and pharmaceutical compositions containing them

Номер патента: WO1992002498A1. Автор: Angelo Rainoldi. Владелец: Pulitzer Italiana S.R.L.. Дата публикации: 1992-02-20.

A kind of sense cognition enhancing robot system based on high in the clouds knowledge fusion

Номер патента: CN107291811A. Автор: 吴朝晖,杨莎,李石坚,潘纲,陈昕伟. Владелец: Zhejiang University ZJU. Дата публикации: 2017-10-24.

Urea type derivative used as nicotinamide ribose phosphate transferase inhibitor, as well as preparation method and application thereof

Номер патента: CN103709096A. Автор: 盛春泉,董国强,张赛龙,徐添颖,缪朝玉. Владелец: Second Military Medical University SMMU. Дата публикации: 2014-04-09.

Screening methods for cognitive enhancers

Номер патента: US20060069245A1. Автор: Timothy Tully,Rusiko Bourtchouladze,Roderick Scott. Владелец: Helicon Therapeutics Inc. Дата публикации: 2006-03-30.

Cognitive enhancement

Номер патента: US8784109B2. Автор: Bob Gottfried. Владелец: Individual. Дата публикации: 2014-07-22.

Cognition enhancement training method and system based on neural regulation

Номер патента: CN114201053A. Автор: 李莎,马珠江,王晓怡. Владелец: Beijing Smart Spirit Technology Co ltd. Дата публикации: 2022-03-18.

Cognition enhancement training method and system based on neural regulation

Номер патента: CN114201053B. Автор: 李莎,马珠江,王晓怡. Владелец: Beijing Smart Spirit Technology Co ltd. Дата публикации: 2022-06-28.

Novel hyperbranched polyesters and their use as wax inhibitor, as pour point depressant, as lubricant or in lubricating oils.

Номер патента: MX2020010096A. Автор: Edward Bohres,XIAO Fu,Radoslaw Kierat,Stefan Frenzel,Anna Maria MUELLER-CRISTADORO,Felix Alexander WESTERHAUS,Tina NOACK. Владелец: BASF SE. Дата публикации: 2020-10-28.

Systems and Methods For Cognitively Enhanced Repetitive Combinatorial Learning Activities For Mathematics

Номер патента: US20230177971A1. Автор: Matthew T. Mowery. Владелец: Individual. Дата публикации: 2023-06-08.

COMPOSITIONS AND PARTICLES CONTAINING CELLULOSIC FIBERS AND STABILIZED-AND/OR ACTIVATED-UREASE INHIBITORS, AS WELL AS METHODS OF MAKING AND USING THE SAME

Номер патента: US20140349835A1. Автор: Tan Zheng,GOYAL GOPAL C.,SHAVER LINNEA J.. Владелец: . Дата публикации: 2014-11-27.

COMPOSITIONS AND PARTICLES CONTAINING CELLULOSIC FIBERS AND STABILIZED- AND/OR ACTIVATED- UREASE INHIBITORS, AS WELL AS METHODS OF MAKING AND USING THE SAME

Номер патента: US20190358974A1. Автор: Tan Zheng,GOYAL GOPAL C.,SHAVER LINNEA J.. Владелец: . Дата публикации: 2019-11-28.

Multi-substituted monocyclopyrimidine JNK (Jun N Terminal) kinase inhibitor as well as preparation method and use thereof

Номер патента: CN103896856A. Автор: 宋磊,叶龙,胡保. Владелец: Individual. Дата публикации: 2014-07-02.

Kallikrein 7 small molecular inhibitor as well as preparation method and application thereof

Номер патента: CN106518868A. Автор: 王德平,李玉林,谭潇,王芳宇,严加林,何丽芳,周冬升. Владелец: Hengyang Normal University. Дата публикации: 2017-03-22.

Hydroxyproline structure-containing HIV-1 protease inhibitor as well as preparation method and application thereof

Номер патента: CN101948418A. Автор: 刘兆鹏,高炳磊. Владелец: Shandong University. Дата публикации: 2011-01-19.

Process for preparation of intermediates for the synthesis of glucose-6-phosphatase inhibitors as well as intermediates.

Номер патента: GR3026497T3. Автор: Horst Dr Hemmerle. Владелец: Hoechst AG. Дата публикации: 1998-07-31.

2-pyridyl-1-substitued imidazoline corrosion inhibitors as well as preparation method and application thereof

Номер патента: CN105949172A. Автор: 袁斌,吕松,区韵莹,黄科程. Владелец: GUANGDONG UNIVERSITY OF TECHNOLOGY. Дата публикации: 2016-09-21.

Aspartyl protease inhibitor as a nematode allergen

Номер патента: EP1546333A1. Автор: David Richard Maass,Margaret Mary Mcneill,Richard John Shaw,Charles Bix Tufts School Vet.Medicine SHOEMAKER. Владелец: Ovita Ltd. Дата публикации: 2005-06-29.

Ex vivo plasma enzyme activity assay using inhibitors as a negative control

Номер патента: US20180080941A1. Автор: Robert W. Brocia. Владелец: Roar Holding LLC. Дата публикации: 2018-03-22.

Ribonuclease L inhibitor as an indicator of chronic fatigue syndrome

Номер патента: US5766859A. Автор: Aristo Vojdani,Pli Mordechai. Владелец: Immunosciences Lab Inc. Дата публикации: 1998-06-16.

COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPRISING NAD GLYCOHYDROLASE INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20130123142A1. Автор: Kim Uh-Hyun,Park Kwang-Hyun,Kim Byung-Ju,Nam Tae-Sik. Владелец: Industrial Cooperation Foundation Chonbuk National University. Дата публикации: 2013-05-16.

EXPRESSION AND EXPORT OF ANGIOGENESIS INHIBITORS AS IMMUNOFUSINS

Номер патента: US20130165634A1. Автор: LI Yue,Gillies Stephen D.,Lo Kin-Ming. Владелец: . Дата публикации: 2013-06-27.

EX VIVO PLASMA ENZYME ACTIVITY ASSAY USING INHIBITORS AS A NEGATIVE CONTROL

Номер патента: US20130196340A1. Автор: BROCIA Robert W.. Владелец: Roar Holding LLC. Дата публикации: 2013-08-01.

SELECTIVE PHOSPHODIESTERASE 9A INHIBITORS AS MEDICAMENTS FOR IMPROVING COGNITIVE PROCESSES

Номер патента: US20130245045A1. Автор: Böss Frank-Gerhard,Erb Christina,Van Kampen Marja,Wunder Frank,Hendrix Martin. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2013-09-19.

AMINOTRIAZOLE- AND AMINOTETRAZOLE-BASED KDM1A INHIBITORS AS EPIGENETIC MODULATORS

Номер патента: US20170001968A1. Автор: Woster Patrick M.,KUTZ Craig J.. Владелец: MUSC Foundation for Research Development. Дата публикации: 2017-01-05.

SELECTIVE BETA-GLUCURONIDASE INHIBITORS AS A TREATMENT FOR SIDE EFFECTS OF CAMPTOTHECIN ANTINEOPLASTIC AGENTS

Номер патента: US20150051205A1. Автор: REDINBO MATTHEW R.. Владелец: The University of North Carolina at Chapel Hill. Дата публикации: 2015-02-19.

EX VIVO PLASMA ENZYME ACTIVITY ASSAY USING INHIBITORS AS A NEGATIVE CONTROL

Номер патента: US20180080941A1. Автор: BROCIA Robert W.. Владелец: Roar Holding LLC. Дата публикации: 2018-03-22.

COMPOSITION FOR INHIBITING ANGIOGENESIS CONTAINING A PEROXIDASIN INHIBITOR AS AN ACTIVE INGREDIENT

Номер патента: US20140171488A1. Автор: Kim Hyun Kyung,Joe Young Ae. Владелец: Catholic University Industry Academic Cooperation Foundation. Дата публикации: 2014-06-19.

SELECTIVE BCRP/ABCG2 TRANSPORTER INHIBITORS AS AGENTS TO ABOLISH RESISTANCE TO ANTI-CANCER AGENTS

Номер патента: US20220267289A1. Автор: BOUMENDJEL Ahcène,FALSON Pierre,MORENO Alexis,PERES Basile,ROUSSEL Emile. Владелец: . Дата публикации: 2022-08-25.

Soybean Transformation Using HPPD Inhibitors as Selection Agents

Номер патента: US20160130592A1. Автор: FAVRE Yannick,PELISSIER Bernard,Coulombier Flavie,Eckert Hélène. Владелец: . Дата публикации: 2016-05-12.

BRAF INHIBITORS AS PARADOX BREAKERS

Номер патента: US20220298145A1. Автор: Wichmann Juergen,Hunziker Daniel,Dolente Cosimo,HEWINGS David Stephen,KRUMMENACHER Daniela,PETTAZZONI Piergiorgio Francesco Tommaso. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2022-09-22.

2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS

Номер патента: US20170166867A1. Автор: Oh Steve,Chai Christina Li Lin,Low Joo Leng,LACO Filip,ZHONG Qixing. Владелец: . Дата публикации: 2017-06-15.

HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS

Номер патента: US20150218171A1. Автор: Zhou Feng,Shih Chuan,ZHONG Boyu,YUAN Hongbin. Владелец: . Дата публикации: 2015-08-06.

COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, CONTAINING PROGRANULIN INHIBITOR AS ACTIVE INGREDIENT

Номер патента: US20160319286A1. Автор: KIM Ju Young,OH Jae Min,YOUN Byung Soo,LEE Myeung Su. Владелец: OSTEONEUROGEN. Дата публикации: 2016-11-03.

HDAC Inhibitors as Anti-Cancer Agents

Номер патента: US20150329560A1. Автор: Almaliti Jehad,Bhansali Pravin,Tillekeratne L. M. Viranga,Al-Hamashi Ayad. Владелец: The University of Toledo. Дата публикации: 2015-11-19.

COMPOSITION FOR INDUCING DEDIFFERENTIATION INTO CANCER STEM CELLS COMPRISING RIBOSOME-ACTIVATING INHIBITOR AS ACTIVE INGREDIENT, CANCER ORGANOID CULTURE METHOD AND ANTICANCER DRUG SCREENING PLATFORM BASED THEREON

Номер патента: US20180355323A1. Автор: Lee Seung Joon,MOON Yuseok. Владелец: Pusan National University Industry-University Cooperation Foundation. Дата публикации: 2018-12-13.

Urinary trypsin inhibitors as diagnostic aid for interstitial cystitis

Номер патента: WO2011008682A1. Автор: Michael J. Pugia. Владелец: Siemens Healthcare Diagnostics Inc. Дата публикации: 2011-01-20.

Cyclin-dependent kinase inhibitors as plant growth regulators

Номер патента: CA2256121A1. Автор: Hong Wang,Larry C. Fowke,William L. Crosby. Владелец: Agriculture and Agri Food Canada AAFC. Дата публикации: 1999-12-08.

Aminopyrimidine and pyridyl amine inhibitor as Hedgehog signal transduction

Номер патента: CN103864770B. Автор: 黄伟,辛敏行,唐锋,沈晗,文珺,刘肇彧,涂崇兴,赵兴俄. Владелец: Jiangsu Simcere Pharmaceutical Co ltd. Дата публикации: 2019-06-11.

Sulphosuccinate and rust inhibitor as lube oil emulsification inhibit

Номер патента: FR2088341A1. Автор: . Владелец: BP PLC. Дата публикации: 1972-01-07.

Cyclin-dependent kinase inhibitors as plant growth regulators

Номер патента: US20060253930A1. Автор: Hong Wang,Larry Fowke,William Crosby. Владелец: Agriculture and Agri Food Canada AAFC. Дата публикации: 2006-11-09.

Aqueous enzyme compositions comprising proteolytic inhibitors as stabilizers

Номер патента: IL87327A0. Автор: . Владелец: Technicon Instr. Дата публикации: 1989-01-31.

Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs

Номер патента: US20070207512A1. Автор: Manuel Navia,Patrick Connelly,James Griffith,Scott Moe,Emanuele Perola,Andrew MAGEE,Paul Ala,Carlos FAERMAN,Janid Ali. Владелец: Pliva D.D.. Дата публикации: 2007-09-06.

Plastics coatings on metal substrates - of improved adhesion using primary and/or secondary inhibitors as subbing agents

Номер патента: DE2020922A1. Автор: Erdmann-Jesnitzer Friedr Habil. Владелец: ERDMANN JESNITZER FRIEDRICH PR. Дата публикации: 1972-03-16.

Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs

Номер патента: CA2451837A1. Автор: Scott T. Moe,Manuel A. Navia,Emanuele Perola,Janid A. Ali,Patrick R. Connelly,James P. Griffith,Carlos H. Faerman,Paul J. Ala,Andrew S. Magee. Владелец: Individual. Дата публикации: 2003-01-09.

Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs

Номер патента: EP1412516A4. Автор: Scott T Moe,Emanuele Perola,Patrick R Connelly,Manuel A Navia,Carlos H Faerman,James P Griffith,Paul J Ala,Janid A Ali,Andrew S Magee. Владелец: Essential Therapeutics Inc. Дата публикации: 2004-09-08.

Predictive biomarkers for EGFR tyrosine kinase inhibitors as anticancer therapy

Номер патента: KR101622454B1. Автор: 조병철,김한상. Владелец: 연세대학교 산학협력단. Дата публикации: 2016-05-18.

Soybean transformation using hppd inhibitors as selection agents

Номер патента: WO2011095460A1. Автор: Bernard Pelissier,Yannick Favre,Flavie Coulombier,Hélène ECKERT. Владелец: Bayer CropScience AG. Дата публикации: 2011-08-11.

Structure-based medicament design methods for identifying D-Ala-D-Ala ligase inhibitors as antibacterial medicaments

Номер патента: CZ200441A3. Автор: Naviaámanuel,Alaápauláj,Griffithájamesáp,Aliájanidáa,Faermanácarlosáh,Moeáscottát,Mageeáandrewás,Connellyápatrickár,Perolaáemanuele. Владелец: Plivaád@Ád. Дата публикации: 2004-08-18.

Human helicase ddx3 inhibitors as therapeutic agents

Номер патента: ITRM20150070A1. Автор: . Владелец: Azienda Ospedaliera Univ Senese. Дата публикации: 2016-08-13.

Discovery of imidazothiazole- and imidazooxazole-based selective HER4 kinase inhibitors as potential anticancer agents

Номер патента: US11795179B2. Автор: Mohammed El-Gamal. Владелец: University Of Sharjah. Дата публикации: 2023-10-24.

Aspartyl protease inhibitor as a nematode allergen

Номер патента: EP1546333A4. Автор: Charles Bix Shoemaker,David Richard Maass,Margaret Mary Mcneill,Richard John Shaw. Владелец: Ovita Ltd. Дата публикации: 2005-12-21.

Boswellia oil, its fractions and compositions for enhancing brain function

Номер патента: US20140342009A1. Автор: Kiran Bhupathiraju,Ganga Raju Gokaraju,Rama Raju Gokaraju,Venkata Kanaka Ranga Raju Gokaraju,Trimurtulu Golakoti,Venkata Krishna Raju Alluri. Владелец: LAILA NUTRACEUTICALS. Дата публикации: 2014-11-20.

Boswellia oil, its fractions and compositions for enhancing brain function

Номер патента: US20130045183A1. Автор: Kiran Bhupathiraju,Ganga Raju Gokaraju,Rama Raju Gokaraju,Venkata Kanaka Ranga Raju Gokaraju,Trimurtulu Golakoti,Venkata Krishna Raju Alluri. Владелец: LAILA NUTRACEUTICALS. Дата публикации: 2013-02-21.

Boswellia oil, its fractions and compositions for enhancing brain function

Номер патента: US09795646B2. Автор: Kiran Bhupathiraju,Ganga Raju Gokaraju,Rama Raju Gokaraju,Venkata Kanaka Ranga Raju Gokaraju,Trimurtulu Golakoti,Venkata Krishna Raju Alluri. Владелец: LAILA NUTRACEUTICALS. Дата публикации: 2017-10-24.

Glycine transporter-1 inhibitors

Номер патента: MY153714A. Автор: Hitchcock Stephen,Qian Wenyuan,Xia Xiaoyang,Amagadzie Albert,Scott S Harried. Владелец: AMGEN INC. Дата публикации: 2015-03-13.

SUBSTITUTED 2-AMINO-3-SULFONYL-TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS OF PRODUCING AND USING SAID COMPOUNDS

Номер патента: RU2384581C2. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко,Володимир Михайлович Кисиль. Владелец: Алла Хем, Ллс. Дата публикации: 2010-03-20.

Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Номер патента: CA3221177A1. Автор: Eva Czirr,Meghan Kerrisk Campbell,Reema Harish. Владелец: Alkahest Inc. Дата публикации: 2023-05-04.

Benzodioxane Modulators of Leukotriene A4 Hydrolase (LTA4H) for Prevention and Treatment of Aging-Associated Diseases

Номер патента: US20240252478A1. Автор: Eva Czirr,Meghan Kerrisk Campbell,Reema Harish. Владелец: Alkahest Inc. Дата публикации: 2024-08-01.

Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Номер патента: EP4426284A1. Автор: Eva Czirr,Meghan Kerrisk Campbell,Reema Harish. Владелец: Alkahest Inc. Дата публикации: 2024-09-11.

Pro-neurogenic compounds

Номер патента: US09701676B2. Автор: Steven L. Mcknight,Andrew A. Pieper,Joseph M. Ready,Enrique Fernandez. Владелец: University of Texas System. Дата публикации: 2017-07-11.

Tetracyclic imidazo-benzodiazepines as gamma-aminobutyric acid receptors

Номер патента: RU2393161C2. Автор: Бернд БЮТТЕЛЬМАНН,Хеннер КНУСТ,Эндрю Уилльям ТОМАС. Владелец: Ф. Хоффманн-Ля Рош Аг. Дата публикации: 2010-06-27.

Hyper-stabilized liposomes increasing directed targeting of mitotic cells

Номер патента: RU2765736C2. Автор: Чан Чжи Адриан НГ,Шень-И Айан ЧЕОНГ. Владелец: Темасек Лайф Сайенсиз Лаборатори Лимитед. Дата публикации: 2022-02-02.

5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile, therapeutic uses thereof

Номер патента: RU2659786C2. Автор: Ян КОЛЛИНС,Майкл ЛЭЙНЧБАРИ,Томас Питер МЭТТЬЮС,ДА ФОНСЕКА МАКХАРДИ Татьяна ФАРИЯ,Джеймс ОЗБОРН,Майкл Ян УОЛТОН,Мишель Доун ГАРРЕТТ. Владелец: Кансер Ресёрч Текнолоджи Лимитед. Дата публикации: 2018-07-04.

Pyridines

Номер патента: US8415379B2. Автор: Roland Jakob-Roetne,Andrew Thomas,Matthew C. Lucas. Владелец: Hoffmann La Roche Inc. Дата публикации: 2013-04-09.

Aryl-isoxazolo-4-yl-oxadiazole derivatives

Номер патента: CA2633425A1. Автор: Bernd Buettelmann,Bo Han,Andrew Thomas,Henner Knust,Andreas Koblet. Владелец: Andreas Koblet. Дата публикации: 2007-06-28.

Thiazoles

Номер патента: US8178522B2. Автор: Roland Jakob-Roetne,Andrew Thomas,Matthew C. Lucas. Владелец: Hoffmann La Roche Inc. Дата публикации: 2012-05-15.

Isoxazole-isoxazole and isoxazole-isothiazole derivatives

Номер патента: CA2749649C. Автор: Roland Jakob-Roetne,Andrew Thomas,Maria-Clemencia Hernandez,Matthew C. Lucas. Владелец: F Hoffmann La Roche AG. Дата публикации: 2017-04-04.

Isoxazole-pyridine derivatives

Номер патента: CA2760166C. Автор: Roland Jakob-Roetne,Andrew Thomas,Matthew C. Lucas. Владелец: F Hoffmann La Roche AG. Дата публикации: 2017-07-18.

Combination of huperzine and nicotinic compounds as a neuroprotective agent

Номер патента: WO2002011712A3. Автор: Alan P Kozikowski,Kenneth J Kellar. Владелец: Univ Georgetown. Дата публикации: 2002-12-27.

Combination of huperzine and nicotinic compounds as a neuroprotective agent

Номер патента: WO2002011712A8. Автор: Alan P Kozikowski,Kenneth J Kellar. Владелец: Univ Georgetown. Дата публикации: 2002-03-21.

Combination of huperzine and nicotinic compounds as a neuroprotective agent

Номер патента: US20020045639A1. Автор: Kenneth Kellar,Alan Kozikowski. Владелец: Individual. Дата публикации: 2002-04-18.

(3-arylsulphonyl quinolin-8-yl-dialkyl-amines - selective serotonin 5-ht6 receptor antagonists, methods for production and use thereof

Номер патента: RU2500672C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Андрей Александрович Иващенко. Дата публикации: 2013-12-10.

Intranasal administration of suramin for treating nervous system disorders

Номер патента: EP4229035A1. Автор: Michael Derby,Zachary ROME. Владелец: Paxmedica Inc. Дата публикации: 2023-08-23.

Allosteric modulators of nicotinic acetylcholine receptors

Номер патента: NZ747408A. Автор: John Sanders,Andrew John Harvey,Brian Campbell,Joseph Duffy,Ian Bell,Deodial Guiadeen,Thomas Greshock,Belinda Huff,Kenneth LEAVITT,Brendan CROWLEY,Vanessa RADA,William Shipe,Linda Suen. Владелец: Merck Sharp & Dohme LLC. Дата публикации: 2024-07-05.

Pro-neurogenic compounds

Номер патента: US09962368B2. Автор: Jef K. De Brabander,Steven L. Mcknight,Andrew A. Pieper,Joseph M. Ready. Владелец: University of Texas System. Дата публикации: 2018-05-08.

Pro-neurogenic compounds

Номер патента: US09884820B2. Автор: Jef K. De Brabander,Steven L. Mcknight,Andrew A. Pieper,Joseph M. Ready. Владелец: University of Texas System. Дата публикации: 2018-02-06.

Ligand with wide range of simultaneous receptor activity, pharmaceutical composition, method of preparing said composition and medicinal agent

Номер патента: RU2374245C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Алла Хем, Ллс. Дата публикации: 2009-11-27.

5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidine-2,4-dione and analogues as microphage elastase inhibitors

Номер патента: RU2391339C2. Автор: Фуде ЯНГ. Владелец: Квест Фармасьютикал Севисес (КьюПиЭс). Дата публикации: 2010-06-10.

Exciter of neurites formation

Номер патента: RU2442582C2. Автор: Тихо ЯБУТА,Фумико ЯНО,Мицуйоси АЗУМА. Владелец: Сэндзю Фармасьютикал Ко., Лтд.. Дата публикации: 2012-02-20.

N, n '-substituted 3, 7-diazabicyclo[3,3,1]nonane drug for memory regeneration in health and disease in patients of all age groups, based pharmaceutical composition and method of application thereof

Номер патента: RU2417082C2. Автор: Сергей Олегович Бачурин,Николай Серафимович Зефиров,Владимир Викторович Григорьев,Мстислав Игоревич Лавров,Владимир Александрович Палюлин,Константин Владимирович Анохин,Наталья Викторовна Комисарова,Анна Александровна Тиунова. Владелец: Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран). Дата публикации: 2011-04-27.

CRYSTALLINE AND SALT FORMS OF THE TGF-βR1 INHIBITOR AND THE METHOD OF OBTAINING THEM

Номер патента: RU2750702C1. Автор: Цзянью ЛУ,Чарльз З. Дин,Лихун ХУ,Хуэйцзюнь ХЭ,Шухуэй Чэнь,Цзянь ЛИ,Шэньи ШИ,Лифан У,Вэйдун ЛИ. Владелец: Джинфлит Терапьютикс (Шанхай) Инк.. Дата публикации: 2021-07-01.

1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1n-pyrazol-5-yl)urea as a trka kinase inhibitor

Номер патента: RU2719489C2. Автор: Стивен У. ЭНДРЮС,Шелли АЛЛЕН,Вэйдун ЛЮ,Брайан БАЕР,Зэкери КРЕЙН,Дэниел Джон УОТСОН. Владелец: Эррэй Биофарма Инк.. Дата публикации: 2020-04-17.

Therapeutic uses of dulaglutide

Номер патента: US20230088005A1. Автор: Hertzel Chaim GERSTEIN. Владелец: Eli Lilly and Co. Дата публикации: 2023-03-23.

Therapeutic uses of dulaglutide

Номер патента: CA3166573A1. Автор: Hertzel Chaim GERSTEIN. Владелец: Eli Lilly and Co. Дата публикации: 2021-08-05.

Treatment of neurodegenerative disorders

Номер патента: EP1959980A2. Автор: Radmila Mileusnic,Steven Peter Russell Rose. Владелец: Open University. Дата публикации: 2008-08-27.

Therapeutic uses of tirzepatide

Номер патента: US20230355719A1. Автор: Axel Haupt,Masahiro Murakami,Matthew Paul Coghlan,Jeffrey Scott RIESMEYER. Владелец: Eli Lilly and Co. Дата публикации: 2023-11-09.

Composition and method of improving cognition

Номер патента: WO2023111062A1. Автор: Fang Huang,Rickard Oste,Lovisa Heyman-Lindén,Nittaya MARUNGRUANG. Владелец: Berry Lab AB. Дата публикации: 2023-06-22.

Therapeutic uses of dulaglutide

Номер патента: AU2021213682A1. Автор: Hertzel Chaim GERSTEIN. Владелец: Eli Lilly and Co. Дата публикации: 2022-08-25.

Treatment of neurodegenerative disorders

Номер патента: WO2007060486A2. Автор: Radmila Mileusnic,Steven Peter Russell Rose. Владелец: THE OPEN UNIVERSITY. Дата публикации: 2007-05-31.

Human neural stem cells expressing human choline acetyltransferase, and use thereof

Номер патента: US9248152B2. Автор: Yun-Bae Kim,Seung Up Kim. Владелец: Industry Academic Cooperation Foundation of CBNU. Дата публикации: 2016-02-02.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: AU2024216537A1. Автор: Steven P. Braithwaite,S. Sakura Minami,Eva Czirr,Ian Gallager,Nina Huber. Владелец: Alkahest Inc. Дата публикации: 2024-09-19.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: AU2019306477B2. Автор: Steven P. Braithwaite,S. Sakura Minami,Eva Czirr,Ian Gallager,Nina Huber,Meghan Kerrisk Campbell,Sam JACKSON. Владелец: Alkahest Inc. Дата публикации: 2024-08-29.

Nmda receptor modulators and their application

Номер патента: RU2621049C2. Автор: Джозеф МОСКАЛ,Амин М. КХАН. Владелец: Нортвестерн Юниверсити. Дата публикации: 2017-05-31.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: NZ758615B2. Автор: Eva Czirr,Ian Gallager,Nina Huber,Steven P Braithwaite,S Sakura Minami. Владелец: Alkahest Inc. Дата публикации: 2024-01-04.

Dosing regimen for treatment of cognitive impairments with blood plasma products

Номер патента: EP4299129A3. Автор: Steven P. Braithwaite,S. Sakura Minami,Eva Czirr,Ian Gallager,Nina Huber. Владелец: Alkahest Inc. Дата публикации: 2024-03-20.

Dosing regimen for treatment of cognitive impairments with blood plasma products

Номер патента: EP4299129A2. Автор: Steven P. Braithwaite,S. Sakura Minami,Eva Czirr,Ian Gallager,Nina Huber. Владелец: Alkahest Inc. Дата публикации: 2024-01-03.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: ZA202301009B. Автор: Eva Czirr,Ian Gallager,Nina Huber,Steven P Braithwaite,S Sakura Minami. Владелец: Alkahest Inc. Дата публикации: 2023-10-25.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: NZ758615A. Автор: Eva Czirr,Ian Gallager,Nina Huber,Steven P Braithwaite,S Sakura Minami. Владелец: Alkahest Inc. Дата публикации: 2023-09-29.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: EP4374921A2. Автор: Steven P. Braithwaite,S. Sakura Minami,Eva Czirr,Ian Gallager,Nina Huber,Meghan Kerrisk Campbell,Sam JACKSON. Владелец: Alkahest Inc. Дата публикации: 2024-05-29.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: AU2018257921B2. Автор: Steven P. Braithwaite,S. Sakura Minami,Eva Czirr,Ian Gallager,Nina Huber. Владелец: Alkahest Inc. Дата публикации: 2024-06-06.

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Номер патента: EP4374921A3. Автор: Steven P. Braithwaite,S. Sakura Minami,Eva Czirr,Ian Gallager,Nina Huber,Meghan Kerrisk Campbell,Sam JACKSON. Владелец: Alkahest Inc. Дата публикации: 2024-06-19.

Co-crystals and pharmaceutical compositions containing same

Номер патента: RU2675270C2. Автор: Юэган Чжан,Майкл УОЛДО,Кваме Виреду НТИ-АДДАЕ,Саймон Адам О'НИЛ,Правин МУДУНУРИ,Бинь СУН,АЛСТЕН Джон Грегг ВАН,Марк ШТРОМАЙЕР,Кэти СТАВРОПУЛОС,Ирина Николаевна КАДИЯЛА,Меттачит НАВАМАЛ. Владелец: Вертекс Фармасьютикалз Инкорпорейтед. Дата публикации: 2018-12-18.

Method of estimation of cognitive development of children from 6 months to 10 years of life

Номер патента: RU2640097C1. Автор: Светлана Борисовна Лазуренко,Алла Васильевна Закрепина,Елена Антоновна Стребелева. Владелец: Елена Антоновна Стребелева. Дата публикации: 2017-12-26.

Method for prediction of patient's cognitive functions after internal carotid artery stenting

Номер патента: RU2740242C1. Автор: Маринэ Мовсесовна Танашян,Эдуард Георгиевич Гемджян,Роман Борисович Медведев,Владимир Львович Щипакин,Александр Юрьевич Кощеев. Владелец: Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН). Дата публикации: 2021-01-12.

Cognition and emotion estimation method

Номер патента: WO2022154133A1. Автор: Naoki Sekiya. Владелец: Naoki Sekiya. Дата публикации: 2022-07-21.

Isoxazolo-pyrazine derivatives

Номер патента: CA2706990C. Автор: Bernd Buettelmann,Roland Jakob-Roetne,Andrew Thomas,Henner Knust. Владелец: F Hoffmann La Roche AG. Дата публикации: 2016-05-10.

Imidazo-benzodiazepine derivatives

Номер патента: CA2584259C. Автор: Henner Knust,Andrew William Thomas. Владелец: F Hoffmann La Roche AG. Дата публикации: 2013-04-02.

Substituted phenoxyacetic acids, their esters and amides containing 2,6-dioxo-2,3,6,7-tetrahydro-1h-pyrin-8-yl fragments - a2a adenosine receptor antagonists and use thereof

Номер патента: RU2477726C1. Автор: Александр Васильевич Иващенко,Илья Матусович Окунь,Олег Дмитриевич Митькин,Мадина Георгиевна Кадиева. Владелец: Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак"). Дата публикации: 2013-03-20.

3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives

Номер патента: CA2048959C. Автор: Richard Charles Effland,Joseph Thomas Klein. Владелец: Aventis Pharmaceuticals Inc. Дата публикации: 2003-07-29.

5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands

Номер патента: US5677321A. Автор: Charles Gluchowski,Yoon T. Jeon. Владелец: Synaptic Pharmaceutical Corp. Дата публикации: 1997-10-14.

Driving characteristic determination device, driving characteristic determination method, and recording medium

Номер патента: US20240000354A1. Автор: Nobuyuki Kunieda,Koichi Emura,Akihiro Ohmoto. Владелец: Panasonic Intellectual Property Management Co Ltd. Дата публикации: 2024-01-04.

SUBSTITUTED 4-SULPHONYL-PYRAZOLES AND 3-SULPHONYL-PYRAZOLO[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT AND METHOD OF OBTAINING THEM

Номер патента: RU2369600C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Алла Хем, Ллс. Дата публикации: 2009-10-10.

8-(biaryl) quinoline pde4 inhibitors

Номер патента: AU2003243870A1. Автор: Yves Girard,Denis Deschenes,Patrick Lacombe,Daniel Dube,Michel Gallant,Dwight Macdonald,Laurence Dube. Владелец: Merck Frosst Canada and Co. Дата публикации: 2004-01-06.

Ligands of 5-ht6 receptors, pharmaceutical formulation, production method and medical product

Номер патента: RU2329044C1. Автор: Александр Васильевич Иващенко,Сергей Евгеньевич Ткаченко,Иль Матусович Окунь,Илья Матусович Окунь,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Алла Хем, Ллс. Дата публикации: 2008-07-20.

Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors

Номер патента: EP1893200A2. Автор: Stefania Gagliardi,Jean-Philippe Rocher,Giovanni Palombi,Piergiuliano Bugada. Владелец: Addex Pharmaceuticals SA. Дата публикации: 2008-03-05.

Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c)

Номер патента: US20210214352A1. Автор: Karl A. Scheidt,Herbert Y. Meltzer,Adam J. Csakai. Владелец: Northwestern University. Дата публикации: 2021-07-15.

4-substituted-phenyl acetamides and arylureas as agonists for the orphan receptor gpr88

Номер патента: WO2023146816A1. Автор: Chunyang JIN,Dongliang Guan,Ann Marie Decker,Md Toufiqur RAHMAN,Chaminda Lakmal HETTI HANDI. Владелец: Research Triangle Institute. Дата публикации: 2023-08-03.

4-substituted-phenyl acetamides and arylureas as agonists for the orphan receptor gpr88

Номер патента: AU2023212020A1. Автор: Chunyang JIN,Dongliang Guan,Ann Marie Decker,Md Toufiqur RAHMAN,Chaminda Lakmal HETTI HANDI. Владелец: Research Triangle Institute. Дата публикации: 2024-07-18.

Substituted quinazolines and analogs and the use thereof

Номер патента: US20030033089A1. Автор: Sui Cai,Ravi Upasani,Nancy Lan. Владелец: Euro Celtique SA. Дата публикации: 2003-02-13.

Substituted quinazolines and analogs and the use thereof

Номер патента: US20040162299A1. Автор: Yan Wang,Sui Cai,Ravi Upasani,Nancy Lan,David Fick,George Field. Владелец: Euro Celtique SA. Дата публикации: 2004-08-19.

Eye models for mental state analysis

Номер патента: WO2024182845A1. Автор: Siyuan Chen,Julien Epps. Владелец: NEWSOUTH INNOVATIONS PTY LIMITED. Дата публикации: 2024-09-12.

Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists

Номер патента: RU2502734C2. Автор: Грегор Джеймс Макдональд,Хосе Мануэль Бартоломе-Небреда,Сусана Конде-Сейде,Гол Михиль Люк Мария Ван,Франсиска ДЕЛЬГАДО-ХИМЕНЕС. Владелец: Янссен Фармацевтика Нв. Дата публикации: 2013-12-27.

Hydroxylated pyrimidyl cyclopentane as proteinkinase (act) inhibitor

Номер патента: RU2520735C2. Автор: Джеймс Ф. БЛЭЙК,Стивен ДО,Николас К. КАЛЛАН,Ян С. МИТЧЕЛЛ,Денгминг КСИАО,Руи КСУ,Кристин ЧАБОТ,Дзун ЛИАНГ,Брайан САФИНА,Биронг ЧЖАНГ,Кит Л. СПЕНСЕР,Йозеф БЕНКСИК. Владелец: Эррэй Биофарма Инк.. Дата публикации: 2014-06-27.

(1,10b-DIHYDRO-2-(AMINOALKYLPHENYL)-5H-PYRAZOLO[1,5-c][1,3] BENZOXAZIN-5-YL) PHENYLMETHANONE DERIVATIVES AS HIV VIRAL REPLICATION INHIBITORS

Номер патента: RU2416615C2. Автор: Абделлах ТАХРИ,Доминик Луи Нестор Гилэйн СЮРЛЕРО,Лили ХУ,Пит Том Берт Поль ВИГЕРИНК. Владелец: Тиботек Фармасьютикалз Лтд.. Дата публикации: 2011-04-20.

Feedback device and method for providing thermal feedback by means of same

Номер патента: US11755116B2. Автор: Kyoung Soo Yi,Se Hwan LIM. Владелец: Tegway Co Ltd. Дата публикации: 2023-09-12.

Retrofittable mask mount system for cognitive load reducing platform

Номер патента: US11890494B2. Автор: Omer Haciomeroglu,Sam J. Cossman,II John Davis Long,Michael RALSTON. Владелец: Qwake Technologies Inc. Дата публикации: 2024-02-06.

Retrofittable mask mount system for cognitive load reducing platform

Номер патента: US20240165434A1. Автор: Omer Haciomeroglu,Sam J. Cossman,II John Davis Long,Michael RALSTON. Владелец: Qwake Technologies Inc. Дата публикации: 2024-05-23.

Video playback device and control method thereof

Номер патента: US11831948B2. Автор: Chanwon Seo,Yehoon KIM,Sojung YUN. Владелец: SAMSUNG ELECTRONICS CO LTD. Дата публикации: 2023-11-28.

Automated assessment of cognitive, fine-motor, and memory skills

Номер патента: US20200302810A1. Автор: Kiju Lee. Владелец: CASE WESTERN RESERVE UNIVERSITY. Дата публикации: 2020-09-24.

Video playback device and control method thereof

Номер патента: US20240031644A1. Автор: Chanwon Seo,Yehoon KIM,Sojung YUN. Владелец: SAMSUNG ELECTRONICS CO LTD. Дата публикации: 2024-01-25.

Video playback device and control method thereof

Номер патента: EP4283528A3. Автор: Chanwon Seo,Yehoon KIM,Sojung YUN. Владелец: SAMSUNG ELECTRONICS CO LTD. Дата публикации: 2024-02-14.

Video playback device and control method thereof

Номер патента: EP4283528A2. Автор: Chanwon Seo,Yehoon KIM,Sojung YUN. Владелец: SAMSUNG ELECTRONICS CO LTD. Дата публикации: 2023-11-29.

Electronic apparatus and server for refining artificial intelligence model, and method of refining artificial intelligence model

Номер патента: US12061955B2. Автор: James Russell GERACI,Bichen SHI,Aonghus LAWLOR,Barry Smyth,Neil Hurley,Ruihai Dong. Владелец: SAMSUNG ELECTRONICS CO LTD. Дата публикации: 2024-08-13.

Cognitive load reducing platform for first responders

Номер патента: US20200151449A1. Автор: Omer Haciomeroglu,Michael E. Ralston,Sam J. Cossman,II John Davis Long. Владелец: Qwake Technologies Inc. Дата публикации: 2020-05-14.

Electronic device for acquiring image at moment intended by user and control method therefor

Номер патента: EP4380174A1. Автор: Sungsoo Choi. Владелец: SAMSUNG ELECTRONICS CO LTD. Дата публикации: 2024-06-05.

Method and system to identify, quantify, and display acoustic transformational structures in speech

Номер патента: US20100145681A1. Автор: Daniel M. Begel. Владелец: Individual. Дата публикации: 2010-06-10.

Line-1 Inhibitors to treat disease.

Номер патента: OA21217A. Автор: Claudio Sturino,Eckard Weber,Malay Doshi,Michael G. CORDINGLEY. Владелец: Transposon Therapeutics, Inc.. Дата публикации: 2024-02-29.

3-acylaminopyridin derivatives, applicable as serine-threonine proteinkinase gsk3b inhibitors, as medications for type ii diabetes treatment

Номер патента: RU2570907C2. Автор: Алексей Сергеевич Морозов,Николай Серафимович Зефиров,Валерий Николаевич Даниленко,Владимир Александрович Палюлин,Мария Георгиевна Алексеева,Дилара Анваровна Мавлетова,Дмитрий Иванович Осолодкин. Владелец: Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан". Дата публикации: 2015-12-20.

Systems and Methods for Enabling Non-Cognitive Radio Devices to Function as Cognitive Radios

Номер патента: US20120058794A1. Автор: . Владелец: . Дата публикации: 2012-03-08.

5-oxo-2-pyrrolidinepropanoic acid and derivatives as cognition activators

Номер патента: ZA833114B. Автор: Donald Eugene Butler. Владелец: Warner Lambert Co. Дата публикации: 1984-01-25.

KEY-BALL-DROP: An innovative game for ALL ages of ALL physical conditions. It combines a host of various sport outlines, played on 8 various length / shape lanes of different surfaces. It utilizes 3 different style or the same type of balls, player choice. Aim is at 7 holes or alternatively drop pins at the other end of the lane. It can be played Solo or with up to 4 competitors. A Game comprises of 8 Lanes and a Complete Match is 3 Rotations for both Physical and Cognitive enhancement.

Номер патента: AU2020903269A0. Автор: Gregory James Keyes. Владелец: Keyes, Gregory James DR. Дата публикации: 2020-10-01.

Metabolites of 9-amino-1,2,3,4-tetrahydroacridine and related compounds as non-hepatotoxic cognitive enhancers for the treatment of alzheimers disease

Номер патента: GB9113110D0. Автор: . Владелец: MARCHBANKS ROGER M. Дата публикации: 1991-08-07.

COMPOSITION COMPRISING OIL PALM PHENOLICS FOR USE IN PROVIDING NEUROPROTECTIVE EFFECTS AND COGNITIVE-ENHANCEMENT

Номер патента: US20120040029A1. Автор: Tan Yew Ai,Wahid Mohd Basri,Sambanthamurthi Ravigadevi S.,Leow Soon-Sen,Manickam Kalyana Sundram P.. Владелец: . Дата публикации: 2012-02-16.

SCREENING METHODS FOR COGNITIVE ENHANCERS

Номер патента: US20120171124A1. Автор: . Владелец: . Дата публикации: 2012-07-05.

Effervescent nootropic supplement tablet. Powdered cognitive enhancing effervescent tablet supplement including various nootropic compounds, including but not

Номер патента: GB201105096D0. Автор: . Владелец: NUTRITION FACTORY Ltd. Дата публикации: 2011-05-11.

Glucosyltransferase inhibitors, as well as dental caries prevention methods and anticarious foods using the same

Номер патента: CA2039538C. Автор: Hiroyuki Ono,Koichi Nakahara,Kyoichi Ogura. Владелец: Suntory Ltd. Дата публикации: 2002-03-12.

Methods for identifying cognitive enhancers

Номер патента: IL271639A. Автор: Knafo Shira. Владелец: Knafo Shira. Дата публикации: 2021-06-30.

Heterocyclic compounds and cognitive enhancers comprising the same as effective components

Номер патента: AU2002230098A1. Автор: Naoki Fukuda,Yoshimasa Yamaguchi,Toshiyuki Matsuno,Seiichiro Kawashima,Kenichi Saitoh,Masaya Higashi. Владелец: Zenyaku Kogyo KK. Дата публикации: 2003-02-20.

Cogniverse: secure metaverse for cognitive enhancement and advanced learning

Номер патента: GB202308904D0. Автор: . Владелец: Univ Of Metaverse. Дата публикации: 2023-07-26.

Clay inhibitor as well as preparation method and application thereof

Номер патента: CN104556771A. Автор: 杨勇,刘浩,刘加平,冉千平,周栋梁,毛永琳. Владелец: Nanjing Bote Building Materials Co Ltd. Дата публикации: 2015-04-29.

Migrating type composite rebar corrosion inhibitor as well as preparation method and application thereof

Номер патента: CN103626418A. Автор: 王涛,张恒,贾恒琼,李海燕,吴韶亮,魏曌,李洪刚,刘子科,邵丕彦. Владелец: Metals and Chemistry Research Institute of CARS. Дата публикации: 2014-03-12.

Hydrogen sulfide slow-release inhibitor as well as preparation method and application thereof

Номер патента: CN104782622A. Автор: 马晓丽,张丽萍,金竹萍,裴雁曦. Владелец: SHANXI UNIVERSITY. Дата публикации: 2015-07-22.

Novel gene of virus original protease inhibitor as well as expression and application thereof

Номер патента: CN101570755B. Автор: 曾凡荣,薛仁风. Владелец: Institute of Plant Protection of Chinese Academy of Agricultural Sciences. Дата публикации: 2011-09-28.

Substituted cyclobutane neuraminidase inhibitors as well as using method and application thereof

Номер патента: CN104447390A. Автор: 任青云,张英俊,张健存,胡柏林,敖丽华. Владелец: Guangdong HEC Pharmaceutical. Дата публикации: 2015-03-25.

Sterides 5 alpha-reductase inhibitor, as well as preparation method and medical application thereof

Номер патента: CN103554210A. Автор: 孙洁,向华,张陆勇,刘元元,严明,宁珊珊,寻国良,廖清江. Владелец: CHINA PHARMACEUTICAL UNIVERSITY. Дата публикации: 2014-02-05.

Pancreatic lipase inhibitor derived from young barley leaves, lipid absorption inhibitor, as well as food and drink containing the same

Номер патента: JP2022014440A. Автор: Hiroshi Sato,Eisuke Kato,浩志 佐藤,英介 加藤. Владелец: Nissei Bio Co Ltd. Дата публикации: 2022-01-19.

Oil field scale inhibitor as well as preparation method and application thereof

Номер патента: CN102703047B. Автор: 王立军,刘喜林,岳大伟,阚艳红,陈定杰,郑秀海. Владелец: China Petroleum and Natural Gas Co Ltd. Дата публикации: 2015-04-08.

A composition based on an aqueous polymer dispersion containing polyurethane acrylate and a corrosion inhibitor, as well as water-based dispersion paints based on it

Номер патента: RU2018144192A. Автор: Дмитрий Васильевич ДУХОПЕЛЬНИКОВ. Владелец: Дмитрий Васильевич ДУХОПЕЛЬНИКОВ. Дата публикации: 2019-01-21.

JAK/STAT3 phosphorylation inhibitor as well as preparation method and application thereof

Номер патента: CN104725398B. Автор: 杨威,牛玉强. Владелец: Individual. Дата публикации: 2017-01-18.

Compositions based on aqueous polymer dispersions containing N-alkylpyrrolidones and corrosion inhibitors, as well as their use

Номер патента: RU2018142593A. Автор: Дмитрий Васильевич ДУХОПЕЛЬНИКОВ. Владелец: Дмитрий Васильевич ДУХОПЕЛЬНИКОВ. Дата публикации: 2019-01-10.

Glucosyltransferase inhibitors, as well as dental caries prevention methods and anticarious foods using the same

Номер патента: CA2039538A1. Автор: Hiroyuki Ono,Koichi Nakahara,Kyoichi Ogura. Владелец: Kyoichi Ogura. Дата публикации: 1991-10-01.

High-efficiency composite hydrate inhibitor as well as preparation method and application thereof

Номер патента: CN102161720A. Автор: 王涛,胡军,李清平,庞维新,姚海元,程兵,程艳,樊栓狮,郎雪梅,王燕鸿,李斯佳,李支文. Владелец: CNOOC Research Center. Дата публикации: 2011-08-24.

Imidazo- and traizolopyridines as inhibitors as 11-beta hydroxysteroid dehydrogenase type I

Номер патента: ZA200710220B. Автор: LI JUN,Wang Haixia,Ruan Zheming,Jeffrey A Robl,Lawrence G Hamann,James J Li,Christopher B Cooper. Владелец: Bristol Myers Squibb Co. Дата публикации: 2009-03-25.

Aspartyl protease inhibitor as a nematode allergen.

Номер патента: ZA200501578B. Автор: Charles Bix Shoemaker,David Richard Maass,Margaret Mary Mcneill,Richard John Shaw. Владелец: Ovita Ltd. Дата публикации: 2005-12-09.

Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular diseases

Номер патента: AU2001288798A1. Автор: Masakazu Sato,Shigeru Okuyama,Kazuya Kameo,Noriyuki Miyata,Richard J. Roman,David R. Harder. Владелец: Medical College of Wisconsin Research Foundation Inc. Дата публикации: 2002-07-18.

TRK inhibitor as anti-cancer drug

Номер патента: AU2019335450B2. Автор: Guangming Chen,Boyu Zhong,Tony Yantao Zhang,Yiju CAO. Владелец: Tyligand Bioscience Shanghai Ltd. Дата публикации: 2024-11-14.

USE OF THE COMBINATION OF PHY906 AND A TYROSINE KINASE INHIBITOR AS A CANCER TREATMENT REGIMEN

Номер патента: US20120009282A1. Автор: Cheng Yung-Chi,Liu Shwu-Huey,Tilton Robert,JIANG ZAOLI. Владелец: . Дата публикации: 2012-01-12.

NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS

Номер патента: US20120053220A1. Автор: Van Leyen Klaus,Holman Theodore R.,Lo Eng H.,Jacobson Matthew P.,Howells David W.. Владелец: . Дата публикации: 2012-03-01.

URINARY TRYPSIN INHIBITORS AS DIAGNOSTIC AID FOR INTERSTITIAL CYSTITIS

Номер патента: US20120115174A1. Автор: Pugia Michael J.. Владелец: SIEMENS HEALTHCARE DIAGNOSTICS INC.. Дата публикации: 2012-05-10.

ARGINASE INHIBITORS AS THERAPEUTICS

Номер патента: US20120129806A1. Автор: . Владелец: . Дата публикации: 2012-05-24.

POLYAMINE TRANSPORT INHIBITORS AS NOVEL THERAPEUTICS

Номер патента: US20120172449A1. Автор: ARCHER Jennifer J.,Phanstiel Otto. Владелец: . Дата публикации: 2012-07-05.

Method Of Inhibiting Myopia And Application Of An Adenylyl Cyclase Inhibitor As A Drug For inhibiting Myopia

Номер патента: US20120270887A1. Автор: Zhou Xiangtian,Qu Jia,Tao Yijin,Pan Miaozhen. Владелец: SCHOOL OF OPHTHALMOLOGY AND OPTOMETRY, WENZHOU MEDICAL COLLEGE. Дата публикации: 2012-10-25.

Protein Arginine Deiminase Inhibitors as Novel Therapeutics for Rheumatoid Arthritis and Cancer

Номер патента: US20120277176A1. Автор: Thompson Paul R.,Causey Corey P.. Владелец: . Дата публикации: 2012-11-01.

SOYBEAN TRANSFORMATION USING HPPD INHIBITORS AS SELECTION AGENTS

Номер патента: US20120311743A1. Автор: . Владелец: Bayer CropScience AG. Дата публикации: 2012-12-06.

SELECTIVE BETA-GLUCURONIDASE INHIBITORS AS A TREATMENT FOR SIDE EFFECTS OF CAMPTOTHECIN ANTINEOPLASTIC AGENTS

Номер патента: US20120322797A1. Автор: Scott John,REDINBO MATTHEW R.,Yeh Li-An,Williams Alfred,Mani Sridhar,Wallace Bret David,Lane Kimberly Terry. Владелец: . Дата публикации: 2012-12-20.

KINESIN INHIBITORS AS CANCER THERAPEUTICS

Номер патента: US20130012560A1. Автор: Renhowe Paul A.,ABRAMS Tinya,BARSANTI Paul,Duhl David,Faure Michel,Walter Annette Olga. Владелец: . Дата публикации: 2013-01-10.

The substituted-amino pyrimidine of inhibitor as EGFR tyrosine kinase

Номер патента: CN104761585B. Автор: 宋运涛,A.J.布里奇. Владелец: Jilin Huikang Pharmaceutical Co ltd. Дата публикации: 2019-03-26.

Preventive and treating agent for apoplexy and brain edema including il-8 bond inhibitor as active ingredient

Номер патента: JPH10182485A. Автор: 綱治 松島,Tetsuya Matsumoto,哲哉 松本,Kiyonobu Ikeda,Tsunaharu Matsushima,Sumihiro Yamashita,純宏 山下,清延 池田. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 1998-07-07.

Apoptosis inhibitor containing aldose reductase inhibitor as active ingredient

Номер патента: JP2003252794A. Автор: Makoto Tanaka,真 田中,和一十 川▲ばた▼,Koichiro Terai,Kazuhito Kawabata,浩一郎 寺井,Atsuto Inoue,敦人 井上. Владелец: Ono Pharmaceutical Co Ltd. Дата публикации: 2003-09-10.

Novel anandamide amidase inhibitors as analgesic agents

Номер патента: CA2615696A1. Автор: Alexandros Makriyannis,Sonyan Lin,William Adam Hill. Владелец: William Adam Hill. Дата публикации: 1997-12-04.

Preventive or therapeutic agent for diseases comprising interleukin 18 inhibitor as an active ingredient

Номер патента: JP4961559B2. Автор: 友昭 星野,久道 相澤. Владелец: 友昭 星野. Дата публикации: 2012-06-27.

Potassium channel inhibitors as therapeutic agents in lymphoma and leukaemia

Номер патента: RU2533288C2. Автор: Евгений Александрович Никитин,Анна Вячеславовна Баранова,Андрей Борисович Судариков,Андрей Владимирович Марахонов,Михаил Юрьевич Скоблов,Белла Вениаминовна Бидерман. Владелец: Федеральное государственное бюджетное учреждение "Медико-генетический научный центр" Российской академии медицинских наук. Дата публикации: 2014-11-20.

POTASSIUM CHANNEL INHIBITORS, AS MEDICINES FOR LYMPHOMAS AND LEUKOSIS

Номер патента: RU2012137945A. Автор: Евгений Александрович Никитин,Анна Вячеславовна Баранова,Андрей Борисович Судариков,Андрей Владимирович Марахонов,Михаил Юрьевич Скоблов,Белла Вениаминовна Бидерман. Владелец: Федеральное государственное бюджетное учреждение "Медико-генетический научный центр" Российской академии медицинских наук. Дата публикации: 2014-03-20.

Use of quinoxalines in combination with protease inhibitors as medicaments for treation, aids and/or hiv infections

Номер патента: TH22511A. Автор: แมนเฟรดรอสเนอร์ นาย,ลอร์ก-ปีเตอร์เคลม นาย,กันเตอร์ไร นาย,มาร์ตินบลูน นาย,อาร์โนลด์พาเบนส์ นาย. Владелец: นาย ธเนศเปเรร่า. Дата публикации: 1996-12-24.

Novel covalent inhibitors as antiviral agents

Номер патента: WO2024137764A1. Автор: Wei Li,Jiang Long,Bin Wang,Yat Sun Or,Hui Cao,Xuri Gao,Jianming Yu,Xuechao Xing,Scott Mitchell,Jiajun Zhang,Matthew C. Rhodes,Yuk Ming SIU. Владелец: Enanta Pharmaceuticals, Inc.. Дата публикации: 2024-06-27.

GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS

Номер патента: US20120004273A1. Автор: Ahmad Nadia Mamoona,Branch Clive Leslie,Jaxa-Chamiec Albert Andrzej,Quai Lai Justine Yeun,Nash David John. Владелец: . Дата публикации: 2012-01-05.

TREATING IMPULSE CONTROL DISORDERS WITH CATECHOL-O-METHYL-TRANSFERASE INHIBITORS

Номер патента: US20120004316A1. Автор: Grant Jon E.. Владелец: . Дата публикации: 2012-01-05.

BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

Номер патента: US20120004225A1. Автор: COLLINS Stephen D.,Partridge John J.,Wanaski Stephen. Владелец: NeuroTherapeutics Pharma, Inc.. Дата публикации: 2012-01-05.

LONG LASTING DRUG FORMULATIONS

Номер патента: US20120003196A1. Автор: Stern Baruch S.,Pearlman Andrew L.. Владелец: . Дата публикации: 2012-01-05.

SUBSTITUTED CYCLOALKANO[e OR d]PYRAZOLO[1,5-a]PYRIMIDINE-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHOD OF PRODUCING SAID COMPOUNDS AND USE

Номер патента: RU2374249C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Алла Хем, Ллс. Дата публикации: 2009-11-27.

SUBSTITUTED 2-ALKYLSULFANYL-3-SULFONYL-PYRAZOLO[1,5-a]PYRIMIDINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS

Номер патента: RU2393159C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Алла Хем, Ллс. Дата публикации: 2010-06-27.

SUBSTITUTED 3-ARYLSULFONYL-PYRAZOLO[1,5-a]PYRIMIDINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS

Номер патента: RU2393158C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Алла Хем, Ллс. Дата публикации: 2010-06-27.

ANTI-CTLA-4 AND CPG-MOTIF-CONTAINING SYNTHETIC OLIGODEOXYNUCLEOTIDE COMBINATION THERAPY FOR CANCER TREATMENT

Номер патента: US20120003179A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

Materials and Methods to Enhance Hematopoietic Stem Cells Engraftment Procedures

Номер патента: US20120003189A1. Автор: Pelus Louis M.,Hoggatt Jonathan,Singh Pratibha. Владелец: . Дата публикации: 2012-01-05.

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS

Номер патента: US20120003227A1. Автор: SUKHATME VIKAS P.,CHAN CHUNKONG BARDEN. Владелец: . Дата публикации: 2012-01-05.

Compositions, Methods and Kits for Nucleic Acid Synthesis and Amplification

Номер патента: US20120003645A1. Автор: Woo Cora L.,Yim Priscilla W.,Berkman Jennifer. Владелец: LIFE TECHNOLOGIES CORPORATION. Дата публикации: 2012-01-05.

IDENTIFICATION OF NEUROPROTECTIVE AGENTS USING PRO-INFLAMMATORY HUMAN GLIAL CELLS

Номер патента: US20120003655A1. Автор: Marchetto Maria C.N.,Gage Fred H.,Glass Christopher K.,Saijo Kaoru,Winner Beate. Владелец: The Salk Institute for Biological Studies. Дата публикации: 2012-01-05.

METHOD OF ISOLATION AND PURIFICATION OF TRYPSIN FROM PRONASE PROTEASE AND USE THEREOF

Номер патента: US20120003691A1. Автор: Tauer Christa,Mitterer Artur,Reiter Manfred,Mundt Wolfgang. Владелец: Baxter Healthcare S.A.. Дата публикации: 2012-01-05.

HERBICIDAL COMPOSITIONS

Номер патента: US20120004105A1. Автор: Zambach Werner,Pitterna Thomas,Jeanmart Stephane Andre Marie,Muehlebach Michel,Maienfisch Peter,Hueter Ottmar Franz,Wenger Jean,Goeghova Marcela. Владелец: SYNGENTA CROP PROTECTION LLC. Дата публикации: 2012-01-05.

Methods of Treating an Overweight or Obese Subject

Номер патента: US20120004162A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

HETEROCYCLICALLY SUBSTITUTED METHOXYPHENYL DERIVATIVES WITH AN OXO GROUP, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS

Номер патента: US20120004165A1. Автор: Keil Stefanie,DEFOSSA Elisabeth,DIETRICH Viktoria,KLABUNDE Thomas,STENGELIN Siegfried,HASCHKE Guido,HERLING Andreas. Владелец: SANOFI. Дата публикации: 2012-01-05.

ARYLOXYALKYLENE-SUBSTITUTED HYDROXYPHENYLHEXYNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер патента: US20120004166A1. Автор: Keil Stefanie,DEFOSSA Elisabeth,DIETRICH Viktoria,KLABUNDE Thomas,STENGELIN Siegfried,HASCHKE Guido,HERLING Andreas. Владелец: SANOFI. Дата публикации: 2012-01-05.

(2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS

Номер патента: US20120004167A1. Автор: Keil Stefanie,DEFOSSA Elisabeth,DIETRICH Viktoria,KLABUNDE Thomas,STENGELIN Siegfried,HASCHKE Guido,HERLING Andreas. Владелец: SANOFI. Дата публикации: 2012-01-05.

TARGETED DELIVERY SYSTEM

Номер патента: US20120004181A1. Автор: MEDINA-KAUWE Lali K.. Владелец: CEDARS-SINAI MEDICAL CENTER. Дата публикации: 2012-01-05.

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INDUCTION AND ENHANCEMENT OF APOPTOSIS IN TUMOR CELLS

Номер патента: US20120004182A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

SPIROCYCLICALLY SUBSTITUTED 1,3-PROPANE DIOXIDE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер патента: US20120004187A1. Автор: . Владелец: SANOFI. Дата публикации: 2012-01-05.

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

Номер патента: US20120004195A1. Автор: Crawford Thomas C.,Reiter Lawrence Alan,Glucksmann Alexandra. Владелец: . Дата публикации: 2012-01-05.

THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN

Номер патента: US20120004217A1. Автор: TAFESSE Laykea,SUN Qun,VICTORY Sam. Владелец: Purdue Pharma L.P.. Дата публикации: 2012-01-05.

SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF

Номер патента: US20120004220A9. Автор: Zhi Lin. Владелец: . Дата публикации: 2012-01-05.

COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING LIPID LEVELS

Номер патента: US20120004223A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

INHIBITORS OF AKT ACTIVITY

Номер патента: US20120004240A1. Автор: Peel Michael R.,Moore,Liu Hao,Siu Tony,SAKAMOTO Toshihiro,III Joseph A.,ONOZAKI Yu,Fan Weiming,PANDI Bharathi,OGINO Yoshio,JENKS Matthew G.,Haxell Thomas F.N.,Kawanishi Nobuhiko,Lee Shuliang,Malaska Michael J.. Владелец: . Дата публикации: 2012-01-05.

The polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof

Номер патента: US20120004249A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

INHIBITION OF FATTY ACID SYNTHESIS BY IODO-NITROBENZAMIDE COMPOUNDS AND METHODS OF TREATMENT THEREOF

Номер патента: US20120004260A1. Автор: Sherman Barry,Ossovskaya Valeria. Владелец: BIPAR SCIENCES, INC.. Дата публикации: 2012-01-05.

MIF MODULATORS

Номер патента: US20120004261A1. Автор: Jorgensen William L.,Bucala Richard J.. Владелец: YALE UNIVERSITY. Дата публикации: 2012-01-05.

PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE

Номер патента: US20120004262A1. Автор: Guibourt Nathalie,ORTEGA MUÑOZ Alberto,CASTRO-PALOMINO LARIA Julio. Владелец: . Дата публикации: 2012-01-05.

SCELETIUM EXTRACT AND USES THEREOF

Номер патента: US20120004275A1. Автор: Gericke Nigel,Harvey Alan,Viljoen Alvaro,Hofmeyr Deon. Владелец: H.L. HALL & SONS LIMITED. Дата публикации: 2012-01-05.

Topical Lightening Composition and Uses Thereof

Номер патента: US20120003168A1. Автор: Lyga John W.,Santhanam Uma,Welsh William J.. Владелец: AVON PRODUCTS, INC.. Дата публикации: 2012-01-05.

CONCRETE SCAFFOLD CONTAINING BMP-2 AND MADE OF BONE POWDER AND FIBRIN GLUE

Номер патента: US20120003272A1. Автор: LEE Jun,Yoon Dong-Yyeon. Владелец: . Дата публикации: 2012-01-05.

METHOD FOR PRODUCING METHACRYLIC ACID

Номер патента: US20120004460A9. Автор: Protzmann Guido,Gropp Udo,Sohnemann Stefanie,Mertz Thomas. Владелец: Evonik Roehm GmbH. Дата публикации: 2012-01-05.

SUBSTITUTED 3,5-DIAMINO-4-SULFONYL-PYRAZOLES AND 2-AMINO-3-SULFONYL-PYRAZOLO-[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THEIR PRODUCTION AND USE

Номер патента: RU2376291C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Алла Хем, Ллс. Дата публикации: 2009-12-20.

TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES - SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS

Номер патента: RU2391343C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко,Володимир Михайлович Кисиль. Владелец: Алла Хем, Ллс. Дата публикации: 2010-06-10.

SUBSTITUTED 3-ARYLSULFONYL-PYRAZOLO[1,5-a]PYRIMIDINE-2,6-DIAMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS

Номер патента: RU2421456C1. Автор: Александр Васильевич Иващенко,Николай Филиппович Савчук,Андрей Александрович Иващенко. Владелец: Общество С Ограниченной Ответственностью "Инновационная Фармацевтика". Дата публикации: 2011-06-20.

Breast Cancer Vaccine

Номер патента: US20120003254A1. Автор: TUOHY Vincent K.. Владелец: . Дата публикации: 2012-01-05.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.